Processing 00000000.tx.1: A Novel RalGEF-like Protein, RGL3, as a Candidate Effector for Rit and Ras* Haipeng Shao and Douglas A. 

Phrase: "A Novel RalGEF-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0378212:RALGEF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1335588:RalGEF [Gene or Genome]
   861   C1706345:RalGEF [Gene or Genome]

Phrase: "like Protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "RGL3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "as"

Phrase: "a Candidate Effector for Rit"

Phrase: "and"

Phrase: "Ras* Haipeng Shao"

Phrase: "and"

Phrase: "Douglas A."
Processing 00000000.tx.2: Andres From the Department of Biochemistry, University of Kentucky College of Medicine, Lexington, Kentucky 40536-0230 Received for publication, March 17,2000, and in revised form, June 21,2000  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The small GTPase Rit is a close relative of Ras, and constitutively active Rit can induce oncogenic transformation. 

Phrase: "Andres From the Department of Biochemistry,"

Phrase: "University of Kentucky College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0557806:College [Manufactured Object]

Phrase: "Lexington,"

Phrase: "Kentucky 40536-0230"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0022557:Kentucky [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "March 17,"

Phrase: "2000,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "June 21,"

Phrase: "2000  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The small GTPase Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   827   C1419390:RIT [Gene or Genome]

Phrase: "is"

Phrase: "a close relative of Ras,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "and"

Phrase: "constitutively active Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   827   C1419390:RIT [Gene or Genome]

Phrase: "can"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "oncogenic transformation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040682:Transformation [Cell Function]
   861   C1510411:Transformation [Pathologic Function]
   861   C1705163:Transformation [Research Activity]
Processing 00000000.tx.3: Although the effector loops of Rit and Ras are highly related, Rit fails to interact with the majority of the known Ras candidate effector proteins, suggesting that novel cellular targets may be responsible for Rit transforming activity. 

Phrase: "Although"

Phrase: "the effector"

Phrase: "loops of Rit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0181687:loops [Medical Device]
   790   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   790   C0419518:Loop [Medical Device]
   790   C0445022:Loop [Spatial Concept]
   790   C1419390:RIT [Gene or Genome]

Phrase: "and"

Phrase: "Ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "are"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: ","

Phrase: "Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with the majority of the known Ras candidate effector proteins,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   754   C0242853:ras Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0034678:RAS [Gene or Genome]
   738   C0205309:Known [Qualitative Concept]
   738   C0680220:majority [Social Behavior]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that novel cellular targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521840:Target [Functional Concept]
   793   C2986546:TARGET [Diagnostic Procedure]

Phrase: "may"

Phrase: "be"

Phrase: "responsible for Rit transforming activity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]
Processing 00000000.tx.4: To gain insight into the cellular function of Rit, we searched for Rit-binding proteins by yeast two-hybrid screening. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "gain"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "insight into the cellular function of Rit,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0233820:Insight, function [Mental Process]
           Insight

Phrase: "we"

Phrase: "searched for Rit-binding proteins"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781 E C0033618:Protein Binding [Molecular Function]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0243122:binding [Functional Concept]
   760   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1419390:RIT [Gene or Genome]
   760   C1706202:Searched [Activity]
   726 E C1552603:search [Intellectual Product]

Phrase: "by yeast two-hybrid screening."
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   861   C0599647:Two Hybrid [Molecular Biology Research Technique]
   812   C0020205:Hybrid [Organism]
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0205448:Two [Quantitative Concept]
   812   C0220908:Screening [Health Care Activity]
   812   C0220909:screening [Functional Concept]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   812   C1698960:screening [Intellectual Product]
   812   C1710031:Screening [Diagnostic Procedure]
   812   C1710477:SCREENING [Research Activity]
   779 E C1305399:screen [Functional Concept]
   779 E C1705053:Screen [Medical Device]
Processing 00000000.tx.5: We identified the C-terminal Rit/Ras interaction domain of a protein we have designated RGL3 (Ral GEF-like 3) that shares 35% sequence identity with the known Ral guanine nucleotide exchange factors (RalGEFs). 

Phrase: "We"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "the C-terminal Rit/Ras interaction domain of a protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   777   C1956034:Protein Interaction Domain [Spatial Concept]
   757   C0162808:Protein Domain [Spatial Concept]
   757   C1514562:Protein Domain [Amino Acid Sequence]
   739   C1880389:Domain [Functional Concept]
   739   C1883221:Domain [Conceptual Entity]
   739   C3541951:Domain [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "designated RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428955:RGL3 [Gene or Genome]

Phrase: "(Ral GEF-like 3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0120465:GEF [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1149049:GEF [Molecular Function]
   770   C1423839:GEF [Gene or Genome]
   770   C3539611:GEF [Gene or Genome]

Phrase: ")"

Phrase: "that"

Phrase: "shares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "35% sequence identity with the known Ral guanine nucleotide exchange factors (RalGEFs)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0424215:Identity [Mental Process]
   738   C2003939:Identity [Finding]
Processing 00000000.tx.6: RGL3, through a C-terminal 99-amino acid domain, interacted in a GTP- and effector loop-dependent manner with Rit and Ras. 

Phrase: "RGL3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "through a C-terminal 99-amino acid domain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C1880389:Domain [Functional Concept]
   795   C1883221:Domain [Conceptual Entity]
   795   C3541951:Domain [Intellectual Product]
   708   C1707271:C-Terminal Amino Acid [Amino Acid Sequence]

Phrase: "interacted in a GTP-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "effector loop-dependent manner with Rit"

Phrase: "and"

Phrase: "Ras."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]
Processing 00000000.tx.7: Importantly, RGL3 exhibited guanine nucleotide exchange activity toward the small GTPase Ral that was stimulated in vivo by the expression of either activated Rit or Ras. 

Phrase: "Importantly,"

Phrase: "RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "guanine nucleotide exchange activity toward the small GTPase Ral"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C1149036:GTPase activity [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "was"

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "in vivo by the expression of either activated Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "or"

Phrase: "Ras."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]
Processing 00000000.tx.8: These data suggest that RGL3 functions as an exchange factor for Ral and may serve as a downstream effector for both Rit and Ras.  

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "functions as an exchange factor"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0120465:exchange factor [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0678640:exchange [Social Behavior]
   760   C0700205:FUNCTION [Classification]
   760   C1521761:Factor [Functional Concept]
   760   C1705273:Function [Intellectual Product]
   760   C2827422:Factor [Conceptual Entity]

Phrase: "for Ral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812284:RAL [Gene or Genome]
  1000   C1704992:RAL [Gene or Genome]

Phrase: "and"

Phrase: "may"

Phrase: "serve as a downstream effector"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522506:Downstream [Spatial Concept]

Phrase: "for both Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "and"

Phrase: "Ras."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]
Processing 00000000.tx.9: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Members of the Ras superfamily of monomeric GTPases function as binary molecular switches to control a wide variety of cellular processes including proliferation, differentiation, nuclear transport, cytoskeleton organization, and vesicular transport (1-3). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Members of the Ras superfamily of monomeric GTPases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0680022:members [Population Group]
   711 E C2698041:Member [Professional or Occupational Group]

Phrase: "function as binary molecular switches to"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C1148560:molecular function [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1705273:Function [Intellectual Product]
   753   C1706942:Binary [Qualitative Concept]
   753   C1707719:SWITCHES [Manufactured Object]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "a wide variety of cellular processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1883525:Variety [Conceptual Entity]
   753   C2346866:Variety [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "proliferation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "nuclear transport,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0872070:Nuclear Transport [Cell Function]
  1000   C1526989:nuclear transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "cytoskeleton organization,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155964:cytoskeleton organisation [Cell Function]
   861   C0029237:Organisation [Physiologic Function]
   861   C0029246:Organization [Organization]
   861   C0220885:organization [Qualitative Concept]
   861   C1300196:Organization [Functional Concept]
   861   C1522486:Organization [Professional or Occupational Group]

Phrase: "and"

Phrase: "vesicular transport"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1325417:vesicular transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "(1-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.10: They share the ability to cycle between inactive GDP- and active GTP-bound structural states. 

Phrase: "They"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "the ability to cycle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "between inactive GDP-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "active GTP-bound structural states."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   881   C0679217:active state [Finding]
   804   C1301808:states [Geographic Area]
   771 E C1442792:State [Functional Concept]
   771 E C3148680:State [Geographic Area]
Processing 00000000.tx.11: In the active GTP-bound state Ras-related proteins interact with a variety of cellular targets to elicit their biological effects (4). 

Phrase: "In the active GTP-bound state Ras-related proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   834   C1335596:ras-related protein [Gene or Genome]
   834   C1335599:Ras-Related Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   834   C1704396:RAS-Related Protein [Amino Acid, Peptide, or Protein,Enzyme]
   829   C0242853:ras Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "interact with a variety of cellular targets to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0007634:Cellular [Cell]
   744   C0178539:Cellular [Functional Concept]
   744   C1883525:Variety [Conceptual Entity]
   744   C2346866:Variety [Conceptual Entity]
   711   C1521840:Target [Functional Concept]
   711   C2986546:TARGET [Diagnostic Procedure]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "their biological effects"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0205460:biological [Qualitative Concept]
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.12: This cycle is tightly controlled in vivo by two classes of regulatory proteins. 

Phrase: "This cycle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511572:Cycle [Temporal Concept]

Phrase: "is"

Phrase: "tightly"

Phrase: "controlled"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C2587213:Controlled [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "in vivo by two classes of regulatory proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.13: Activation, through the dissociation of bound GDP and subsequent binding of GTP, is catalyzed by guanine nucleotide exchange factors (GEFs)1 (5). 

Phrase: "Activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "through the dissociation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "of bound GDP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "subsequent binding of GTP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1149035:GTP Binding [Molecular Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "catalyzed by guanine nucleotide exchange factors"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   882   C0120465:Guanine Nucleotide Exchange Factors [Amino Acid, Peptide, or Protein,Enzyme]
           exchange factor
   790   C0018328:guanine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0678640:exchange [Social Behavior]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "(GEFs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0120465:GEF [Amino Acid, Peptide, or Protein,Enzyme]
   966   C1149049:GEF [Molecular Function]
   966   C1423839:GEF [Gene or Genome]
   966   C3539611:GEF [Gene or Genome]

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.14: Return to the inactive state is stimulated by GTPase-activating proteins that promote rapid hydrolysis (6), thus completing the cycle. 

Phrase: "Return to the inactive state"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332156:Return to [Qualitative Concept]
           Return

Phrase: "is"

Phrase: "stimulated by GTPase-activating proteins"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   862   C0061928:GTPase-Activating Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   851 E C1419277:GTPase-ACTIVATING PROTEIN [Gene or Genome]
   851 E C2984553:GTPase-Activating Protein [Amino Acid, Peptide, or Protein]
   760   C0018296:GTPase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1879547:activating [Activity]
   760   C1948023:Stimulated [Natural Phenomenon or Process]
   726 E C1515877:Activate [Functional Concept]

Phrase: "that"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "rapid hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "(6"

Phrase: ")"

Phrase: ","

Phrase: "thus"

Phrase: "completing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205197:Complete [Qualitative Concept]

Phrase: "the cycle."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511572:Cycle [Temporal Concept]
Processing 00000000.tx.15: The prototypic Ras proteins, Ha-, Ki, and N-Ras, play a pivotal role in the control of cellular growth and differentiation through their interaction with a variety of cellular effectors that in turn activate downstream signaling pathways (1, 7, 8). 

Phrase: "The prototypic Ras proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0242853:ras Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Ha-,"

Phrase: "Ki,"

Phrase: "and"

Phrase: "N-Ras,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0809246:N-ras [Gene or Genome]
  1000   C1705519:N-RAS [Gene or Genome]
   861   C0034678:RAS [Gene or Genome]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a pivotal role in the control of cellular growth"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "differentiation through their interaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007589:Differentiation [Cell Function]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2945687:Differentiation [Functional Concept]

Phrase: "with a variety"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1883525:Variety [Conceptual Entity]
  1000   C2346866:Variety [Conceptual Entity]

Phrase: "of cellular effectors"

Phrase: "that in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "downstream signaling pathways"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0037080:Signal Pathways [Molecular Function]
   884   C0037083:signaling pathway [Cell Function]
   884   C0086982:Signaling Pathway [Molecular Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "7,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.16: The best characterized of the Ras effectors are the Raf family of serine-threonine kinases including Raf1, B-Raf, and A-Raf (9). 

Phrase: "The best"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1522427:Best [Qualitative Concept]
   966 E C0205170:Well [Qualitative Concept]
   966 E C3146287:Well [Manufactured Object]

Phrase: "characterized of the Ras effectors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0034678:RAS [Gene or Genome]
   760   C1880022:Characterized [Activity]

Phrase: "are"

Phrase: "the Raf family of serine-threonine kinases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0031727:Kinase Family [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0015576:Family [Family Group]
   748   C1704727:Family [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Raf1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0139905:RAF1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812215:RAF1 [Gene or Genome]

Phrase: "B-Raf,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0104940:b-raf [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1425569:RAF [Gene or Genome]
   861   C1706586:RAF [Gene or Genome]
   861   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "A-Raf (9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1425569:RAF [Gene or Genome]
   827   C1706586:RAF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.17: Once activated by Ras-GTP, through a mechanism that is incompletely understood, Raf kinases trigger a cascade of protein kinases that results in the activation of extracellular signal-regulated kinases 1and 2(10). 

Phrase: "Once"

Phrase: "activated by Ras-GTP,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0034678:RAS [Gene or Genome]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "through a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "is"

Phrase: "incompletely"

Phrase: "understood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]

Phrase: ","

Phrase: "Raf kinases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1449849:raf Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1425569:RAF [Gene or Genome]
   861   C1706586:RAF [Gene or Genome]

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "a cascade of protein kinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1155502:protein kinase cascade [Molecular Function]
   760   C1707310:Cascade [Manufactured Object]

Phrase: "that"

Phrase: "results in the activation of extracellular signal-regulated kinases 1and 2"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   797   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   797   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   796   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   796   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   738   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0521119:Extracellular [Cell Component]
   738   C0851285:Regulated [Governmental or Regulatory Activity]
   738   C1274040:Result [Functional Concept]
   738   C1546471:Result [Idea or Concept]
   738   C1710082:Signal [Phenomenon or Process]
   738   C1879547:Activation [Activity]
   738   C2825142:Result [Finding]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.18: Ras-mediated extracellular signal-regulated kinase activation leads to the stimulation of various transcription factors that regulate the expression of genes involved in proliferation and oncogenesis (9, 11, 12). 

Phrase: "Ras-mediated extracellular signal-regulated kinase activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1879547:Activation [Activity]

Phrase: "leads to the stimulation of various transcription factors"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   770   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0040649:Transcription [Genetic Function]
   744   C0181586:leads [Medical Device]
   744   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   744   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C1948023:Stimulation [Natural Phenomenon or Process]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
   711   C1521761:Factor [Functional Concept]
   711   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "regulate"

Phrase: "the expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0017262:Gene Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "involved in proliferation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0334094:Proliferation [Pathologic Function]
   790   C1314939:Involved [Functional Concept]
   790   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "oncogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007621:Oncogenesis [Neoplastic Process]
  1000   C0596263:Oncogenesis [Neoplastic Process]

Phrase: "(9,"

Phrase: "11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.19: Whereas the Raf/extracellular signal-regulated kinase pathway is a central downstream signaling pathway activated by Ras, recent studies have established that Raf-independent pathways are also required for Ras function. 

Phrase: "Whereas"

Phrase: "the Raf/extracellular signal-regulated kinase pathway"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C0037080:Signal Pathway [Molecular Function]
   799   C1704259:Pathway [Molecular Function]
   799   C1705987:Pathway [Conceptual Entity]
   713   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   713   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a central downstream signaling pathway"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0037083:signaling pathway [Cell Function]
   861   C0086982:Signaling Pathway [Molecular Function]
   844 E C0037080:Signal Pathway [Molecular Function]
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]

Phrase: "activated by Ras,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0034678:RAS [Gene or Genome]
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that Raf-independent pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "are"

Phrase: "also"

Phrase: "required for Ras function."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0031843:function [Physiologic Function]
   770   C0034678:RAS [Gene or Genome]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1514873:Required [Functional Concept]
   770   C1705273:Function [Intellectual Product]
Processing 00000000.tx.20: Due in large part to yeast two-hybrid screening analysis, an expanding number of potential Ras effectors have been identified (reviewed in Ref. 1). 

Phrase: "Due in large part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0678226:due [Functional Concept]
   770   C3146286:Due [Idea or Concept]

Phrase: "to yeast two-hybrid screening analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]

Phrase: "an expanding number of potential Ras effectors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "("

Phrase: "reviewed in Ref. 1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0140145:REF-1 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1332102:REF-1 [Gene or Genome]
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.21: Although these proteins do not share obvious sequence similarity, they each bind Ras in a manner that requires an intact effector region and is GTP-dependent. 

Phrase: "Although"

Phrase: "these proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "obvious sequence similarity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1710052:Sequence Similarity [Quantitative Concept]
   827   C2348205:Similarity [Qualitative Concept]

Phrase: "they"

Phrase: "each"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "Ras in a manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0034678:RAS [Gene or Genome]

Phrase: "that"

Phrase: "requires"

Phrase: "an intact effector region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "is"

Phrase: "GTP-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "dependent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]
Processing 00000000.tx.22: Evidence has been presented recently that in addition to the Raf kinases, Ras can activate RalGEF proteins, which serve as guanine nucleotide exchange factors for the Ras-like GTPase Ral (1, 13), and phosphatidylinositol 3-kinase (PI-3K) (14), which leads to the activation of both Rho family GTPases (3) and the protein kinase AKT (15, 16). 

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "that in addition to the Raf kinases,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1449849:raf Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1425569:RAF [Gene or Genome]
   748   C1706586:RAF [Gene or Genome]
   748   C1883712:Addition [Functional Concept]

Phrase: "Ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "RalGEF proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "serve as guanine nucleotide exchange factors"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   882   C0120465:Guanine Nucleotide Exchange Factors [Amino Acid, Peptide, or Protein,Enzyme]
           exchange factor
   790   C0018328:guanine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0678640:exchange [Social Behavior]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "for the Ras-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "like GTPase Ral (1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0018296:GTPase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812284:RAL [Gene or Genome]
   827   C1704992:RAL [Gene or Genome]

Phrase: "13"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "phosphatidylinositol 3-kinase (PI-3K)"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "leads to the activation of both Rho family GTPases"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C2246181:Rho GTPase activation [Organism Function]
   762   C0174045:rho GTPases [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0015576:Family [Family Group]
   742   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   742   C0181586:leads [Medical Device]
   742   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   742   C1522538:Lead [Functional Concept]
   742   C1704727:Family [Conceptual Entity]
   742   C1879547:Activation [Activity]
   742   C2348269:Lead [Element, Ion, or Isotope]
   742   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "the protein kinase AKT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]
   734   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(15,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.23: Studies with Ras effector loop mutants suggest that Ras-mediated cellular transformation requires the activation of at least two of these three known cellular pathways (Raf, RalGDSs, and PI-3K) (1). 

Phrase: "Studies with Ras effector loop mutants"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Ras-mediated cellular transformation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1510411:Cellular Transformation [Pathologic Function]
           Transformation
   812   C0040682:Transformation [Cell Function]
   812   C1705163:Transformation [Research Activity]

Phrase: "requires"

Phrase: "the activation of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "at least two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205448:Two [Quantitative Concept]

Phrase: "of these three known cellular pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]

Phrase: "(Raf,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425569:RAF [Gene or Genome]
  1000   C1706586:RAF [Gene or Genome]

Phrase: "RalGDSs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0378212:ralGDS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966   C1335588:RALGDS [Gene or Genome]

Phrase: "and"

Phrase: "PI-3K"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.24: Therefore, Ras exerts its cellular functions through the activation of numerous effector pathways. 

Phrase: "Therefore,"

Phrase: "Ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "its cellular functions through the activation of numerous effector pathways."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   743   C0007613:Cellular Function [Cell Function]
   741   C1321099:Activation function [Physiologic Function]
   739   C0542341:Functions [Functional Concept]
   706 E C0031843:function [Physiologic Function]
   706 E C0700205:FUNCTION [Classification]
   706 E C1705273:Function [Intellectual Product]
Processing 00000000.tx.25: We recently identified two novel Ras-related GTPases, Rit and Rin (17), that share ~50% sequence identity with Ras. 

Phrase: "We recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "two novel Ras-related GTPases,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0751983:ras-Related GTPases [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "and"

Phrase: "Rin (17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419388:RIN [Gene or Genome]
   861   C1882531:RIN [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "that"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "~50% sequence identity with Ras."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0424215:Identity [Mental Process]
   760   C2003939:Identity [Finding]
Processing 00000000.tx.26: We found that stable expression of constitutively active Rit (Rit79L), but not activated Rin, induces strong growth transformation to NIH3T3 cells.2 Rit79L-transformed cells proliferate in low serum, form colonies in soft agar, and form tumors in nude mice similar to that of the analogous Ha-Ras61L oncogenic mutant. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that stable expression of constitutively active Rit (Rit79L"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not activated Rin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1419388:RIN [Gene or Genome]
   827   C1882531:RIN [Qualitative Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "strong growth transformation to NIH3T3 cells.2 Rit79L-transformed cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   741   C0040682:cell transformation [Cell Function]
           Transformation
   741   C1510411:Cell Transformation [Pathologic Function]
           Transformation
   739   C1705163:Transformation [Research Activity]

Phrase: "proliferate in low serum,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205251:low [Qualitative Concept]
   770   C0229671:Serum [Body Substance]
   770   C1299352:Low [Qualitative Concept]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]
   770   C1550472:low [Idea or Concept]

Phrase: "form colonies in soft agar,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439158:colonies [Quantitative Concept]
   726 E C1947989:Colony [Cell]

Phrase: "and"

Phrase: "form tumors in nude mice"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0027651:Tumors [Neoplastic Process]
   726 E C1578706:Tumor [Intellectual Product]
   726 E C3273930:Tumor [Finding]

Phrase: "similar to that of the analogous Ha-Ras61L oncogenic mutant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.27: Furthermore, Rit79L stimulates transcription from reporter constructs controlled by minimal promoters containing recognition sites for SRF, NF-B, Elk, and Jun. 

Phrase: "Furthermore,"

Phrase: "Rit79L"

Phrase: "stimulates"

Phrase: "transcription from reporter constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040649:Transcription [Genetic Function]

Phrase: "controlled by minimal promoters"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   833   C0332298:Controlled by [Functional Concept]
   770   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0547040:Minimal [Qualitative Concept]
   770   C1524031:MINIMAL [Qualitative Concept]
   770   C2587213:Controlled [Functional Concept]
   770   C2945599:Minimal [Qualitative Concept]
   737 E C0243148:control [Qualitative Concept]
   737 E C1550141:Control [Substance]
   737 E C1882979:Control [Conceptual Entity]
   737 E C3274648:Control [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "recognition sites for SRF,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205145:Sites [Spatial Concept]
   770   C0524637:Recognition [Mental Process]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "NF-B,"

Phrase: "Elk,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325228:Elk [Mammal]

Phrase: "and"

Phrase: "Jun."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.28: However, no activation of extracellular signal-regulated kinase, c-Jun N-terminal kinase, or p38, or of PI-3K/Akt/PKB kinases was observed. 

Phrase: "However,"

Phrase: "no activation of extracellular signal-regulated kinase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1879547:Activation [Activity]

Phrase: "c-Jun N-terminal kinase,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0248813:c-jun N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0380051:c-JUN N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   937   C1367731:JUN N-terminal kinase [Gene or Genome]
   911   C0872123:c JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1334482:Jun kinase [Gene or Genome]
   875   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1707271:C-Terminal [Amino Acid Sequence]
   840   C0162508:c-Jun [Gene or Genome]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0205088:Terminal [Temporal Concept]
   804   C1553033:[c] [Quantitative Concept]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]
   804   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "p38,"

Phrase: "or of PI-3K/Akt/PKB kinases"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   800   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   772 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0541150:PKB Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   767   C1335204:PkB kinase [Gene or Genome]
   744   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0812228:AKT [Gene or Genome]
   744   C2348046:Phosphatidylinositol [Lipid]

Phrase: "was"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.29: The high degree of amino acid conservation between the effector loops of Ras and Rit when combined with the ability of activated Rit to transform NIH3T3 cells raised the possibility that Rit-dependent cellular transformation might be mediated in part by the activation of known Ras effector proteins. 

Phrase: "The high degree of amino acid conservation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0441889:Degree [Qualitative Concept]
   748   C0449286:Degree [Quantitative Concept]
   748   C0542560:Degree [Intellectual Product]
   748   C1561545:degree [Quantitative Concept]
   748   C2348088:Degree [Quantitative Concept]

Phrase: "between the effector"

Phrase: "loops of Ras"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034678:RAS [Gene or Genome]
   790   C0181687:loops [Medical Device]
   790   C0419518:Loop [Medical Device]
   790   C0445022:Loop [Spatial Concept]

Phrase: "and"

Phrase: "Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "when"

Phrase: "combined with the ability of activated Rit to"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   744   C0085732:Ability [Organism Attribute]
   744   C0205195:Combined [Qualitative Concept]
   744   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   744   C1419390:RIT [Gene or Genome]
   744   C1879547:Activated [Activity]
   711 E C0336789:Combine [Manufactured Object]
   711 E C1515877:Activate [Functional Concept]

Phrase: "transform"

Phrase: "NIH3T3 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "raised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442818:Raised [Quantitative Concept]

Phrase: "the possibility"

Phrase: "that Rit-dependent cellular transformation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1510411:Cellular Transformation [Pathologic Function]
           Transformation
   812   C0040682:Transformation [Cell Function]
   812   C1705163:Transformation [Research Activity]

Phrase: "might"

Phrase: "be"

Phrase: "mediated in part"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of known Ras effector proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0242853:ras Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.30: However, a combination of biochemical and yeast two-hybrid studies suggest that Rit may interact with only a limited subset of the known Ras-binding proteins, including Ral exchange factors and AF-6 (17). 

Phrase: "However,"

Phrase: "a combination of biochemical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205195:Combination [Qualitative Concept]
   770   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "yeast two-hybrid studies"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   861   C0599647:Two Hybrid [Molecular Biology Research Technique]
   812   C0020205:Hybrid [Organism]
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0205448:Two [Quantitative Concept]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "may"

Phrase: "interact with only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205171:Only [Quantitative Concept]
   790   C1720467:Only [Intellectual Product]

Phrase: "a limited subset of the known Ras-binding proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1515021:Subset [Classification]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Ral exchange factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   867   C0120465:exchange factor [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0678640:exchange [Social Behavior]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "AF-6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334516:AF-6 [Gene or Genome]
  1000   C1706479:AF-6 [Gene or Genome]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.31: Taken together these results suggest that Rit might use unique signaling pathways to regulate cellular proliferation and transformation. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "might"

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "unique signaling pathways to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C0037080:Signal Pathways [Molecular Function]
   844   C0037083:signaling pathway [Cell Function]
   844   C0086982:Signaling Pathway [Molecular Function]
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]

Phrase: "regulate"

Phrase: "cellular proliferation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020507:Cellular proliferation [Pathologic Function]
  1000   C0596290:Cellular Proliferation [Cell Function]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "transformation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040682:Transformation [Cell Function]
  1000   C1510411:Transformation [Pathologic Function]
  1000   C1705163:Transformation [Research Activity]
Processing 00000000.tx.32: In order to elucidate the signal transduction pathway(s) utilized by Rit, the yeast two-hybrid system was used to isolate Rit-binding proteins. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "elucidate"

Phrase: "the signal transduction pathway"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0086982:Signal Transduction Pathway [Molecular Function]
   913   C0037080:Signal Pathway [Molecular Function]
   901   C0037083:Signal Transduction [Cell Function]
   827   C1160185:transduction [Organism Function]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "("

Phrase: "s)"

Phrase: "utilized by Rit,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   790   C1419390:RIT [Gene or Genome]

Phrase: "the yeast two-hybrid system"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0599647:Yeast Two Hybrid System [Molecular Biology Research Technique]
           Two Hybrid
  1000   C1961118:Yeast Two-Hybrid System [Molecular Biology Research Technique]
   812   C0020205:Hybrid [Organism]
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0205448:Two [Quantitative Concept]
   812   C0449913:System [Functional Concept]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "isolate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370215:Isolate [Substance]
  1000   C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "Rit-binding proteins."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
Processing 00000000.tx.33: This screen identified clones encoding a new member of the growing family of RalGEFs that we have termed RGL3 (Ral GDS-like 3). 

Phrase: "This screen identified clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0009013:Clones [Cell]
   793 E C1522642:Clone [Tissue]
   743 E C1704387:Clonal [Qualitative Concept]
   721 E C0796368:clonality [Diagnostic Procedure]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a new member of the growing family of RalGEFs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   749   C0086282:Family member [Family Group]
   749   C1611821:Family Member [Intellectual Product]
   735   C0680022:member [Population Group]
   735   C2698041:Member [Professional or Occupational Group]

Phrase: "that"

Phrase: "we"

Phrase: "have"

Phrase: "termed RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428955:RGL3 [Gene or Genome]

Phrase: "(Ral GDS-like 3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0378212:ral-GDS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0451184:GDS [Intellectual Product]
   770   C0812284:RAL [Gene or Genome]
   770   C1149049:GDS [Molecular Function]
   770   C1418244:GdS [Gene or Genome]
   770   C1704992:RAL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.34: In this study, we show that RGL3 interacts with GTP-bound Ras and Rit in an effector loop-dependent manner. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "interacts with GTP-bound Ras"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0034678:RAS [Gene or Genome]
   760   C0332297:bound [Spatial Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "and"

Phrase: "Rit in an effector loop-dependent manner."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   748   C1419390:RIT [Gene or Genome]
Processing 00000000.tx.35: In addition, evidence is presented demonstrating that RGL3 is a Ral exchange factor whose in vivo GEF activity is stimulated by GTP-bound Rit and Ras. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "is"

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "demonstrating"

Phrase: "that RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "is"

Phrase: "a Ral exchange factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0120465:exchange factor [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0678640:exchange [Social Behavior]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "whose in vivo GEF activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "stimulated by GTP-bound Rit"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   762   C0332297:Bounded by [Spatial Concept]
           bound
   760   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1419390:RIT [Gene or Genome]
   760   C1689898:% bound [Quantitative Concept]
   760   C1948023:Stimulated [Natural Phenomenon or Process]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "and"

Phrase: "Ras."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]
Processing 00000000.tx.36: Expression of activated Rit in HEK293 cells caused an increase in GTP-bound Ral levels and provides the first evidence for a potential link between the Rit and Ral signal transduction pathways. 

Phrase: "Expression of activated Rit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "an increase in GTP-bound Ral levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "the first evidence for a potential link"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332120:Evidence [Functional Concept]

Phrase: "between the Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "and"

Phrase: "Ral signal transduction pathways."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0086982:Signal Transduction Pathways [Molecular Function]
   875   C0037080:Signal Pathways [Molecular Function]
   861   C0037083:Signal Transduction [Cell Function]
   812   C1160185:transduction [Organism Function]
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]
   812   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.37: Therefore, the results of this study demonstrate that RGL3 is an exchange factor for Ral GTPases that may represent a downstream binding target for both the Rit and Ras GTPases.  

Phrase: "Therefore,"

Phrase: "the results of this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results study [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "is"

Phrase: "an exchange factor for Ral GTPases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0120465:exchange factor [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0678640:exchange [Social Behavior]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a downstream binding target for both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1521840:Target [Functional Concept]
   753   C2986546:TARGET [Diagnostic Procedure]

Phrase: "the Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "and"

Phrase: "Ras GTPases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0034678:RAS [Gene or Genome]
Processing 00000000.tx.38: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Two-hybrid Screen-- The mouse embryo two-hybrid cDNA library (18) in pVP16 (LEU2, ampr) was obtained from Dr. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Two-hybrid Screen"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0599647:Two Hybrid [Molecular Biology Research Technique]
   827   C0020205:Hybrid [Organism]
   827   C0205448:Two [Quantitative Concept]
   827   C0220908:screen [Health Care Activity]
   827   C1305399:screen [Functional Concept]
   827   C1705053:Screen [Medical Device]

Phrase: "-"

Phrase: "-"

Phrase: "The mouse embryo two-hybrid cDNA library"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   799   C0023621:Library [Manufactured Object,Organization]
   799   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(18"

Phrase: ")"

Phrase: "in pVP16"

Phrase: "(LEU2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1333223:LEU2 [Gene or Genome]
  1000   C1705129:LEU2 [Gene or Genome]
  1000   C1861281:LEU2 [Gene or Genome]
  1000   C3540595:Leu2 [Gene or Genome]

Phrase: "ampr"

Phrase: ")"

Phrase: "was"

Phrase: "obtained from Dr."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1301820:Obtained [Functional Concept]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.39: Michael White (University of Texas Southwestern Medical Center, Dallas). 

Phrase: "Michael White"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007457:White [Population Group]
   861   C0043157:White [Population Group]
   861   C0220938:White [Qualitative Concept]

Phrase: "(University of Texas Southwestern Medical Center,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   904   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   827   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   827   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   799   C0039711:Texas [Geographic Area]
   799   C0041740:University [Manufactured Object,Organization]
   799   C0205099:Center [Spatial Concept]
   799   C0205476:Medical [Functional Concept]
   799   C1710136:Southwestern [Spatial Concept]

Phrase: "Dallas"

Phrase: ")."
Processing 00000000.tx.40: The yeast two-hybrid vectors pGBDC1-3 (TRP1, ampr), pGADC1-3 (LEU2, ampr), and the Saccharomyces cerevisiae strain PJ69-4A was provided by Dr. 

Phrase: "The yeast two-hybrid vectors pGBDC1-3"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   827   C0599647:Two Hybrid [Molecular Biology Research Technique]
   799   C0020205:Hybrid [Organism]
   799   C0036025:yeast [Fungus]
   799   C0043392:Yeast [Food]
   799   C0043393:Yeast [Fungus]
   799   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0205448:Two [Quantitative Concept]
   799   C0442335:Vectors [Spatial Concept]
   799   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   766 E C1705099:Vector [Idea or Concept]

Phrase: "(TRP1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0700256:trp 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1421165:TRP1 [Gene or Genome]
  1000   C1421168:TRP1 [Gene or Genome]

Phrase: "ampr"

Phrase: ")"

Phrase: ","

Phrase: "pGADC1-3"

Phrase: "(LEU2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1333223:LEU2 [Gene or Genome]
  1000   C1705129:LEU2 [Gene or Genome]
  1000   C1861281:LEU2 [Gene or Genome]
  1000   C3540595:Leu2 [Gene or Genome]

Phrase: "ampr"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the Saccharomyces cerevisiae strain PJ69-4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0450373:4a [Intellectual Product]
   804   C1553636:4a [Medical Device]

Phrase: "was"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.41: Philip James (University of Wisconsin, Madison) (19). 

Phrase: "Philip James"

Phrase: "(University of Wisconsin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041740:University [Manufactured Object,Organization]
   827   C0043193:Wisconsin [Geographic Area]

Phrase: "Madison"

Phrase: ")"

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.42: For library screening, the yeast reporter stain PJ69-4A transformed with a bait plasmid that expressed a fusion between the GAL4 DNA binding domain and wild type Rit deleted of its C-terminal 18amino acids was grown in synthetic minimal media lacking tryptophan. 

Phrase: "For library screening,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0220908:Screening [Health Care Activity]
   861   C0220909:screening [Functional Concept]
   861   C1698960:screening [Intellectual Product]
   861   C1710031:Screening [Diagnostic Procedure]
   861   C1710477:SCREENING [Research Activity]

Phrase: "the yeast reporter stain PJ69-4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0450373:4a [Intellectual Product]
   804   C1553636:4a [Medical Device]

Phrase: "transformed with a bait plasmid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1510411:Transformed [Pathologic Function]

Phrase: "that"

Phrase: "expressed"

Phrase: "a fusion between the GAL4 DNA binding domain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332466:Fusion [Functional Concept]
   744   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "wild type Rit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   827   C1419390:RIT [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "deleted of its C-terminal 18amino acids"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C1707271:C-Terminal [Amino Acid Sequence]
   748   C0001128:Acids [Chemical]
   748   C0205088:Terminal [Temporal Concept]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]
   748   C1880274:Deleted [Activity]
   714 E C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "grown in synthetic minimal media"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C0547040:Minimal [Qualitative Concept]
   760   C1254021:Media [Tissue]
   760   C1524031:MINIMAL [Qualitative Concept]
   760   C1883254:synthetic [Activity]
   760   C2945599:Minimal [Qualitative Concept]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "tryptophan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041249:Tryptophan [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.43: Preliminary studies indicated that a Gal4-Rit fusion bearing a C-terminal deletion in Rit was more efficiently imported to the nucleus (data not shown). 

Phrase: "Preliminary studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0439611:Preliminary [Temporal Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "a Gal4-Rit fusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "a C-terminal deletion in Rit"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1707271:C-Terminal [Amino Acid Sequence]
   753   C0205088:Terminal [Temporal Concept]
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   753   C1880274:Deletion [Activity]

Phrase: "was"

Phrase: "more efficiently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "imported to the nucleus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0887839:nucleus import [Cell Function]
   770   C0007610:Nucleus [Cell Component]
   770   C0699788:Imported [Occupational Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.44: Yeast cells were made competent and transformed with 1mg of the mouse-cDNA library in the presence of sheared carrier DNA as described (17). 

Phrase: "Yeast cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C2700289:Yeast Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "competent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086035:Competent [Qualitative Concept]

Phrase: "and"

Phrase: "transformed with 1mg of the mouse-cDNA library"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   744   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0023621:Library [Manufactured Object,Organization]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C1510411:Transformed [Pathologic Function]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of sheared carrier DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.45: After recovery, approximately 1107 primary transformants were selected for growth at 30C for 15days on synthetic media lacking tryptophan, leucine, adenine, and histidine and containing 2mM 3-aminotriazole. 

Phrase: "After recovery,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237820:Recovery [Activity]
  1000   C1555688:recovery [Idea or Concept]
  1000   C2004454:Recovery [Organism Function]

Phrase: "approximately 1107 primary transformants"

Phrase: "were"

Phrase: "selected for growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0018270:'growth' NOS [Organism Function]
   790   C0220844:growth [Physiologic Function]
   790   C1621966:Growth [Organ or Tissue Function]
   790   C2911660:Growth [Activity]
   756   C1707391:Select [Activity]

Phrase: "at 30C"

Phrase: "for 15days"

Phrase: "on synthetic media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "tryptophan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041249:Tryptophan [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "leucine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "adenine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "histidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "containing 2mM 3-aminotriazole."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002602:Aminotriazole [Hazardous or Poisonous Substance,Organic Chemical]
Processing 00000000.tx.46: Surviving colonies were streaked onto synthetic minimal media lacking tryptophan and leucine and containing 80mg/liter 5-bromo-4-chloro-3-indolyl--D-galactoside (X-Gal) to test for -galactosidase expression. 

Phrase: "Surviving colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439158:colonies [Quantitative Concept]
   827 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "streaked onto synthetic minimal media"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C0547040:Minimal [Qualitative Concept]
   760   C1254021:Media [Tissue]
   760   C1524031:MINIMAL [Qualitative Concept]
   760   C1883254:synthetic [Activity]
   760   C2945599:Minimal [Qualitative Concept]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726   C2348542:Streak [Idea or Concept]
   726 E C3244283:medium [Intellectual Product]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "tryptophan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041249:Tryptophan [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "leucine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "containing 80mg/liter 5-bromo-4-chloro-3-indolyl"

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "galactoside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016956:galactoside [Carbohydrate]

Phrase: "(X-Gal) to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0049081:X-gal [Carbohydrate]

Phrase: "test for -galactosidase expression."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0392366:test [Intellectual Product]
Processing 00000000.tx.47: We obtained three independent groups (including four independent isolates of RGL3-RBD). 

Phrase: "We"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "three independent groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "four independent isolates of RGL3-RBD"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0370215:isolates [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.48: The pVP16 plasmids containing putative Rit-interacting cDNAs were rescued from yeast cells and transformed into Escherichia coli strain HB101. 

Phrase: "The pVP16 plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "putative Rit-interacting cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "rescued from yeast cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C2700289:Yeast Cells [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C0036025:yeast [Fungus]
   770   C0043392:Yeast [Food]
   770   C0043393:Yeast [Fungus]
   770   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "transformed into Escherichia coli strain HB101."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0014834:Escherichia coli [Bacterium]
   753   C0014833:Escherichia [Bacterium]
   753   C0080194:Strain [Injury or Poisoning]
   753   C0456178:strain [Intellectual Product]
   753   C1510411:Transformed [Pathologic Function]
   753   C1518614:Strain [Organism]
   753   C2987481:Strain [Mental Process]
Processing 00000000.tx.49: Those cDNAs that exhibited a Rit-dependent genotype upon retransformation were characterized further. 

Phrase: "Those cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "that"

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a Rit-dependent genotype upon retransformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017431:Genotype [Organism Attribute]

Phrase: "were"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "further."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]
Processing 00000000.tx.50: Two-hybrid Analysis of RGL3-RBD Interaction with Small GTP-binding Proteins-- For two-hybrid assays, competent PJ69-4A yeast were co-transformed with pVP16-RGL3-RBD and wild type or mutant small GTP-binding proteins as described previously (17). 

Phrase: "Two-hybrid Analysis of RGL3-RBD Interaction"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0599647:Two Hybrid [Molecular Biology Research Technique]
   762   C0237688:Interaction Analysis [Quantitative Concept]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0020205:Hybrid [Organism]
   742   C0205448:Two [Quantitative Concept]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "with Small GTP-binding Proteins"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   983   C1412506:small GTP binding protein [Gene or Genome]
   983   C1419270:small GTP binding protein [Gene or Genome]
   923   C0086376:GTP-Binding Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   890 E C1427594:GTP-binding protein [Gene or Genome]
   861   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1149035:GTP Binding [Molecular Function]
   812   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "-"

Phrase: "-"

Phrase: "For two-hybrid assays,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0752172:Two-Hybrid Assays [Molecular Biology Research Technique]
   901   C0599647:Two Hybrid [Molecular Biology Research Technique]
   827   C0020205:Hybrid [Organism]
   827   C0205448:Two [Quantitative Concept]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "competent PJ69-4A yeast"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "co-transformed with pVP16-RGL3-RBD"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   767   C2610644:CO binding [Molecular Function]
   744   C0243122:binding [Functional Concept]
   744   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1419390:RIT [Gene or Genome]
   744   C1428955:RGL3 [Gene or Genome]
   744   C1510411:Transformed [Pathologic Function]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "mutant small GTP-binding proteins"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   921   C1412506:small GTP binding protein [Gene or Genome]
   921   C1419270:small GTP binding protein [Gene or Genome]
   897   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   884   C0086376:GTP-Binding Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   851 E C1427594:GTP-binding protein [Gene or Genome]
   840   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1149035:GTP Binding [Molecular Function]
   804   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.51: The plasmids containing Ras-like small GTP-binding proteins (pGBT9-Ha-Ras, pGBT9-Rap1A, pGBT9-Rap1B, and pGBT9-RalA) were kindly provided by Dr. 

Phrase: "The plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "Ras-like small GTP-binding proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   809   C0812284:RAS-LIKE PROTEIN [Gene or Genome]
   783   C0242853:ras Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0034678:RAS [Gene or Genome]

Phrase: "(pGBT9-Ha-Ras,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034678:RAS [Gene or Genome]

Phrase: "pGBT9-Rap1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0967718:RAP1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1335590:RAP1A [Gene or Genome]

Phrase: "pGBT9-Rap1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419266:RAP1B [Gene or Genome]

Phrase: "and"

Phrase: "pGBT9-RalA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0765159:RALA [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812284:RALA [Gene or Genome]

Phrase: ")"

Phrase: "were"

Phrase: "kindly"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.52: Gilbert White (University of North Carolina, Chapel Hill) (20). 

Phrase: "Gilbert White"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007457:White [Population Group]
   861   C0043157:White [Population Group]
   861   C0220938:White [Qualitative Concept]

Phrase: "(University of North Carolina,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0028407:North Carolina [Geographic Area]
   812   C0041740:University [Manufactured Object,Organization]
   812   C1709269:North [Spatial Concept]

Phrase: "Chapel Hill"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442532:Hill [Spatial Concept]

Phrase: ")"

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.53: Transformants were plated on minimal synthetic medium lacking tryptophan and leucine. 

Phrase: "Transformants"

Phrase: "were"

Phrase: "plated on minimal synthetic medium lacking tryptophan"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   748   C0009458:Medium [Intellectual Product]
   748   C0041249:Tryptophan [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0332268:Lacking [Qualitative Concept]
   748   C0439536:Medium [Quantitative Concept]
   748   C0547040:Minimal [Qualitative Concept]
   748   C1524031:MINIMAL [Qualitative Concept]
   748   C1705217:Medium [Substance]
   748   C1883254:synthetic [Activity]
   748   C2945599:Minimal [Qualitative Concept]
   748   C3244283:medium [Intellectual Product]
   714   C0005971:Plate [Medical Device]
   714   C1139930:plate [Medical Device]
   714   C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "leucine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.54: Colonies were then streaked on plates containing 2mM 3-aminotriazole and lacking tryptophan, leucine, adenine, and histidine to assay for growth. 

Phrase: "Colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439158:colonies [Quantitative Concept]
   966 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "streaked on plates"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1139930:plates [Medical Device]
   756 E C0005971:Plate [Medical Device]
   756   C2348542:Streak [Idea or Concept]
   756 E C3537155:Plate [Manufactured Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "2mM 3-aminotriazole"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002602:Aminotriazole [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "and"

Phrase: "lacking tryptophan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041249:Tryptophan [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "leucine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "adenine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "histidine to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "assay for growth."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0005507:Assay [Laboratory Procedure]
   790   C0018270:'growth' NOS [Organism Function]
   790   C0220844:growth [Physiologic Function]
   790   C0243073:assay [Qualitative Concept]
   790   C1510438:Assay [Laboratory Procedure]
   790   C1621966:Growth [Organ or Tissue Function]
   790   C2911660:Growth [Activity]
Processing 00000000.tx.55: -Galactosidase activity was determined using the Luminescent -Galactosidase Detection Kit II (CLONTECH). 

Phrase: "-Galactosidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150051:galactosidase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Luminescent -Galactosidase Detection Kit II"

Phrase: "(CLONTECH"

Phrase: ")."
Processing 00000000.tx.56: The ability of pGBT9-RalA to interact with pVP16-RalBD was confirmed using this system (data not shown). 

Phrase: "The ability of pGBT9-RalA to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "interact with pVP16-RalBD"

Phrase: "was"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.57: cDNA Cloning and 5'-RACE of RGL3-- PCR was performed on pVP16-RGL3-Rit binding domain (RBD) to isolate the 99-amino acid C-terminal Rit-binding domain containing 5'-XbaI and 3'-HindIII restriction sites. 

Phrase: "cDNA Cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "5'-RACE of RGL3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0034510:Race [Population Group]
   770   C1706779:RACE [Gene or Genome]

Phrase: "--"

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "performed on pVP16-RGL3-Rit binding domain (RBD) to"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   744   C0243122:binding [Functional Concept]
   744   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   744   C0884358:Performed [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1419390:RIT [Gene or Genome]
   744   C1428955:RGL3 [Gene or Genome]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "isolate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370215:Isolate [Substance]
  1000   C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "the 99-amino acid C-terminal Rit-binding domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]
   703   C1148572:amino acid binding [Molecular Function]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5'-XbaI"

Phrase: "and"

Phrase: "3'-HindIII restriction sites."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C1882940:Restriction Site [Nucleotide Sequence]
   812   C0205145:Sites [Spatial Concept]
   812   C0443288:Restriction [Functional Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.58: The product was subcloned to the corresponding sites of pGEX-KG to create pGEX-KG-RGL3-RBD. 

Phrase: "The product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514468:product [Entity]
  1000   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "subcloned to the corresponding sites of pGEX-KG to"

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "pGEX-KG-RGL3-RBD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1880389:Domain [Functional Concept]
   799   C1883221:Domain [Conceptual Entity]
   799   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.59: The 288-bp cDNA insert was excised from this vector and radiolabeled with [-32P]dCTP using a Nick Translation labeling kit (Life Technologies, Inc.). 

Phrase: "The 288-bp cDNA insert"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0441587:Insert [Health Care Activity]
   812   C1743766:Insert [Medical Device]
   812   C1883719:Insert [Functional Concept]

Phrase: "was"

Phrase: "excised from this vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]

Phrase: "and"

Phrase: "radiolabeled with"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1527121:Radiolabeled [Qualitative Concept]
   799 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "[-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]dCTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045191:dCTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Nick Translation labeling kit (Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.60: Sixty six RGL3 cDNAs were isolated from a total of ~5105 plaque-forming units of a mouse kidney library (21). 

Phrase: "Sixty six RGL3 cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "isolated from a total of ~5105 plaque-forming units"
Meta Candidates (Total=18; Excluded=6; Pruned=0; Remaining=12)
   790   C1882406:PLAQUE-FORMING UNITS [Quantitative Concept]
   742   C0011389:Plaque [Disease or Syndrome]
   742   C0205409:Isolated [Functional Concept]
   742   C0205431:Forming [Functional Concept]
   742   C0332461:Plaque [Finding]
   742   C0333463:plaque [Acquired Abnormality]
   742   C0439148:Units [Quantitative Concept]
   742   C0439175:% total [Quantitative Concept]
   742   C0439810:Total [Qualitative Concept]
   742   C1519795:Units [Quantitative Concept]
   742   C1522492:Forming [Functional Concept]
   742   C1548221:Isolated [Idea or Concept]
   708 E C0348078:Form [Qualitative Concept]
   708 E C0370215:Isolate [Substance]
   708 E C0376315:Form [Manufactured Object]
   708 E C1704753:Unit [Manufactured Object]
   708 E C1875400:ISOLATE [Pharmacologic Substance]
   708 E C1880519:Unit [Quantitative Concept]

Phrase: "of a mouse kidney library"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0023621:Library [Manufactured Object,Organization]
   827   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1517673:Mouse Kidney [Tissue]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.61: The size of each cDNA insert was determined by restriction mapping, and selected clones were analyzed by DNA sequencing using T7, SP6, and specific internal primers. 

Phrase: "The size of each cDNA insert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0456389:size [Spatial Concept]

Phrase: "was"

Phrase: "determined by restriction mapping,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0035269:Restriction Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0443288:Restriction [Functional Concept]
   770   C1283195:Mapping [Activity]
   737 E C0024779:Map [Manufactured Object]
   737 E C1706473:Map [Conceptual Entity]

Phrase: "and"

Phrase: "selected clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "analyzed by DNA sequencing"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0162326:DNA sequencing [Nucleotide Sequence]
   833   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0936012:Analyzed [Research Activity]
   770   C1553778:Sequencing [Intellectual Product]
   770   C1561491:Sequencing [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "T7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1179691:T7 [Body Location or Region]

Phrase: "SP6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450548:SP6 [Body Location or Region]
  1000   C1422729:SP6 [Gene or Genome]

Phrase: "and"

Phrase: "specific internal primers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.62: Of the initial positives, none was found to be full-length at the 5' end. 

Phrase: "Of the initial positives,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]

Phrase: "none"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "full-length at the 5' end."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0443225:Full [Qualitative Concept]
   753   C1444754:Length [Quantitative Concept]
   753   C1706316:LENGTH [Research Activity]
Processing 00000000.tx.63: To obtain the extreme 5' end of the RGL3 cDNA clone, 5'-RACE was carried out using the SMART RACE cDNA amplification kit (CLONTECH) according to the manufacturer's instructions. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the extreme 5' end of the RGL3 cDNA clone,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0444930:End [Spatial Concept]
   742   C2746065:End [Temporal Concept]

Phrase: "5'-RACE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034510:Race [Population Group]
   861   C1706779:RACE [Gene or Genome]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the SMART RACE cDNA amplification kit (CLONTECH"

Phrase: ")"

Phrase: "according to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.64: First-strand synthesis was primed with a specific oligonucleotide corresponding to a sequence located near the 5' end of the longest RGL3 cDNA (5' CAC AGT CCT CCG CAA ACT C 3'). 

Phrase: "First-strand synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]

Phrase: "was"

Phrase: "primed with a specific oligonucleotide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205369:Specific [Qualitative Concept]
   760   C0871133:primed [Functional Concept]
   760   C1552740:specific [Intellectual Product]

Phrase: "corresponding to a sequence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]

Phrase: "located near the 5' end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0444930:End [Spatial Concept]
   760   C2746065:End [Temporal Concept]
   704 E C0205088:Terminal [Temporal Concept]
   704 E C1705314:Terminal [Manufactured Object]
   704 E C1705315:Terminal [Spatial Concept]

Phrase: "of the longest RGL3 cDNA (5' CAC AGT CCT CCG CAA ACT C 3'"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   787   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   787   C0079613:ACT [Therapeutic or Preventive Procedure]
   787   C0266539:CCT [Congenital Abnormality,Disease or Syndrome]
   787   C1428955:RGL3 [Gene or Genome]
   787   C1516476:CCG [Health Care Related Organization]
   787   C1522425:Longest [Qualitative Concept]
   754 E C0205166:Long [Qualitative Concept]
   754 E C1706317:Long [Qualitative Concept]
   704 E C1444754:Length [Quantitative Concept]
   704 E C1706316:LENGTH [Research Activity]

Phrase: ")."
Processing 00000000.tx.65: Poly(A)+ mRNA was purified from mouse kidney using Straight As mRNA Isolation System (Novagen), and an RGL3-specific oligonucleotide (5' GTC TGC TCT CCC TTA GCC TCC TTC AAG 3') was used in the 5'-RACE PCR. 

Phrase: "Poly(A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032400:Poly A [Nucleic Acid, Nucleoside, or Nucleotide]
           poly
   861   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0747726:POLY [Conceptual Entity]

Phrase: ")"

Phrase: "+ mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "purified from mouse kidney"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1517673:Mouse Kidney [Tissue]
   770   C0022646:Kidney [Body Part, Organ, or Organ Component]
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C0227665:kidney [Body Part, Organ, or Organ Component]
   770   C1278978:Kidney [Body Part, Organ, or Organ Component]
   770   C1514845:KIDNEY [Tissue]
   770   C1998793:Purified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Straight As mRNA Isolation System"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0445291:Straight [Spatial Concept]

Phrase: "(Novagen"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "an RGL3-specific oligonucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(5' GTC TGC TCT CCC TTA GCC TCC TTC AAG 3'"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   788   C0077072:TCC [Organic Chemical,Pharmacologic Substance]
   788   C0439084:>5 [Quantitative Concept]
   788   C0677634:TCT [Laboratory Procedure]
   788   C0728893:+5 [Quantitative Concept]
   788   C0796552:AAG [Antibiotic,Organic Chemical]
   788   C1167383:TCC [Cell Component]
   788   C1417239:AAG [Gene or Genome]
   788   C1420714:TGC [Gene or Genome]
   788   C1627773:TTA [Finding]
   788   C1861305:TCC [Disease or Syndrome]
   788   C2986643:AAG [Gene or Genome]

Phrase: ")"

Phrase: "was"

Phrase: "used in the 5'-RACE PCR."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0034510:Race [Population Group]
   753   C0677874:pCR [Finding]
   753   C1273517:used [Finding]
   753   C1706779:RACE [Gene or Genome]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.66: Two independently isolated RGL3 5'-RACE products were sequenced and found to encode identical nucleotide sequences. 

Phrase: "Two independently isolated RGL3 5'-RACE products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C1514468:Products [Entity]
   762 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "encode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "identical nucleotide sequences."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   901   C0004793:Sequences, Nucleotide [Nucleotide Sequence]
       E   Sequence
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.67: To construct a full RGL3 coding region, nucleotides 1-402 of 5'-RACE RGL3 were amplified by PCR to contain a 5'-EcoRI site and ligated to nucleotide 403-2129 of the largest library cDNA clone through a unique internal BglII site in the bacterial expression vector pGEX-KG. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "a full RGL3 coding region,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0079941:Coding Region [Gene or Genome]
   812   C0009219:Coding [Occupational Activity]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   779 E C0805701:Code [Intellectual Product]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "nucleotides 1-402 of 5'-RACE RGL3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0034510:Race [Population Group]
   748   C1428955:RGL3 [Gene or Genome]
   748   C1706779:RACE [Gene or Genome]

Phrase: "were"

Phrase: "amplified by PCR to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a 5'-EcoRI site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "ligated to nucleotide 403-2129 of the largest library cDNA clone"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   754   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   738   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0009013:Clone [Cell]
   738   C0023621:Library [Manufactured Object,Organization]
   738   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0443228:Largest [Quantitative Concept]
   738   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C1522642:Clone [Tissue]
   704 E C0549177:Large [Quantitative Concept]

Phrase: "through a unique internal BglII site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "in the bacterial expression vector pGEX-KG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0022718:KG [Geographic Area]
   804   C0439209:kg [Quantitative Concept]
Processing 00000000.tx.68: The resulting plasmid, pGEX-KG-RGL3WT, was characterized by restriction mapping, and the entire coding region was sequenced on both strands. 

Phrase: "The resulting plasmid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "pGEX-KG-RGL3WT,"

Phrase: "was"

Phrase: "characterized by restriction mapping,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0035269:Restriction Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0443288:Restriction [Functional Concept]
   770   C1283195:Mapping [Activity]
   770   C1880022:Characterized [Activity]
   737 E C0024779:Map [Manufactured Object]
   737 E C1706473:Map [Conceptual Entity]

Phrase: "and"

Phrase: "the entire coding region"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0079941:Coding Region [Gene or Genome]
   827   C0009219:Coding [Occupational Activity]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   793 E C0805701:Code [Intellectual Product]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "was"

Phrase: "sequenced on both strands."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   737   C0004793:Sequence [Nucleotide Sequence]
   737   C0162326:Sequence [Nucleotide Sequence]
   737   C0162327:Sequence [Nucleotide Sequence]
   737   C1519249:Sequence [Functional Concept]
   737   C1704972:Strand [Spatial Concept]
   737   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.69: Plasmid Construction-- Bacterial expression and yeast two-hybrid vectors for wild type and mutant Rit have been described previously (17). 

Phrase: "Plasmid Construction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "--"

Phrase: "Bacterial expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "yeast two-hybrid vectors for wild type"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0442335:Vectors [Spatial Concept]
   714 E C1705099:Vector [Idea or Concept]

Phrase: "and"

Phrase: "mutant Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   861   C1419390:RIT [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.70: Mammalian expression constructs were prepared by polymerase chain reaction amplification of the desired fragment containing flanking BglII restriction sites. 

Phrase: "Mammalian expression constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "prepared by polymerase chain reaction amplification"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0337112:Chain [Manufactured Object]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1517480:Amplification [Molecular Biology Research Technique]
   753   C1521871:Amplification [Phenomenon or Process]
   753   C1524075:Chain [Idea or Concept]
   753   C1705759:Amplification [Cell or Molecular Dysfunction]
   719   C1521827:Prepare [Functional Concept]

Phrase: "of the desired fragment containing flanking BglII restriction sites."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   795   C0205145:Sites [Spatial Concept]
   795   C0443288:Restriction [Functional Concept]
   785   C1882940:Restriction Site [Nucleotide Sequence]
   762 E C1515974:Site [Body Location or Region]
   762 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.71: The products were subcloned to the BamHI site of pKH3 (22), and each plasmid was verified by DNA sequencing. 

Phrase: "The products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "subcloned to the BamHI site of pKH3"

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "each plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "verified by DNA sequencing."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0162326:DNA sequencing [Nucleotide Sequence]
   833   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1553778:Sequencing [Intellectual Product]
   770   C1561491:Sequencing [Functional Concept]
   770   C1711411:Verified [Functional Concept]
Processing 00000000.tx.72: This allowed expression of Rit bearing three copies of the influenza hemagglutinin (HA) epitope tag at the N terminus. 

Phrase: "This allowed expression of Rit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "three copies of the influenza hemagglutinin (HA) epitope tag"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1948062:Copies [Manufactured Object]

Phrase: "at the N terminus."
Processing 00000000.tx.73: To express full-length constitutively activated Ras in HEK293 cells, pCGN-RasQ61L (Dr. Adrienne Cox, University of North Carolina at Chapell Hill) was digested with BamHI, and the released DNA fragment was inserted into the corresponding site in pKH3. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "full-length constitutively activated Ras in HEK293 cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0034678:RAS [Gene or Genome]

Phrase: "pCGN-RasQ61L"

Phrase: "(Dr. Adrienne Cox,"

Phrase: "University of North Carolina at Chapell Hill"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0028407:North Carolina [Geographic Area]
   748   C0041740:University [Manufactured Object,Organization]
   748   C1709269:North [Spatial Concept]

Phrase: ")"

Phrase: "was"

Phrase: "digested with BamHI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "the released DNA fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "inserted into the corresponding site"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   781   C1705686:Insert Site [Nucleotide Sequence]
   760   C0205145:Site [Spatial Concept]
   760   C0441587:Inserted [Health Care Activity]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]
   726 E C1743766:Insert [Medical Device]
   726 E C1883719:Insert [Functional Concept]

Phrase: "in pKH3."
Processing 00000000.tx.74: RGL3 was expressed using a modified mammalian expression vector. 

Phrase: "RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "was"

Phrase: "expressed"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a modified mammalian expression vector."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vector [Spatial Concept]
   812   C1705099:Vector [Idea or Concept]
Processing 00000000.tx.75: As a first step in constructing this plasmid, the 3 HA tag region of pKH3 was released by XbaI/EcoRI digestion and subcloned to NheI/EcoRI digested pcDNA3.1+Zeo to create pcDNA3.1+Zeo3HA. 

Phrase: "As a first step in constructing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C2827421:Construct [Classification]

Phrase: "this plasmid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "the 3 HA tag region of pKH3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]

Phrase: "was"

Phrase: "released by XbaI/EcoRI digestion"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   760   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0012238:Digestion [Organism Function]
   760   C0391871:Released [Functional Concept]
   760   C1283071:Released [Functional Concept]
   760   C2349986:Digestion [Research Activity]
   726 E C0030685:Release [Health Care Activity]
   726 E C0439180:% release [Quantitative Concept]
   726 E C0680255:release [Health Care Activity]
   726 E C1963578:Release [Therapeutic or Preventive Procedure]
   704 E C0443277:Peptic [Functional Concept]

Phrase: "and"

Phrase: "subcloned to NheI/EcoRI"

Phrase: "digested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0868946:digested [Physiologic Function]

Phrase: "pcDNA3.1+Zeo to"

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "pcDNA3.1+Zeo3HA."
Processing 00000000.tx.76: The BamHI/XhoI fragment of pBluescript-II-SK(+) (Stratagene), containing the polylinker, was then subcloned to the vector to create pcDNA3.1+Zeo3HAa. 

Phrase: "The BamHI/XhoI fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "of pBluescript-II-SK(+) (Stratagene"

Phrase: ")"

Phrase: ","

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the polylinker,"

Phrase: "was"

Phrase: "then subcloned to the vector to"

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "pcDNA3.1+Zeo3HAa."
Processing 00000000.tx.77: Finally, the BamHI/HindIII fragment of pcDNA3.1+Zeo3HAa was replaced by the corresponding polylinker region of pGEX-KG to generate pcDNA3.1+Zeo3HAb. 

Phrase: "Finally,"

Phrase: "the BamHI/HindIII fragment of pcDNA3.1+Zeo3HAa"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "replaced by the corresponding polylinker region of pGEX-KG to"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C1299987:Replaced by [Functional Concept]
           replaced
   739   C0017446:Region [Geographic Area]
   739   C0022718:KG [Geographic Area]
   739   C0205147:Region [Spatial Concept]
   739   C0439209:kg [Quantitative Concept]
   739   C0559956:Replaced [Functional Concept]
   706 E C1554078:Replace [Idea or Concept]

Phrase: "generate"

Phrase: "pcDNA3.1+Zeo3HAb."
Processing 00000000.tx.78: The entire open reading frame of RGL3 cDNA was excised from pGEX-KG-RGL3WT by digestion with EcoRI/HindIII and subcloned to the corresponding sites of pcDNA3.1+Zeo3HAb, yielding pcDNA3.1+Zeo3HAb-RGL3. 

Phrase: "The entire open reading frame of RGL3 cDNA"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C0079941:Open Reading Frame [Gene or Genome]
   770   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   744   C0034754:Reading [Daily or Recreational Activity]
   744   C0175566:Open [Spatial Concept]
   744   C0180979:Frame [Medical Device]
   744   C1705179:Reading [Finding]
   744   C1705858:Frame [Manufactured Object]

Phrase: "was"

Phrase: "excised from pGEX-KG-RGL3WT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0022718:KG [Geographic Area]
   760   C0439209:kg [Quantitative Concept]

Phrase: "by digestion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0012238:Digestion [Organism Function]
  1000   C2349986:Digestion [Research Activity]
   944 E C0443277:Peptic [Functional Concept]

Phrase: "with EcoRI/HindIII"

Phrase: "and"

Phrase: "subcloned to the corresponding sites of pcDNA3.1+Zeo3HAb,"

Phrase: "yielding"

Phrase: "pcDNA3.1+Zeo3HAb-RGL3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1428955:RGL3 [Gene or Genome]
Processing 00000000.tx.79: A fragment that encodes amino acids 1-507 of RGL3 (removing the RGL3-RBD) was prepared by PCR amplification of the desired fragment containing 5'-EcoRI and 3'-HindIII sites and a new 3' stop codon. 

Phrase: "A fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "that"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "amino acids 1-507 of RGL3"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   753   C0450381:507 [Intellectual Product]
   753   C1428955:RGL3 [Gene or Genome]
   719 E C0202406:Acid [Laboratory Procedure]

Phrase: "("

Phrase: "removing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0849355:remove [Qualitative Concept]
   966   C1883720:Remove [Activity]
   966   C3244314:remove [Functional Concept]

Phrase: "the RGL3-RBD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "prepared by PCR amplification of the desired fragment"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0332255:fragment [Functional Concept]
   744   C0677874:pCR [Finding]
   744   C1517480:Amplification [Molecular Biology Research Technique]
   744   C1521871:Amplification [Phenomenon or Process]
   744   C1705759:Amplification [Cell or Molecular Dysfunction]
   744   C1708096:Fragment [Qualitative Concept]
   711   C0871633:desire [Mental Process]
   711   C1521827:Prepare [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5'-EcoRI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "3'-HindIII sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "a new 3' stop codon."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0242611:Stop Codon [Nucleotide Sequence]
   812   C0009221:Codon [Nucleotide Sequence]
   812   C1095825:Codon [Plant]
Processing 00000000.tx.80: The product was subcloned to the EcoRI/HindIII sites of pcDNA3.1+Zeo3HAb to generate pcDNA3.1+Zeo3HAb-RGL3-RBD. 

Phrase: "The product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514468:product [Entity]
  1000   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "subcloned to the EcoRI/HindIII sites of pcDNA3.1+Zeo3HAb to"

Phrase: "generate"

Phrase: "pcDNA3.1+Zeo3HAb-RGL3-RBD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C1880389:Domain [Functional Concept]
   795   C1883221:Domain [Conceptual Entity]
   795   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.81: To produce recombinant RGL3-RBD protein, the RGL3-RBD PCR product was subcloned into the vectors pTrcHisA (Invitrogen) and pGEX-KG. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "recombinant RGL3-RBD protein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   895   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   839   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the RGL3-RBD PCR product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1514468:product [Entity]
   799   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "subcloned into the vectors pTrcHisA"

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "and"

Phrase: "pGEX-KG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022718:KG [Geographic Area]
   861   C0439209:kg [Quantitative Concept]
Processing 00000000.tx.82: To express His6 and Myc epitope-tagged RGL3 protein, the desired product was generated by PCR (5'-EcoRI and 3'-HindIII sites) and subcloned into pcDNA()MycHisA (Invitrogen) to generate pcDNA-MycHisA-RGL3. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "His6"

Phrase: "and"

Phrase: "Myc epitope-tagged RGL3 protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   897   C0919474:MYC Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the desired product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "generated by PCR (5'-EcoRI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0677874:pCR [Finding]
   760   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "3'-HindIII sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "subcloned into pcDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C1883178:Subclone [Cell]

Phrase: "("

Phrase: ")"

Phrase: "MycHisA"

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "pcDNA-MycHisA-RGL3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1428955:RGL3 [Gene or Genome]
Processing 00000000.tx.83: To produce recombinant His6-RGL3RBD protein, pGEX-KG-RGL3-RBD was digested with BamHI/HindIII, and the excised RGL3-RBD coding DNA was inserted into pET32a (Novagen) BamHI/HindIII sites to create pET32aRGL3RBD. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "recombinant His6-RGL3RBD protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "pGEX-KG-RGL3-RBD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1880389:Domain [Functional Concept]
   799   C1883221:Domain [Conceptual Entity]
   799   C3541951:Domain [Intellectual Product]

Phrase: "was"

Phrase: "digested with BamHI/HindIII,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "the excised RGL3-RBD coding DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "inserted into pET32a"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0441587:Inserted [Health Care Activity]
   756 E C1743766:Insert [Medical Device]
   756 E C1883719:Insert [Functional Concept]

Phrase: "(Novagen"

Phrase: ")"

Phrase: "BamHI/HindIII sites to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "pET32aRGL3RBD."
Processing 00000000.tx.84: All constructs were analyzed by restriction mapping, and all PCR products were fully sequenced. 

Phrase: "All constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "analyzed by restriction mapping,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0035269:Restriction Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0443288:Restriction [Functional Concept]
   770   C0936012:Analyzed [Research Activity]
   770   C1283195:Mapping [Activity]
   737 E C0024779:Map [Manufactured Object]
   737 E C1706473:Map [Conceptual Entity]

Phrase: "and"

Phrase: "all PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "fully"

Phrase: "sequenced."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.85: Northern Blot Analysis-- A single-stranded cDNA probe corresponding to mouse RGL3 (amino acids 613-709) was radiolabeled with [-32P]dCTP by nick translation and used to probe a mouse multiple tissue Northern blot (CLONTECH). 

Phrase: "Northern Blot Analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C1621557:Northern Blot [Research Device]

Phrase: "-"

Phrase: "-"

Phrase: "A single-stranded cDNA probe"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0441084:Single probe [Medical Device]
   812   C0182400:Probe [Medical Device]
   812   C1704681:Probe [Gene or Genome]
   812   C2347609:Probe [Chemical Viewed Functionally]
   812   C3536729:Probe [Manufactured Object]

Phrase: "corresponding to mouse RGL3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C1428955:RGL3 [Gene or Genome]

Phrase: "(amino acids 613-709"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "was"

Phrase: "radiolabeled with"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1527121:Radiolabeled [Qualitative Concept]
   799 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "[-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]dCTP by nick translation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0045191:dCTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "a mouse multiple tissue Northern blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0005861:Northern Blot [Molecular Biology Research Technique]
   840   C1621557:Northern Blot [Research Device]
   804   C1709269:Northern [Spatial Concept]

Phrase: "(CLONTECH"

Phrase: ")."
Processing 00000000.tx.86: The probe was used at a concentration of 2106 cpm/ml in Rapid-hyb buffer (Amersham Pharmacia Biotech), according to manufacturer's instructions. 

Phrase: "The probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "was"

Phrase: "used at a concentration of 2106 cpm/ml"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   750   C1524063:Use of [Functional Concept]
   744   C0086045:Concentration [Mental Process]
   744   C0439526:/mL [Quantitative Concept]
   744   C1273517:used [Finding]
   744   C1446561:Concentration [Quantitative Concept]
   711 E C0042153:use [Functional Concept]
   711 E C0457083:Use [Functional Concept]
   711 E C1947944:Use [Intellectual Product]

Phrase: "in Rapid-hyb buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: ","

Phrase: "according to manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.87: After washing, the blot was exposed to Kodak X-Omat AR film for the indicated time. 

Phrase: "After washing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "the blot"

Phrase: "was"

Phrase: "exposed to Kodak X-Omat AR film"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0332157:Exposed to [Clinical Attribute]
           Exposed
   748   C0086296:Film [Manufactured Object]
   748   C1561571:film [Biomedical or Dental Material]
   748   C1561572:film [Substance]
   748   C2986463:AR+ [Finding]

Phrase: "for the indicated time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.88: Recombinant Protein Production and Antibodies-- Recombinant GST-hRitC- (bearing a short C-terminal deletion), GST-HaRas, GST-RGL3RBD, GST-RGL3RBD, GST-RheB, GST-mRinC-, GST-Rap1A, GST-TC21, GST-R-Ras, and GST-RalBD fusion proteins were purified by glutathione-agarose affinity column as described previously (17). 

Phrase: "Recombinant Protein Production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033268:production [Occupational Activity]
   734   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "Antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "--"

Phrase: "Recombinant GST-hRitC-"

Phrase: "("

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "a short C-terminal deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1442161:Deletion [Cell or Molecular Dysfunction]
   812   C1511760:Deletion [Genetic Function]
   812   C1880274:Deletion [Activity]

Phrase: ")"

Phrase: ","

Phrase: "GST-HaRas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2758676:Hara [Fish]

Phrase: "GST-RGL3RBD,"

Phrase: "GST-RGL3RBD,"

Phrase: "GST-RheB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419383:RHEB [Gene or Genome]
   861   C1419384:RHEB [Gene or Genome]

Phrase: "GST-mRinC-,"

Phrase: "GST-Rap1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0967718:RAP1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1335590:RAP1A [Gene or Genome]

Phrase: "GST-TC21,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1335647:TC21 [Gene or Genome]
   861   C1447284:TC21 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1704999:TC21 [Gene or Genome]

Phrase: "GST-R-Ras,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034678:RAS [Gene or Genome]

Phrase: "and"

Phrase: "GST-RalBD fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332466:Fusion [Functional Concept]
   812   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "purified by glutathione-agarose affinity column"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0036681:Agarose [Carbohydrate]
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1510827:Affinity [Natural Phenomenon or Process]
   753   C1706132:Column [Idea or Concept]
   753   C1998793:Purified [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.89: Recombinant GST fusion proteins were dialyzed (20mM Tris-Cl, pH 7.5,100mM NaCl, 1mM DTT, 1mM MgCl2, and 20% glycerol) for 12h at 4C and stored in multiple aliquots at 70C. 

Phrase: "Recombinant GST fusion proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0034857:Recombinant Fusion Proteins [Amino Acid, Peptide, or Protein]
   902   C0034861:Recombinant Proteins [Amino Acid, Peptide, or Protein]
   827   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332466:Fusion [Functional Concept]
   812   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "dialyzed"

Phrase: "(20mM Tris-Cl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "100mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "1mM DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "1mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "20% glycerol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "for 12h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456695:/12h [Temporal Concept]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "and"

Phrase: "stored in multiple aliquots"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439064:Multiple [Quantitative Concept]
   737   C1510844:Aliquot [Quantitative Concept]
   737   C1698986:Store [Functional Concept]

Phrase: "at 70C."
Processing 00000000.tx.90: Recombinant His6-RitC-, His6-Ha-Ras, His6-RalA, His6-Rab1A, His6-RGL3RBD, and His6-RGL3RBD proteins were expressed and purified as described (17). 

Phrase: "Recombinant His6-RitC-,"

Phrase: "His6-Ha-Ras,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034678:RAS [Gene or Genome]

Phrase: "His6-RalA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0765159:RALA [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812284:RALA [Gene or Genome]

Phrase: "His6-Rab1A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419187:RAB1A [Gene or Genome]

Phrase: "His6-RGL3RBD,"

Phrase: "and"

Phrase: "His6-RGL3RBD proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "expressed"

Phrase: "and"

Phrase: "purified as described"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1552738:described [Idea or Concept]
   790   C1998793:Purified [Functional Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.91: Protein concentrations were determined by the Bradford assay (Bio-Rad), using bovine serum albumin as a standard. 

Phrase: "Protein concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427716:Protein concentration [Laboratory Procedure]
   983   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "determined by the Bradford assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0005507:Assay [Laboratory Procedure]
   760   C0243073:assay [Qualitative Concept]
   760   C1510438:Assay [Laboratory Procedure]

Phrase: "(Bio-Rad"

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "bovine serum albumin as a standard."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   790   C0728877:serum albumin [Laboratory or Test Result]
   783 E C0523465:Albumin - serum [Laboratory Procedure]
   753   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0007452:Bovine [Mammal]
   753   C0229671:Serum [Body Substance]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
Processing 00000000.tx.92: Anti-Rit polyclonal antibody was produced by immunizing rabbits with purified GST-hRitC- fusion protein (see above). 

Phrase: "Anti-Rit polyclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "produced by immunizing rabbits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0034493:Rabbit [Mammal]

Phrase: "with purified GST-hRitC- fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332466:Fusion [Functional Concept]
   804   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.93: GST-hRitC- fusion protein (750g) was mixed with Freund's complete adjuvant and injected subcutaneously into the back of a female New Zealand White rabbit, age 6months. 

Phrase: "GST-hRitC- fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332466:Fusion [Functional Concept]
   812   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "(750g"

Phrase: ")"

Phrase: "was"

Phrase: "mixed with Freund's complete adjuvant"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   862   C0016712:Freund's complete adjuvant [Immunologic Factor,Pharmacologic Substance]
           Complete adjuvant
           Freund's Adjuvant
   760   C0001551:Adjuvant, NOS [Immunologic Factor,Pharmacologic Substance]
   760   C0001552:Adjuvant [Chemical Viewed Functionally]
   760   C0205197:Complete [Qualitative Concept]
   760   C0205430:Mixed [Functional Concept]
   760   C0725685:COMPLEAT [Food]
   760   C1522673:Adjuvant [Functional Concept]
   760   C3160715:Mixed [Finding]
   726 E C1421951:MIX [Gene or Genome]
   726 E C1720722:Mix [Qualitative Concept]

Phrase: "and"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "subcutaneously into the back of a female New Zealand White rabbit,"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   797   C0324547:New Zealand white rabbit [Mammal]
           New Zealand White
           New Zealand rabbit
   756   C0027978:New Zealand [Geographic Area]
   756   C0205095:Back of [Spatial Concept]
           Back
   738   C0004600:Back [Body Location or Region]
   738   C0007457:White [Population Group]
   738   C0015780:Female [Finding]
   738   C0034493:Rabbit [Mammal]
   738   C0043157:White [Population Group]
   738   C0043210:female [Population Group]
   738   C0086287:female [Population Group]
   738   C0205314:New [Temporal Concept]
   738   C0220938:White [Qualitative Concept]
   738   C0460009:Back [Body Location or Region]
   738   C1705497:Female [Qualitative Concept]
   738   C1705498:Female [Qualitative Concept]
   738   C1995000:Back [Body Location or Region]

Phrase: "age 6months."
Processing 00000000.tx.94: Before the first injection, preimmune serum was obtained from the rabbit. 

Phrase: "Before the first injection,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "preimmune serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "was"

Phrase: "obtained from the rabbit."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0034493:Rabbit [Mammal]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.95: Four additional injections were given at 4-week intervals using 250g of GST-hRitC- mixed with Freund's incomplete adjuvant. 

Phrase: "Four additional injections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0021485:injections [Therapeutic or Preventive Procedure]
   827   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   827   C1828121:Injections [Functional Concept]
   793 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "were"

Phrase: "given at 4-week intervals"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0332174:/week [Temporal Concept]
   760   C0439230:week [Temporal Concept]
   760   C1272706:intervals [Temporal Concept]
   760   C1442162:GIVEN [Conceptual Entity]
   760   C1550718:given [Idea or Concept]
   760   C3244317:given [Intellectual Product]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]
   726 E C1947971:Give [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "250g of GST-hRitC-"

Phrase: "mixed with Freund's incomplete adjuvant."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   862   C0281643:Freund's Incomplete Adjuvant [Carbohydrate,Pharmacologic Substance]
   806   C0301976:Incomplete adjuvant [Immunologic Factor]
   797   C0016712:Freund's Adjuvant [Immunologic Factor,Pharmacologic Substance]
   760   C0001551:Adjuvant, NOS [Immunologic Factor,Pharmacologic Substance]
   760   C0001552:Adjuvant [Chemical Viewed Functionally]
   760   C0205257:Incomplete [Quantitative Concept]
   760   C0205430:Mixed [Functional Concept]
   760   C0728938:incomplete [Quantitative Concept]
   760   C1522673:Adjuvant [Functional Concept]
   760   C1548386:incomplete [Idea or Concept]
   760   C3160715:Mixed [Finding]
   726 E C1421951:MIX [Gene or Genome]
   726 E C1720722:Mix [Qualitative Concept]
Processing 00000000.tx.96: Bleeds were taken 10days after each injection. 

Phrase: "Bleeds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019080:bleed [Pathologic Function]

Phrase: "were"

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "10days after each injection."
Processing 00000000.tx.97: In Vitro Interaction of RGL3-RBD with Ras-like GTPases-- Recombinant His6-RitC- and His6-Ha-Ras proteins were loaded with [35S]GTPS or [3H]GDP as follows: 10nmol of His6-RitC- or His6-Ha-Ras in a total volume of 400l were loaded with either 10M [35S]GTPS (2Ci/mmol) or [3H]GDP (2Ci/mmol) in buffer that contained either 1mM [Mg]Free (for Rit, 20mM Tris, pH 7.5,100mM NaCl, 1mM MgCl2, 1mM DTT, and 1mg/ml BSA) or 10M [Mg]Free (for Ha-Ras, 20mM Tris, pH 7.5,100mM NaCl, 0.919mM MgCl2, 1mM EDTA, 1mM DTT, and 1mg/ml BSA) at 30C for 30min. 

Phrase: "In Vitro Interaction of RGL3-RBD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1704675:Interaction [Functional Concept]

Phrase: "with Ras-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "like GTPases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "--"

Phrase: "Recombinant His6-RitC-"

Phrase: "and"

Phrase: "His6-Ha-Ras proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   912   C0079972:Ha-ras Protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0242853:ras Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "loaded with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C1708715:Loaded [Activity]
   799 E C1550025:Load [Idea or Concept]
   799 E C1704782:Load [Manufactured Object]

Phrase: "[35S"

Phrase: "]GTPS or [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442460:3H [Temporal Concept]

Phrase: "]GDP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "10nmol of His6-RitC-"

Phrase: "or"

Phrase: "His6-Ha-Ras in a total volume of 400l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0034678:RAS [Gene or Genome]

Phrase: "were"

Phrase: "loaded with either 10M"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C1442446:10M [Temporal Concept]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]

Phrase: "[35S"

Phrase: "]GTPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(2Ci/mmol) or [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1442460:3H [Temporal Concept]

Phrase: "]GDP (2Ci/mmol) in buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439190:MMOLE [Quantitative Concept]

Phrase: "that contained either 1mM"

Phrase: "[Mg]"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439269:mg% [Quantitative Concept]
  1000   C1960952:mg % [Quantitative Concept]
  1000   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "Free"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332296:free [Functional Concept]
  1000   C1880497:Free [Qualitative Concept]
  1000   C1996904:Free [Qualitative Concept]

Phrase: "("

Phrase: "for Rit,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "20mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "100mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "1mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1mM DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "1mg/ml BSA)"

Phrase: "or"

Phrase: "10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: "[Mg]"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439269:mg% [Quantitative Concept]
  1000   C1960952:mg % [Quantitative Concept]
  1000   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "Free"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332296:free [Functional Concept]
  1000   C1880497:Free [Qualitative Concept]
  1000   C1996904:Free [Qualitative Concept]

Phrase: "("

Phrase: "for Ha-Ras,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034678:RAS [Gene or Genome]

Phrase: "20mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "100mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.919mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1mM DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "1mg/ml BSA) at 30C"

Phrase: "for 30min."
Processing 00000000.tx.98: MgCl2 was then added to the reaction mixture to a final concentration of 10mM. 

Phrase: "MgCl2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added to the reaction mixture"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0439962:Mixture [Substance]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1524062:Added [Functional Concept]
   726 E C1883712:Add [Functional Concept]

Phrase: "to a final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 10mM."
Processing 00000000.tx.99: A sample (10l) was removed from each reaction, and the extent of guanine nucleotide binding was determined by rapid filtration using BA85 nitrocellulose filters as described previously (17). 

Phrase: "A sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "(10l"

Phrase: ")"

Phrase: "was"

Phrase: "removed from each reaction,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0443286:Reaction [Functional Concept]
   770   C0849355:Removed [Qualitative Concept]
   770   C1114821:Reaction [Clinical Attribute]
   737 E C1883720:Remove [Activity]
   737 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "the extent of guanine nucleotide binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439792:Extent [Spatial Concept]

Phrase: "was"

Phrase: "determined by rapid filtration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0016107:filtration [Laboratory Procedure]
   770   C0439831:Rapid [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "BA85 nitrocellulose filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0180860:Filters [Manufactured Object]
   793 E C0581406:Filter [Medical Device]
   793 E C1522664:Filter [Intellectual Product]
   793 E C1704449:Filter [Conceptual Entity]
   793 E C1704684:Filter [Medical Device]
   793 E C1875155:FILTER [Medical Device]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.100: For the in vitro binding studies, the indicated concentrations of His6-RitC- or His6-Ha-Ras preloaded with either [35S]GTPS or [3H]GDP were incubated for 1h at 4C with gentle agitation in 300l of binding buffer (20mM Tris-Cl, pH 7.5,150mM NaCl, 20mM MgCl2, 20mM imidazole, and 1% Nonidet P40) containing 30l (50% slurry) of glutathione-agarose beads pre-complexed with either 2nmol of GST or GST-RGL3-RBD. 

Phrase: "For the in vitro binding studies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   906   C0681828:in vitro study [Research Activity]
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "the indicated concentrations of His6-RitC-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "or"

Phrase: "His6-Ha-Ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034678:RAS [Gene or Genome]

Phrase: "preloaded with either"

Phrase: "[35S"

Phrase: "]GTPS or [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442460:3H [Temporal Concept]

Phrase: "]GDP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "incubated for 1h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442450:1H [Temporal Concept]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "with gentle agitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0085631:Agitation [Sign or Symptom]

Phrase: "in 300l"

Phrase: "of binding buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(20mM Tris-Cl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "20mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "20mM imidazole,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020923:Imidazole [Organic Chemical,Pharmacologic Substance]
   861   C0020924:imidazole [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "1% Nonidet P40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3539611:P40 [Gene or Genome]

Phrase: ")"

Phrase: "containing 30l"

Phrase: "(50% slurry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883043:Slurry [Substance]

Phrase: ")"

Phrase: "of glutathione-agarose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036681:Agarose [Carbohydrate]

Phrase: "beads"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0991566:Beads [Biomedical or Dental Material]
  1000   C2346972:Bead [Spatial Concept]

Phrase: "pre-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332152:Pre [Temporal Concept]
  1000   C0740175:Pre [Qualitative Concept]
  1000   C2257086:PRE [Genetic Function]

Phrase: "complexed with either 2nmol of GST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0439855:Complex [Qualitative Concept]
   719   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "or"

Phrase: "GST-RGL3-RBD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.101: The agarose beads were pelleted in a microcentrifuge (6,000rpm for 15s), and the supernatant was removed. 

Phrase: "The agarose beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0991566:Beads [Biomedical or Dental Material]
   827 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "pelleted in a microcentrifuge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0441436:Pellet [Manufactured Object]
   737   C0993610:Pellet [Biomedical or Dental Material]
   737   C1998480:Pellet [Quantitative Concept]

Phrase: "(6,"

Phrase: "000rpm for 15s"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "removed."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]
Processing 00000000.tx.102: The pelleted beads were washed five times with 1ml of ice-cold binding buffer, and the bound radioactivity was quantified by liquid scintillation counting. 

Phrase: "The pelleted beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0991566:Beads [Biomedical or Dental Material]
   827 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "five times with 1ml of ice-cold binding buffer,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0040223:times [Temporal Concept]
   742   C1632851:Times [Quantitative Concept]
   708 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "the bound radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "quantified by liquid scintillation counting."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0036406:Scintillation Counting [Laboratory Procedure]
   760   C0302908:Liquid [Substance]
   760   C0678573:scintillation [Natural Phenomenon or Process]
   760   C1304698:Liquid [Finding]
   760   C1546699:Liquid NOS [Intellectual Product]
   760   C1561501:Liquid NOS [Substance]
   726   C0750480:Count [Activity]
   726   C1705566:Count [Quantitative Concept]
   726   C1709793:Quantify [Quantitative Concept]
Processing 00000000.tx.103: For each quantity of His6-RitC- or His6-HRas used, the specific binding was determined by subtracting counts bound to GST alone from counts bound by the GST-RGL3-RBD fusion protein. 

Phrase: "For each quantity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1265611:Quantity [Quantitative Concept]
  1000   C1554108:Quantity [Intellectual Product]
  1000   C1561573:Quantity [Intellectual Product]

Phrase: "of His6-RitC-"

Phrase: "or"

Phrase: "His6-HRas"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0079471:HRAS [Gene or Genome]
   861   C0079972:HRAS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1616867:HRAS [Gene or Genome]
   861   C1619700:HRA [Congenital Abnormality,Disease or Syndrome]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "the specific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205369:Specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1552740:specific [Intellectual Product]

Phrase: "was"

Phrase: "determined by subtracting counts"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0439157:counts [Quantitative Concept]
   737 E C0750480:Count [Activity]
   737 E C1705566:Count [Quantitative Concept]
   737   C1719767:Subtract [Intellectual Product]
   737   C2348589:Subtract [Phenomenon or Process]

Phrase: "bound to GST"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "alone from counts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205171:Alone [Quantitative Concept]
   790   C0439044:alone [Finding]
   790   C0679994:alone [Group Attribute]

Phrase: "bound by the GST-RGL3-RBD fusion protein."
Meta Candidates (Total=24; Excluded=0; Pruned=0; Remaining=24)
   777   C1514535:Protein Binding Domain [Amino Acid Sequence]
   760   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   757   C0033618:Protein Binding [Molecular Function]
   757   C0162808:Protein Domain [Spatial Concept]
   757   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0522527:Protein bound [Qualitative Concept]
   757   C1514562:Protein Domain [Amino Acid Sequence]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0243122:binding [Functional Concept]
   739   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   739   C0332297:bound [Spatial Concept]
   739   C0332466:Fusion [Functional Concept]
   739   C1145667:Binding [Activity]
           Bound
   739   C1167622:Binding [Molecular Function]
           Bound
   739   C1293131:Fusion [Therapeutic or Preventive Procedure]
   739   C1419390:RIT [Gene or Genome]
   739   C1428955:RGL3 [Gene or Genome]
   739   C1689898:% bound [Quantitative Concept]
   739   C1880389:Domain [Functional Concept]
   739   C1883221:Domain [Conceptual Entity]
   739   C2349209:Bound [Conceptual Entity]
   739   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.104: To test the interaction of RGL3-RBD with a series of Ras subfamily GTPases, 40g of recombinant GST-small GTPase fusion protein or GST alone was incubated with 5M [35S]GTPS (2Ci/mmol) or [3H]GDP (2Ci/mmol) in a total volume of 80l of loading buffer that contained 20mM Tris, pH 7.5,100mM NaCl, 5mM EDTA, 1mM DTT, and 1mg/ml BSA at 25C for 10min. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the interaction of RGL3-RBD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1704675:Interaction [Functional Concept]

Phrase: "with a series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: "of Ras subfamily GTPases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "40g of recombinant GST-small GTPase fusion protein"

Phrase: "or"

Phrase: "GST"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "was"

Phrase: "incubated with 5M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "[35S"

Phrase: "]GTPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(2Ci/mmol) or [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1442460:3H [Temporal Concept]

Phrase: "]GDP (2Ci/mmol) in a total volume of 80l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0439190:MMOLE [Quantitative Concept]

Phrase: "of loading buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "that contained 20mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "100mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "5mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1mM DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "1mg/ml BSA at 25C"

Phrase: "for 10min."
Processing 00000000.tx.105: MgCl2 was added to the reaction mixture to a final concentration of 10mM and incubated at 25C for 15min. 

Phrase: "MgCl2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "added to the reaction mixture"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0439962:Mixture [Substance]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1524062:Added [Functional Concept]
   726 E C1883712:Add [Functional Concept]

Phrase: "to a final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 10mM"

Phrase: "and"

Phrase: "incubated at 25C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 15min."
Processing 00000000.tx.106: One-half of the reaction mixture (40l) was removed from each reaction to determine the amount of guanine nucleotide binding as described above. 

Phrase: "One-half of the reaction mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2825407:Half [Quantitative Concept]

Phrase: "(40l"

Phrase: ")"

Phrase: "was"

Phrase: "removed from each reaction to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0443286:Reaction [Functional Concept]
   760   C0849355:Removed [Qualitative Concept]
   760   C1114821:Reaction [Clinical Attribute]
   726 E C1883720:Remove [Activity]
   726 E C3244314:remove [Functional Concept]

Phrase: "determine"

Phrase: "the amount of guanine nucleotide binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "as described above."
Processing 00000000.tx.107: The other half of the reaction mixture (40l) was incubated with 20g of His6-RGL3RBD and 20l (50% slurry) of Ni-NTA Sepharose for 1h at 4C with gentle agitation in 200l of binding buffer. 

Phrase: "The"

Phrase: "other half of the reaction mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2825407:Half [Quantitative Concept]

Phrase: "(40l"

Phrase: ")"

Phrase: "was"

Phrase: "incubated with 20g of His6-RGL3RBD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "20l"

Phrase: "(50% slurry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883043:Slurry [Substance]

Phrase: ")"

Phrase: "of Ni-NTA Sepharose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036681:Sepharose [Carbohydrate]

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "with gentle agitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0085631:Agitation [Sign or Symptom]

Phrase: "in 200l"

Phrase: "of binding buffer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.108: The beads were pelleted and washed and the bound radioactivity quantified as described above. 

Phrase: "The beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "pelleted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0441436:Pellet [Manufactured Object]
   966   C0993610:Pellet [Biomedical or Dental Material]
   966   C1998480:Pellet [Quantitative Concept]

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "the bound radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "quantified as described above."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1552739:described quantified [Idea or Concept]
   770   C1552738:described [Idea or Concept]
   737   C1709793:Quantify [Quantitative Concept]
Processing 00000000.tx.109: Interaction of in Vitro Translated RGL3 with Rit and Ras-- Radiolabeled full-length RGL3 was generated by in vitro transcription and translation in the presence of [35S]methionine using the Single Tube ProteinTM System 3(STP3) Kit (Novagen) according to the instructions of the manufacturer, with pCITE-4C-RGL3 as template. 

Phrase: "Interaction of in Vitro Translated RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]

Phrase: "with Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "and"

Phrase: "Ras-- Radiolabeled full-length RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1428955:RGL3 [Gene or Genome]

Phrase: "was"

Phrase: "generated by in vitro transcription"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]
   760   C0040649:Transcription [Genetic Function]
   760   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "translation in the presence of [35S"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0040712:Translation [Intellectual Product]
   753   C0597295:translation [Molecular Function]
   753   C1519614:Translation [Genetic Function]

Phrase: "]methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Single Tube ProteinTM System 3"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   804   C0037179:Single [Population Group]
   804   C0087136:single [Finding]
   804   C0175730:Tube [Medical Device]
   804   C0205171:Single [Quantitative Concept]
   804   C0449913:System [Functional Concept]
   804   C1547937:Tube NOS [Intellectual Product]
   804   C1553451:System [Manufactured Object]
   804   C1561954:tube [Conceptual Entity]
   804   C1704459:System [Medical Device]
   804   C1704730:TUBE [Medical Device]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "(STP3"

Phrase: ")"

Phrase: "Kit (Novagen"

Phrase: ")"

Phrase: "according to the instructions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302828:instructions [Intellectual Product]
  1000   C1442085:Instructions [Idea or Concept]
  1000   C3263700:Instructions [Clinical Attribute]
   966 E C0039401:Instruction [Educational Activity]

Phrase: "of the manufacturer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0947322:Manufacturer [Intellectual Product]
  1000   C1705426:Manufacturer [Population Group]

Phrase: "with pCITE-4C-RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1428955:RGL3 [Gene or Genome]

Phrase: "as template."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0728990:TEMPLATE [Medical Device]
  1000   C1514575:Template [Conceptual Entity]
  1000   C1705542:Template [Idea or Concept]
Processing 00000000.tx.110: The pCITE-4C-RGL3 plasmid was constructed by excising the EcoRI/XhoI fragment from pcDNA3.1+Zeo3HAb-RGL3 and cloning it to the corresponding sites of pCITE-4C (Novagen). 

Phrase: "The pCITE-4C-RGL3 plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "constructed by excising"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C2827421:Construct [Classification]

Phrase: "the EcoRI/XhoI fragment from pcDNA3.1+Zeo3HAb-RGL3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332255:fragment [Functional Concept]
   742   C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009015:Cloning [Research Activity]

Phrase: "it to the corresponding sites of pCITE-4C"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   754   C2945843:Site of [Qualitative Concept]
   744   C0205145:Sites [Spatial Concept]
   744   C0450376:4c [Intellectual Product]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]

Phrase: "(Novagen"

Phrase: ")."
Processing 00000000.tx.111: For binding experiments, recombinant GST or a series of GST-Ras-related fusion proteins were each preloaded with either GTPS or GDP as described above. 

Phrase: "For binding experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "recombinant GST"

Phrase: "or"

Phrase: "a series of GST-Ras-related fusion proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0205549:Series [Quantitative Concept]
   744   C2348044:Series [Intellectual Product]

Phrase: "were"

Phrase: "each"

Phrase: "preloaded with either GTPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "GDP as described above."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.112: Each reaction contained 5l of the in vitro translated [35S]methionine-labeled RGL3 protein diluted into 150l of binding buffer (50mM Tris-Cl, pH 7.5,120mM NaCl, 10mM MgCl2, 1% Triton X-100) containing 20M of either GTPS or GDP together with 10g of preloaded GST-hRitC-, GST-Ha-Ras, GST-RheB, or GST alone and 20l (50% slurry) of glutathione-agarose beads. 

Phrase: "Each reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "5l of the in vitro translated"

Phrase: "[35S"

Phrase: "]methionine-labeled RGL3 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "diluted into 150l of binding buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   719   C1720119:Dilute [Functional Concept]
   719   C1948037:Dilute [Functional Concept]

Phrase: "(50mM Tris-Cl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "120mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "10mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: ")"

Phrase: "containing 20M of either GTPS"

Phrase: "or"

Phrase: "GDP together with 10g of preloaded GST-hRitC-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "GST-Ha-Ras,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034678:RAS [Gene or Genome]

Phrase: "GST-RheB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419383:RHEB [Gene or Genome]
   861   C1419384:RHEB [Gene or Genome]

Phrase: "or"

Phrase: "GST"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "and"

Phrase: "20l"

Phrase: "(50% slurry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883043:Slurry [Substance]

Phrase: ")"

Phrase: "of glutathione-agarose beads."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0991566:Beads [Biomedical or Dental Material]
   793 E C2346972:Bead [Spatial Concept]
Processing 00000000.tx.113: After incubation for 2h at 4C with gentle rotation, the beads were pelleted by brief centrifugation and washed four times with 1ml of ice-cold binding buffer. 

Phrase: "After incubation"

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "with gentle rotation,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0035868:Rotation [Functional Concept]
   861   C0677597:Rotation [Functional Concept]
   789 E C0445237:Rotational [Spatial Concept]

Phrase: "the beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "pelleted by brief centrifugation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0007703:Centrifugation [Laboratory Procedure]
   770   C1282927:brief [Qualitative Concept]
   770   C1879313:Brief [Temporal Concept]
   737   C0441436:Pellet [Manufactured Object]
   737   C0993610:Pellet [Biomedical or Dental Material]
   737   C1998480:Pellet [Quantitative Concept]

Phrase: "and"

Phrase: "washed four times with 1ml of ice-cold binding buffer."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   739   C0040223:times [Temporal Concept]
   739   C1632851:Times [Quantitative Concept]
   706 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.114: The bound proteins were specifically eluted by resuspending the pellets in 15l of release buffer (PBS containing 25mM glutathione) for 10min on ice. 

Phrase: "The bound proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "specifically"

Phrase: "eluted by resuspending"

Phrase: "the pellets in 15l of release buffer"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0993610:pellets [Biomedical or Dental Material]
   714 E C0441436:Pellet [Manufactured Object]
   714 E C1998480:Pellet [Quantitative Concept]

Phrase: "(PBS containing 25mM glutathione"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "for 10min"

Phrase: "on ice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]
Processing 00000000.tx.115: Samples were analyzed by SDS-polyacrylamide gel electrophoresis on 8% polyacrylamide gels. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "analyzed by SDS-polyacrylamide gel electrophoresis"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   882   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   833   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C0936012:Analyzed [Research Activity]
   753   C1382104:Gel [Substance]

Phrase: "on 8% polyacrylamide gels."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   827   C0017243:Gels [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   793 E C1382104:Gel [Substance]
Processing 00000000.tx.116: The gels were stained with Coomassie Blue to detect GST and GST fusion proteins, treated with Amplify (Amersham Pharmacia Biotech), dried, and exposed to film. 

Phrase: "The gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "stained with Coomassie Blue to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
   760   C1260957:Blue [Qualitative Concept]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "GST"

Phrase: "and"

Phrase: "GST fusion proteins,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   867   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "treated with"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C1522326:Treated [Functional Concept]
   799 E C1292734:TREAT [Functional Concept]

Phrase: "Amplify"

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: ","

Phrase: "dried"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1512080:Dried [Qualitative Concept]
  1000   C2827485:Dried [Body Substance]
   966 E C0011682:Dry [Natural Phenomenon or Process]
   966 E C0205222:Dry [Qualitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "film."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086296:Film [Manufactured Object]
  1000   C1561571:film [Biomedical or Dental Material]
  1000   C1561572:film [Substance]
Processing 00000000.tx.117: Mammalian Cell Transfections and in Vivo Interactions-- HEK293 cells were cultured in Dulbecco's modified Eagle's medium containing 5% (v/v) fetal bovine serum, 50g/ml gentamicin and plated 24h prior to transfection at 70% confluence. 

Phrase: "Mammalian Cell Transfections"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]
   734   C1512977:Mammalian Cell [Cell]

Phrase: "and"

Phrase: "in Vivo Interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1704675:Interaction [Functional Concept]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "--"

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in Dulbecco's modified Eagle's medium"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   767   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   753   C0009458:Medium [Intellectual Product]
   753   C0325564:Eagle [Bird]
   753   C0392747:Modified [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1551720:Eagle [Population Group]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "(v/v) fetal bovine serum,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0007452:Bovine [Mammal]
   804   C0015965:Fetal [Embryonic Structure]
   804   C0229671:Serum [Body Substance]
   804   C0521457:Fetal [Functional Concept]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]

Phrase: "50g/ml gentamicin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017436:Gentamicin [Antibiotic,Carbohydrate]
   827   C0546866:Gentamicin [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "plated 24h prior to transfection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456696:/24h [Temporal Concept]
   760   C1442770:24H [Temporal Concept]

Phrase: "at 70% confluence."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0205200:Confluent [Qualitative Concept]
Processing 00000000.tx.118: Monolayers of HEK293 cells were transiently co-transfected with either 10g of pKH3RasQ61L or pKH3RitQ79L and 10g pcDNA3.1MycHisA-RGL3/10-cm dish using the calcium phosphate technique as described previously (21, 23). 

Phrase: "Monolayers of HEK293 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0872351:monolayers [Clinical Drug]

Phrase: "were"

Phrase: "transiently"

Phrase: "co-transfected with either 10g of pKH3RasQ61L"

Phrase: "or"

Phrase: "pKH3RitQ79L"

Phrase: "and"

Phrase: "10g pcDNA3.1MycHisA-RGL3/10-cm dish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0020498:DISH [Disease or Syndrome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the calcium phosphate technique"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0449851:Technique [Functional Concept]
   743 E C0025664:techniques [Intellectual Product]
   734   C0006711:calcium phosphate [Inorganic Chemical,Pharmacologic Substance]
   734   C0006712:Calcium/Phosphate [Inorganic Chemical,Pharmacologic Substance]
   734   C1161320:calcium phosphate [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(21,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.119: Cells were harvested 48h after transfection by scraping in phosphate-buffered saline (PBS) and resuspended in ice-cold hypotonic buffer (25mM Hepes, pH 7.5,10mM MgCl2, 1mM DTT, 1mM phenylmethanesulfonyl fluoride, 1g/ml leupeptin, 1g/mg pepstatin, 1g/mg aprotinin). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "48h after transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1442464:48H [Temporal Concept]

Phrase: "by scraping"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0184933:Scraping [Therapeutic or Preventive Procedure]
   966 E C0444082:scrape [Body Substance]

Phrase: "in phosphate-buffered saline (PBS)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "resuspended in ice-cold hypotonic buffer"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0456963:Ice cold [Qualitative Concept]
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0009264:Cold [Natural Phenomenon or Process]
   753   C0009443:Cold [Disease or Syndrome]
   753   C0020746:Ice [Inorganic Chemical]
   753   C0234192:Cold [Physiologic Function]
   753   C0241938:Hypotonic [Pathologic Function]

Phrase: "(25mM Hepes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "10mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1mM DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "1mM phenylmethanesulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0031493:Phenylmethanesulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   827   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1g/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "1g/mg pepstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "1g/mg aprotinin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.120: The cell pellet was incubated for 30min and lysed by 10strokes in a Dounce homogenizer on ice. 

Phrase: "The cell pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441436:Pellet [Manufactured Object]
   861   C0993610:Pellet [Biomedical or Dental Material]
   861   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "incubated for 30min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "lysed by 10strokes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0024348:lysed [Pathologic Function]

Phrase: "in a Dounce homogenizer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0181200:homogenizer [Medical Device]

Phrase: "on ice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]
Processing 00000000.tx.121: The homogenate was centrifuged at 4C for 3min at 103g, and the postnuclear supernatant was transferred to a fresh tube. 

Phrase: "The homogenate"

Phrase: "was"

Phrase: "centrifuged at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   756   C0179834:centrifuge [Medical Device]

Phrase: "for 3min"

Phrase: "at 103g,"

Phrase: "and"

Phrase: "the postnuclear supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "transferred to a fresh tube."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0175730:Tube [Medical Device]
   760   C0348011:transferred [Functional Concept]
   760   C0443224:Fresh [Qualitative Concept]
   760   C1547937:Tube NOS [Intellectual Product]
   760   C1561954:tube [Conceptual Entity]
   760   C1704730:TUBE [Medical Device]
   760   C2827486:Fresh [Body Substance]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]
Processing 00000000.tx.122: This material was then centrifuged at 4C for 15min at 105g to yield 105g supernatant and 105g pellet fractions. 

Phrase: "This material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Material [Substance]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "centrifuged at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   756   C0179834:centrifuge [Medical Device]

Phrase: "for 15min"

Phrase: "at 105g to"

Phrase: "yield"

Phrase: "105g supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]

Phrase: "and"

Phrase: "105g pellet fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.123: The 105g pellet was resuspended in ice-cold lysis buffer (25mM Hepes, 100mM NaCl, 10mM MgCl2, 1% Nonidet P-40, 1mM DTT, 1mM phenylmethanesulfonyl fluoride, 1g/ml leupeptin, 1g/mg pepstatin, 1g/mg aprotinin, pH 7.5) and incubated on ice for 30min, and insoluble material was eliminated by centrifugation at 4C for 20min at 12103 rpm. 

Phrase: "The 105g pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441436:Pellet [Manufactured Object]
   861   C0993610:Pellet [Biomedical or Dental Material]
   861   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "resuspended in ice-cold lysis buffer"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0456963:Ice cold [Qualitative Concept]
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0009264:Cold [Natural Phenomenon or Process]
   753   C0009443:Cold [Disease or Syndrome]
   753   C0020746:Ice [Inorganic Chemical]
   753   C0024348:Lysis [Pathologic Function]
   753   C0234192:Cold [Physiologic Function]
   753   C1536403:lysis [Cell Function]

Phrase: "(25mM Hepes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "100mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "10mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: "1mM DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "1mM phenylmethanesulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0031493:Phenylmethanesulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   827   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1g/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "1g/mg pepstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "1g/mg aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "incubated on ice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 30min,"

Phrase: "and"

Phrase: "insoluble material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]

Phrase: "was"

Phrase: "eliminated by centrifugation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C0849355:Eliminated [Qualitative Concept]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "for 20min"

Phrase: "at 12103 rpm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0582523:rpm [Quantitative Concept]
Processing 00000000.tx.124: Solubilized membrane extracts (200g) were resuspended in 200l of binding buffer (20mM Tris-HCl, 250mM NaCl, 1mM MgCl2, 10M GTP, 0.1% Triton X-100, 50mM imidazole, pH 7.5) and incubated with 20l of a 50% slurry of Ni-NTA beads for 2h at 4C with end-over-end rotation to allow isolation of MycHis6-tagged RGL3. 

Phrase: "Solubilized membrane extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2828366:Extract [Substance]

Phrase: "(200g"

Phrase: ")"

Phrase: "were"

Phrase: "resuspended in 200l of binding buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "(20mM Tris-HCl,"

Phrase: "250mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "1mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "10M GTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "0.1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "50mM imidazole,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020923:Imidazole [Organic Chemical,Pharmacologic Substance]
   861   C0020924:imidazole [Organic Chemical,Pharmacologic Substance]

Phrase: "pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "incubated with 20l of a 50% slurry of Ni-NTA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0028132:NTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   739   C1439852:Incubated [Laboratory Procedure]
   739   C1883043:Slurry [Substance]
   739   C2348274:Ni [Element, Ion, or Isotope]

Phrase: "beads for 2h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0991566:Beads [Biomedical or Dental Material]
   790   C1292425:2H [Temporal Concept]
   790   C2346972:Bead [Spatial Concept]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "with end-over-end rotation to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0035868:Rotation [Functional Concept]
   804   C0677597:Rotation [Functional Concept]
   733 E C0445237:Rotational [Spatial Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "isolation of MycHis6-tagged RGL3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0204727:Isolation [Therapeutic or Preventive Procedure]
   760   C0205409:Isolation [Functional Concept]
   760   C0220862:isolation [Laboratory Procedure]
Processing 00000000.tx.125: The Ni-NTA beads were then pelleted in a microcentrifuge for 10s at 14103 rpm, and the supernatant was discarded. 

Phrase: "The Ni-NTA beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0991566:Beads [Biomedical or Dental Material]
   793 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "pelleted in a microcentrifuge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0441436:Pellet [Manufactured Object]
   737   C0993610:Pellet [Biomedical or Dental Material]
   737   C1998480:Pellet [Quantitative Concept]

Phrase: "for 10s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552124:10s [Body Part, Organ, or Organ Component]

Phrase: "at 14103 rpm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0582523:rpm [Quantitative Concept]

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "discarded."
Processing 00000000.tx.126: The pelleted Ni-NTA beads were then washed three times with ice-cold binding buffer (1ml), after which bound proteins were released by boiling in SDS-PAGE loading buffer and subjected to SDS-polyacrylamide gel electrophoresis on two separate 8% polyacrylamide gels. 

Phrase: "The pelleted Ni-NTA beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0991566:Beads [Biomedical or Dental Material]
   779 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with ice-cold binding buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0040223:times [Temporal Concept]
   748   C1632851:Times [Quantitative Concept]
   714 E C3541383:Time [Temporal Concept]

Phrase: "(1ml"

Phrase: ")"

Phrase: ","

Phrase: "after"

Phrase: "which"

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "released by boiling"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0391871:Released [Functional Concept]
   790   C1283071:Released [Functional Concept]
   756 E C0030685:Release [Health Care Activity]
   756   C0242301:Boil [Disease or Syndrome]
   756 E C0439180:% release [Quantitative Concept]
   756 E C0680255:release [Health Care Activity]
   756   C1546559:Boil [Intellectual Product]
   756 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "in SDS-PAGE loading buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "subjected to SDS-polyacrylamide gel electrophoresis"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   882   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   833   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C1382104:Gel [Substance]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "on two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "8% polyacrylamide gels."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   827   C0017243:Gels [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   793 E C1382104:Gel [Substance]
Processing 00000000.tx.127: The presence of RGL3 in the pellet fraction was detected by immunoblotting with monoclonal anti-Myc antibody (9E10) and visualized by ECL (Amersham Pharmacia Biotech), whereas co-precipitated HA-tagged RasQ61L and RitQ79L proteins were revealed by immunoblotting with the anti-HA monoclonal 12CA5. 

Phrase: "The presence of RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the pellet fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "detected by immunoblotting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "with monoclonal anti-Myc antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(9E10"

Phrase: ")"

Phrase: "and"

Phrase: "visualized by ECL (Amersham Pharmacia Biotech"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0234621:Visualized [Functional Concept]
   753   C0331955:Pharmacia [Health Care Related Organization]
   753   C1332684:ECL [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "co-precipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "HA-tagged RasQ61L"

Phrase: "and"

Phrase: "RitQ79L proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "revealed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0443289:Revealed [Qualitative Concept]

Phrase: "with the anti-HA monoclonal 12CA5."
Processing 00000000.tx.128: In Vitro Binding of RGL3RBD Domain with Ras-like Small GTPases-- The ability of His6-RGL3RBD (the isolated RGL3 CDC25 domain) to bind immobilized Ras-like GTPases was determined essentially as described previously (17). 

Phrase: "In Vitro Binding of RGL3RBD Domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "with Ras-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "like Small GTPases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751984:Small GTPases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "-"

Phrase: "-"

Phrase: "The ability of His6-RGL3RBD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "("

Phrase: "the isolated RGL3 CDC25 domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "immobilized Ras-like GTPases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   898   C1538770:Ras like GTPase [Gene or Genome]
   770   C0034678:RAS [Gene or Genome]

Phrase: "was"

Phrase: "determined"

Phrase: "essentially"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.129: Glutathione-agarose beads containing 5g of GST or GST-Ras-related fusion protein were incubated at 30C for 10min in 200l of stripping buffer (20mM Tris-HCl, 150mM NaCl, 10mM EDTA, 5% glycerol, 0.1% Nonidet P-40, 0.1% BSA, 1mM DTT, pH 7.5) to release bound nucleotides. 

Phrase: "Glutathione-agarose beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0991566:Beads [Biomedical or Dental Material]
   793 E C2346972:Bead [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5g of GST"

Phrase: "or"

Phrase: "GST-Ras-related fusion protein"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   888   C1335596:ras-related protein [Gene or Genome]
   888   C1335599:Ras-Related Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   888   C1704396:RAS-Related Protein [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0242853:Ras protein [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332466:Fusion [Functional Concept]
   804   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "incubated at 30C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 10min"

Phrase: "in 200l"

Phrase: "of stripping buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(20mM Tris-HCl,"

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "10mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "5% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "0.1% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   804   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   804   C0439509:/40 [Temporal Concept]

Phrase: "0.1% BSA,"

Phrase: "1mM DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "bound nucleotides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.130: The beads (10l) were washed three times with stripping buffer and resuspended in 100l of stripping buffer containing 5g of His6-RGL3RBD protein. 

Phrase: "The beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "(10l"

Phrase: ")"

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with stripping buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "resuspended in 100l of stripping buffer containing 5g of His6-RGL3RBD protein."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   736   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0185047:Stripping [Therapeutic or Preventive Procedure]
   736   C0332256:Containing [Functional Concept]
   736   C2700400:Containing [Activity]
   703 E C1321564:Strip [Medical Device]
Processing 00000000.tx.131: Following inversion at 4C for 2h, beads were washed four times with ice-cold stripping buffer, and bound proteins were eluted with 15l of elution buffer (25mM glutathione in PBS) and resolved by SDS-polyacrylamide gel electrophoresis on 8% polyacrylamide gels. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "inversion at 4C"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0021943:Inversion [Cell or Molecular Dysfunction]
   790   C0021945:Inversion [Anatomical Abnormality]
   790   C1705687:Inversion [Cell or Molecular Dysfunction]
   790   C2349984:Inversion [Spatial Concept]

Phrase: "for 2h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "four times with ice-cold stripping buffer,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0040223:times [Temporal Concept]
   748   C1632851:Times [Quantitative Concept]
   714 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "bound proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "eluted with 15l of elution buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C1441565:Elution [Laboratory Procedure]

Phrase: "(25mM glutathione in PBS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "and"

Phrase: "resolved by SDS-polyacrylamide gel electrophoresis"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   882   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   833   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C1382104:Gel [Substance]
   753   C1514893:Resolved [Idea or Concept]
   753   C2699488:Resolved [Conceptual Entity]

Phrase: "on 8% polyacrylamide gels."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   827   C0017243:Gels [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   793 E C1382104:Gel [Substance]
Processing 00000000.tx.132: Following electrophoretic transfer to nitrocellulose, RGL3RBD was detected by Western blotting with monoclonal anti-T7 tag antibody and ECL reagents (Amersham Pharmacia Biotech). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "electrophoretic transfer to nitrocellulose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040671:Transfer [Mental Process]
   770   C1705822:Transfer [Activity]

Phrase: "RGL3RBD"

Phrase: "was"

Phrase: "detected by Western blotting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "with monoclonal anti-T7 tag antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "ECL reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.133: The nucleotide dependence of RGL3RBD binding to Ral proteins was compared with the interaction of the CDC25 domain from the known RalGEF, RLF (RLFRBD). 

Phrase: "The nucleotide dependence of RGL3RBD binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011546:Dependence [Mental Process]
   753   C0439857:Dependence [Mental or Behavioral Dysfunction]
   753   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "to Ral proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0220304:ral Protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "compared with the interaction of the CDC25 domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C1704675:Interaction [Functional Concept]
   744   C1707455:Compared [Activity]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3538850:CDC25 [Gene or Genome]
   744   C3541951:Domain [Intellectual Product]

Phrase: "from the known RalGEF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0378212:RALGEF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1335588:RalGEF [Gene or Genome]
   861   C1706345:RalGEF [Gene or Genome]

Phrase: "RLF (RLFRBD"

Phrase: ")."
Processing 00000000.tx.134: Glutathione-agarose beads containing bound GST or GST-Ral were incubated in stripping buffer for 10min at 25C to release the bound nucleotides. 

Phrase: "Glutathione-agarose beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0991566:Beads [Biomedical or Dental Material]
   793 E C2346972:Bead [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "bound GST"

Phrase: "or"

Phrase: "GST-Ral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0812284:RAL [Gene or Genome]
   861   C1704992:RAL [Gene or Genome]

Phrase: "were"

Phrase: "incubated in stripping buffer"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0185047:Stripping [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]
   737 E C1321564:Strip [Medical Device]

Phrase: "for 10min"

Phrase: "at 25C to"

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "the bound nucleotides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.135: The beads (10l, 500pmol of protein) were then collected by centrifugation and resuspended in the same buffer or in Ral exchange buffer (20mM Tris, pH 7.5,50mM NaCl, 10mM EDTA, 20mM MgCl2, 5% glycerol, 1mM DTT) containing either 1mM GTPS or GDP. 

Phrase: "The beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "(10l,"

Phrase: "500pmol of protein"

Phrase: ")"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "collected by centrifugation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "resuspended in the same buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0445247:Same [Qualitative Concept]

Phrase: "or in Ral exchange buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0678640:exchange [Social Behavior]
   760   C0812284:RAL [Gene or Genome]
   760   C1704992:RAL [Gene or Genome]

Phrase: "(20mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "50mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "10mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "20mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "5% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "1mM DTT)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "either 1mM GTPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "GDP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.136: Following incubation at 25C for 30min to allow nucleotide binding, the beads were pelleted and resuspended in 200l of binding buffer (20mM Tris-HCl, pH 7.5,50mM NaCl, 5% glycerol, 1% BSA, 1% Nonidet P-40, 1mM DTT) containing the respective concentrations of MgCl2 and nucleotide or EDTA. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "incubation at 25C"

Phrase: "for 30min to"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "nucleotide binding,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1148916:nucleotide binding [Molecular Function]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "the beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "pelleted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0441436:Pellet [Manufactured Object]
   966   C0993610:Pellet [Biomedical or Dental Material]
   966   C1998480:Pellet [Quantitative Concept]

Phrase: "and"

Phrase: "resuspended in 200l of binding buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "(20mM Tris-HCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "50mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "5% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "1% BSA,"

Phrase: "1% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: "1mM DTT)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the respective concentrations of MgCl2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "nucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "EDTA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.137: To this was added 100pmol of RGL3RBD or RLFRBD. 

Phrase: "To this"

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "100pmol of RGL3RBD"

Phrase: "or"

Phrase: "RLFRBD."
Processing 00000000.tx.138: After inversion at 4C for 2h, beads were pelleted, washed three times with PBS adjusted to maintain the same MgCl2 and nucleotide concentrations. 

Phrase: "After inversion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021943:Inversion [Cell or Molecular Dysfunction]
  1000   C0021945:Inversion [Anatomical Abnormality]
  1000   C1705687:Inversion [Cell or Molecular Dysfunction]
  1000   C2349984:Inversion [Spatial Concept]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "for 2h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "pelleted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0441436:Pellet [Manufactured Object]
   966   C0993610:Pellet [Biomedical or Dental Material]
   966   C1998480:Pellet [Quantitative Concept]

Phrase: ","

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with PBS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "adjusted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456081:Adjusted [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "the same MgCl2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "nucleotide concentrations."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.139: The beads were resuspended in 20l of SDS-PAGE loading buffer, heated at 95C for 5min to release bound protein, and resolved by SDS-polyacrylamide gel electrophoresis on 8% gels. 

Phrase: "The beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "resuspended in 20l of SDS-PAGE loading buffer,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C1704732:Page [Intellectual Product]
   744   C1708715:Loading [Activity]
   711 E C1550025:Load [Idea or Concept]
   711 E C1704782:Load [Manufactured Object]

Phrase: "heated at 95C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "for 5min to"

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "bound protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "resolved by SDS-polyacrylamide gel electrophoresis"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   882   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   833   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C1382104:Gel [Substance]
   753   C1514893:Resolved [Idea or Concept]
   753   C2699488:Resolved [Conceptual Entity]

Phrase: "on 8% gels."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]
Processing 00000000.tx.140: RGL3RBD and RLFRBD were detected by Western blotting using monoclonal anti-T7 tag antibody and visualized by chemiluminescence (Pierce). 

Phrase: "RGL3RBD"

Phrase: "and"

Phrase: "RLFRBD"

Phrase: "were"

Phrase: "detected by Western blotting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "monoclonal anti-T7 tag antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "visualized by chemiluminescence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   790   C0234621:Visualized [Functional Concept]
   790   C1450278:Chemiluminescence [Natural Phenomenon or Process]

Phrase: "(Pierce"

Phrase: ")."
Processing 00000000.tx.141: In Vitro Guanine Nucleotide Exchange Reactions-- GDP dissociation from recombinant Ral and Ha-Ras in the presence and absence of recombinant RGL3RBD or RLFRBD proteins was measured using a previously described method (17). 

Phrase: "In Vitro Guanine Nucleotide Exchange Reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   766   C0443286:Reaction [Functional Concept]
   766   C1114821:Reaction [Clinical Attribute]

Phrase: "--"

Phrase: "GDP dissociation from recombinant Ral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "Ha-Ras in the presence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0034678:RAS [Gene or Genome]

Phrase: "and"

Phrase: "absence of recombinant RGL3RBD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "RLFRBD proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a previously described method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.142: Briefly, 2M recombinant His6-tagged Ral or GST-Ha-Ras protein was incubated with 2M [3H]GDP in loading buffer (50l total volume) that contained 20mM Tris-HCl, pH 7.5,100mM NaCl, 1mM EDTA, 0.919mM MgCl2, 1mM DTT, and 1g/l BSA at 30C for 30min to allow [3H]GDP loading. 

Phrase: "Briefly,"

Phrase: "2M recombinant His6-tagged Ral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0812284:RAL [Gene or Genome]
   804   C1704992:RAL [Gene or Genome]

Phrase: "or"

Phrase: "GST-Ha-Ras protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0079972:Ha-ras Protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0242853:Ras protein [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "incubated with 2M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1439852:Incubated [Laboratory Procedure]
   790   C3171718:2M [Quantitative Concept]

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]GDP in loading buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(50l total volume"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0449468:Total Volume [Quantitative Concept]
           *Volume
   827   C0439175:% total [Quantitative Concept]
   827   C0439810:Total [Qualitative Concept]
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2700258:Volume [Laboratory Procedure]

Phrase: ")"

Phrase: "that contained 20mM Tris-HCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "100mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "0.919mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1mM DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "1g/l BSA at 30C"

Phrase: "for 30min to"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]GDP loading."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]
Processing 00000000.tx.143: MgCl2 was then added to the reaction mixture to adjust the final MgCl2 concentration to 5mM. 

Phrase: "MgCl2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added to the reaction mixture to"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0439962:Mixture [Substance]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1524062:Added [Functional Concept]
   719 E C1883712:Add [Functional Concept]

Phrase: "adjust"

Phrase: "the final MgCl2 concentration to 5mM."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.144: Unlabeled GDP was added to the reaction buffer to a final concentration of 1mM to initiate [3H]GDP dissociation in the presence or absence of 5M recombinant His6-tagged RGL3RBD or RLFRBD fusion protein. 

Phrase: "Unlabeled GDP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "added to the reaction buffer"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1524062:Added [Functional Concept]
   726 E C1883712:Add [Functional Concept]

Phrase: "to a final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 1mM to"

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]GDP dissociation in the presence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "or"

Phrase: "absence of 5M recombinant His6-tagged RGL3RBD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "RLFRBD fusion protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]
Processing 00000000.tx.145: At the indicated times after the addition of unlabeled GDP, the samples were diluted into 2ml of ice-cold washing buffer (20mM Tris-HCl, 100mM NaCl, 10mM MgCl2, 1mM DTT, pH 7.5), filtered on BA85 nitrocellulose membrane, washed, and counted as described previously (17). 

Phrase: "At the indicated times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "after the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of unlabeled GDP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "diluted into 2ml of ice-cold washing buffer"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0456963:Ice cold [Qualitative Concept]
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0009264:Cold [Natural Phenomenon or Process]
   744   C0009443:Cold [Disease or Syndrome]
   744   C0020746:Ice [Inorganic Chemical]
   744   C0234192:Cold [Physiologic Function]
   744   C0441648:Washing [Activity]
   711   C1720119:Dilute [Functional Concept]
   711   C1948037:Dilute [Functional Concept]

Phrase: "(20mM Tris-HCl,"

Phrase: "100mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "10mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1mM DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "filtered on BA85 nitrocellulose membrane,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0025255:Membrane [Tissue]
   760   C0596901:Membrane [Cell Component]
   760   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   760   C1706182:Membrane [Manufactured Object]
   726   C0180860:Filter [Manufactured Object]
   726   C0581406:Filter [Medical Device]
   726   C1522664:Filter [Intellectual Product]
   726   C1704449:Filter [Conceptual Entity]
   726   C1704684:Filter [Medical Device]
   726   C1875155:FILTER [Medical Device]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "and"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.146: Ral Activation Assays-- In vivo Ral activation was determined using GST-RalBD essentially as described previously (24-27). 

Phrase: "Ral Activation Assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "--"

Phrase: "In vivo Ral activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GST-RalBD essentially"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(24-27"

Phrase: ")."
Processing 00000000.tx.147: To construct the RalBD expression plasmid, PCR was performed on EST clone AA085990 (which encodes hRLIP76) to introduce 5'-BamHI and 3'-EcoRI sites flanking the RLIP76-RalBD domain. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "the RalBD expression plasmid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "performed on EST clone AA085990"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0009013:Clone [Cell]
   760   C0884358:Performed [Functional Concept]
   760   C1522642:Clone [Tissue]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "("

Phrase: "which"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "hRLIP76"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "introduce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292748:introduce [Functional Concept]

Phrase: "5'-BamHI"

Phrase: "and"

Phrase: "3'-EcoRI sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "the RLIP76-RalBD domain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.148: The PCR product was subcloned to BamHI/EcoRI-digested pGEX-KG, and GST-RalBD was produced in bacteria as described above. 

Phrase: "The PCR product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "subcloned to BamHI/EcoRI-digested pGEX-KG,"

Phrase: "and"

Phrase: "GST-RalBD"

Phrase: "was"

Phrase: "produced in bacteria"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0004611:Bacteria [Bacterium]
   790   C1510439:bacteria [Functional Concept]
   790   C2347473:% Bacteria [Quantitative Concept]
   718 E C0521009:Bacterial [Qualitative Concept]

Phrase: "as described above."
Processing 00000000.tx.149: HEK293 cells (3106 cells per 10-cm plate) were transiently transfected with 10g of pcDNA3.1Zeo, pcDNA3.1Zeo3HAb-RGL3, or pcDNA3.1Zeo3HAb-RGL3-RBD using the calcium-phosphate method (28). 

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(3106 cells per 10-cm plate"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   783   C1166718:cells plate [Cell Component]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with 10g of pcDNA3.1Zeo,"

Phrase: "pcDNA3.1Zeo3HAb-RGL3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1428955:RGL3 [Gene or Genome]

Phrase: "or"

Phrase: "pcDNA3.1Zeo3HAb-RGL3-RBD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1880389:Domain [Functional Concept]
   799   C1883221:Domain [Conceptual Entity]
   799   C3541951:Domain [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the calcium-phosphate method"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]
   734   C0006711:calcium phosphate [Inorganic Chemical,Pharmacologic Substance]
   734   C0006712:Calcium/Phosphate [Inorganic Chemical,Pharmacologic Substance]
   734   C1161320:calcium phosphate [Pharmacologic Substance]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.150: The activation status of endogenous RalA in HEK293 cells was determined using GST-RalBD. 

Phrase: "The activation status of endogenous RalA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449438:Status [Qualitative Concept]

Phrase: "in HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GST-RalBD."
Processing 00000000.tx.151: Briefly, 40h after transfection, cells were washed once with ice-cold PBS and lysed in 600l of ice-cold buffer D (50mM Tris-HCl, 200mM NaCl, 10mM MgCl2, 1% Nonidet P-40, 15% glycerol, 1mM DTT, 1mM phenylmethanesulfonyl fluoride, 1g/ml leupeptin, 1g/mg pepstatin, 1g/mg aprotinin, pH 7.5). 

Phrase: "Briefly,"

Phrase: "40h after transfection,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once with ice-cold PBS"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0456963:Ice cold [Qualitative Concept]
   774   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0009264:Cold [Natural Phenomenon or Process]
   748   C0009443:Cold [Disease or Syndrome]
   748   C0020746:Ice [Inorganic Chemical]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0036082:Saline [Substance]
   748   C0234192:Cold [Physiologic Function]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   748   C1720092:Once [Intellectual Product]
   748   C1948045:Once [Temporal Concept]

Phrase: "and"

Phrase: "lysed in 600l of ice-cold buffer"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0456963:Ice cold [Qualitative Concept]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0009264:Cold [Natural Phenomenon or Process]
   748   C0009443:Cold [Disease or Syndrome]
   748   C0020746:Ice [Inorganic Chemical]
   748   C0024348:lysed [Pathologic Function]
   748   C0234192:Cold [Physiologic Function]

Phrase: "D ("

Phrase: "50mM Tris-HCl,"

Phrase: "200mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "10mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: "15% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "1mM DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "1mM phenylmethanesulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0031493:Phenylmethanesulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   827   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1g/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "1g/mg pepstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "1g/mg aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.152: The homogenate was centrifuged at 4C for 30min at 12,000rpm, and the protein concentration of the clarified lysate was determined. 

Phrase: "The homogenate"

Phrase: "was"

Phrase: "centrifuged at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   756   C0179834:centrifuge [Medical Device]

Phrase: "for 30min"

Phrase: "at 12,"

Phrase: "000rpm,"

Phrase: "and"

Phrase: "the protein concentration of the clarified lysate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0427716:Protein concentration [Laboratory Procedure]
   778   C1304757:Protein concentration [Laboratory or Test Result]
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "determined."
Processing 00000000.tx.153: For analysis of Ral-GTP levels, 1.5mg of cell lysate was combined with GST-RalBD (20g) and 10l of a 50% (v/v) slurry of glutathione-agarose beads in a 500-l reaction for 2h at 4C with gentle rotation. 

Phrase: "For analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "of Ral-GTP levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "1.5mg of cell lysate"

Phrase: "was"

Phrase: "combined with GST-RalBD"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0205195:Combined [Qualitative Concept]
   737 E C0336789:Combine [Manufactured Object]

Phrase: "(20g"

Phrase: ")"

Phrase: "and"

Phrase: "10l of a 50%"

Phrase: "(v/v) slurry of glutathione-agarose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883043:Slurry [Substance]

Phrase: "beads in a 500-l reaction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0443286:Reaction [Functional Concept]
   753   C0991566:Beads [Biomedical or Dental Material]
   753   C1114821:Reaction [Clinical Attribute]
   753   C2346972:Bead [Spatial Concept]

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "with gentle rotation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0035868:Rotation [Functional Concept]
   861   C0677597:Rotation [Functional Concept]
   789 E C0445237:Rotational [Spatial Concept]
Processing 00000000.tx.154: The beads were pelleted by brief centrifugation (2103 rpm) and washed three times (1ml) with ice-cold buffer D.

Phrase: "The beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "pelleted by brief centrifugation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0007703:Centrifugation [Laboratory Procedure]
   770   C1282927:brief [Qualitative Concept]
   770   C1879313:Brief [Temporal Concept]
   737   C0441436:Pellet [Manufactured Object]
   737   C0993610:Pellet [Biomedical or Dental Material]
   737   C1998480:Pellet [Quantitative Concept]

Phrase: "(2103 rpm)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0582523:rpm [Quantitative Concept]

Phrase: "and"

Phrase: "washed three times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: "(1ml"

Phrase: ")"

Phrase: "with ice-cold buffer D."
Processing 00000000.tx.155: The bound proteins were eluted by boiling for 5min in 20l of 2 SDS sample buffer and separated by SDS-polyacrylamide gel electrophoresis (10% polyacrylamide gel). 

Phrase: "The bound proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "eluted by boiling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0242301:Boil [Disease or Syndrome]
   756   C1546559:Boil [Intellectual Product]

Phrase: "for 5min"

Phrase: "in 20l"

Phrase: "of 2 SDS sample buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "separated by SDS-polyacrylamide gel electrophoresis"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   882   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   833   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   753   C1382104:Gel [Substance]

Phrase: "(10% polyacrylamide gel"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   827   C1382104:Gel [Substance]

Phrase: ")."
Processing 00000000.tx.156: The presence of Ral in the pellet was detected by immunoblotting with monoclonal anti-RalA antibody (Transduction Laboratories, Lexington, KY). 

Phrase: "The presence of Ral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "detected by immunoblotting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "with monoclonal anti-RalA antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Transduction Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "Lexington,"

Phrase: "KY"

Phrase: ")."
Processing 00000000.tx.157: To control for equal RGL3 expression, clarified whole cell lysates (10g) were analyzed by SDS-PAGE and immunoblotted with anti-HA monoclonal 12CA5. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "control for equal RGL3 expression,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0205163:Equal [Qualitative Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1428955:RGL3 [Gene or Genome]
   760   C1549782:Equal [Idea or Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "clarified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarified [Activity]

Phrase: "whole cell lysates"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate
   827   C0007634:Cell [Cell]
   827   C0444667:Whole [Quantitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "(10g"

Phrase: ")"

Phrase: "were"

Phrase: "analyzed by SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0936012:Analyzed [Research Activity]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "immunoblotted with anti-HA monoclonal 12CA5."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0018909:Haemagglutinin, NOS [Immunologic Factor]
   753   C0746619:monoclonal [Finding]
   719   C0020985:Immunoblot [Laboratory Procedure]
Processing 00000000.tx.158: To examine the ability of oncogenic Rit to activate Ral, HEK293 cells (3106 cells per 10-cm plate) were transiently co-transfected with 5g of pKH3B-RalA and either 10g of pKH3-RitWT, pKH3-RitQ79L, or pKH3-Rit79L58C using the calcium-phosphate method (28), and the activation status of HA-RalA was determined using GST-RalBD. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the ability of oncogenic Rit to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "Ral,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812284:RAL [Gene or Genome]
  1000   C1704992:RAL [Gene or Genome]

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(3106 cells per 10-cm plate"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   783   C1166718:cells plate [Cell Component]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "transiently"

Phrase: "co-transfected with 5g of pKH3B-RalA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0765159:RALA [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0812284:RALA [Gene or Genome]

Phrase: "and"

Phrase: "either 10g of pKH3-RitWT,"

Phrase: "pKH3-RitQ79L,"

Phrase: "or"

Phrase: "pKH3-Rit79L58C"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the calcium-phosphate method"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]
   734   C0006711:calcium phosphate [Inorganic Chemical,Pharmacologic Substance]
   734   C0006712:Calcium/Phosphate [Inorganic Chemical,Pharmacologic Substance]
   734   C1161320:calcium phosphate [Pharmacologic Substance]

Phrase: "(28"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the activation status of HA-RalA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449438:Status [Qualitative Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GST-RalBD."
Processing 00000000.tx.159: The presence of GTP-bound HA-RalA was determined by SDS-PAGE analysis and immunoblotting the GST pellet fraction with anti-HA monoclonal 12CA5, whereas the expression of Rit and Ras was monitored in whole cell lysates by immunoblotting using anti-HA monoclonal 12CA5. 

Phrase: "The presence of GTP-bound HA-RalA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "determined by SDS-PAGE analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "the GST pellet fraction with anti-HA monoclonal 12CA5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1264633:Fraction [Quantitative Concept]
   742   C1554103:Fraction [Idea or Concept]

Phrase: "whereas"

Phrase: "the expression of Rit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "was"

Phrase: "monitored in whole cell lysates"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C1881488:Cell Lysate [Physical Object]
           Lysate
   760   C0007634:Cell [Cell]
   760   C0444667:Whole [Quantitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726   C0030695:monitor [Health Care Activity]
   726   C0150369:monitor [Health Care Activity]
   726   C0181904:Monitor [Medical Device]
   726   C0596972:Monitor [Medical Device]
   726   C1521743:Monitor [Professional or Occupational Group]
   726   C1704646:Monitor [Manufactured Object]

Phrase: "by immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-HA monoclonal 12CA5."
Processing 00000000.tx.160: The expression of activated Rit alone is also sufficient to stimulate GDP/GTP exchange on Ral via endogenous RalGEF family proteins (see Fig. 9). 

Phrase: "The expression of activated Rit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "is"

Phrase: "also sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205410:Sufficient [Qualitative Concept]

Phrase: "stimulate"

Phrase: "GDP/GTP exchange on Ral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0678640:exchange [Social Behavior]

Phrase: "via endogenous RalGEF family proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.161: The ability of oncogenic Rit or Ras to stimulate RGL3 exchange activity was examined in HEK293 cell monolayers transiently transfected with either pKH3RasQ61L (2g), pKH3RitQ79L (5g), or pKH3Rit79L58C (5g) together with 3g of pcDNA3.1+Zeo3HAb-RGL3 or pcDNA3.1+Zeo3HAb-RGL3-RBD by the calcium phosphate method (28). 

Phrase: "The ability of oncogenic Rit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "or"

Phrase: "Ras to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034678:RAS [Gene or Genome]

Phrase: "stimulate"

Phrase: "RGL3 exchange activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "examined in HEK293 cell monolayers transiently"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C2936239:HEK293 Cell [Cell]
   753   C0007634:Cell [Cell]
   753   C0332128:Examined [Finding]
   753   C0872351:monolayers [Clinical Drug]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "transfected with either pKH3RasQ61L"

Phrase: "(2g"

Phrase: ")"

Phrase: ","

Phrase: "pKH3RitQ79L"

Phrase: "(5g"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "pKH3Rit79L58C"

Phrase: "(5g"

Phrase: ")"

Phrase: "together with 3g"

Phrase: "of pcDNA3.1+Zeo3HAb-RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1428955:RGL3 [Gene or Genome]

Phrase: "or"

Phrase: "pcDNA3.1+Zeo3HAb-RGL3-RBD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C1880389:Domain [Functional Concept]
   795   C1883221:Domain [Conceptual Entity]
   795   C3541951:Domain [Intellectual Product]

Phrase: "by the calcium phosphate method"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]
   734   C0006711:calcium phosphate [Inorganic Chemical,Pharmacologic Substance]
   734   C0006712:Calcium/Phosphate [Inorganic Chemical,Pharmacologic Substance]
   734   C1161320:calcium phosphate [Pharmacologic Substance]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.162: The activation of endogenous RalA was determined as described above.  

Phrase: "The activation of endogenous RalA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "determined as described above."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1552738:described [Idea or Concept]
Processing 00000000.tx.163: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Isolation of RalGDS-related Protein as a Rit-interacting Protein-- A yeast two-hybrid screen was carried out to identify proteins that interact with Rit. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Isolation of RalGDS-related Protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0204727:Isolation [Therapeutic or Preventive Procedure]
   760   C0205409:Isolation [Functional Concept]
   760   C0220862:isolation [Laboratory Procedure]

Phrase: "as a Rit-interacting Protein-- A yeast two-hybrid screen"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   812   C0599647:Two Hybrid [Molecular Biology Research Technique]
   793   C0020205:Hybrid [Organism]
   793   C0036025:yeast [Fungus]
   793   C0043392:Yeast [Food]
   793   C0043393:Yeast [Fungus]
   793   C0205448:Two [Quantitative Concept]
   793   C0220908:screen [Health Care Activity]
   793   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   793   C1305399:screen [Functional Concept]
   793   C1705053:Screen [Medical Device]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439787:Out [Spatial Concept]
   861   C0849355:Out [Qualitative Concept]

Phrase: "identify"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "interact with Rit."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   790   C1419390:RIT [Gene or Genome]
Processing 00000000.tx.164: Ten million yeast transformants co-expressing a C-terminally truncated Rit bait plasmid and a cDNA library prepared from mouse embryo (18) were screened (see "Experimental Procedures" for details). 

Phrase: "Ten million yeast transformants"

Phrase: "co-expressing"

Phrase: "a C-terminally truncated Rit bait plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "a cDNA library"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   861   C0023621:Library [Manufactured Object,Organization]
   861   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "prepared from mouse embryo"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0013935:Embryo [Embryonic Structure]
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C1305370:Embryo [Embryonic Structure]
   737   C1521827:Prepare [Functional Concept]

Phrase: "(18"

Phrase: ")"

Phrase: "were"

Phrase: "screened"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0220908:screen [Health Care Activity]
   966   C1305399:screen [Functional Concept]
   966   C1705053:Screen [Medical Device]

Phrase: "(see ""Experimental Procedures"""
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]

Phrase: "for details"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522508:Details [Qualitative Concept]
   966 E C1561567:detail [Functional Concept]

Phrase: ")."
Processing 00000000.tx.165: Forty strong positives were obtained that showed both interaction-dependent growth on selection media and interaction-dependent expression of LacZ activity. 

Phrase: "Forty strong positives"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0439178:% Positive [Quantitative Concept]
   793   C1446409:Positive [Qualitative Concept]
   793   C1514241:Positive [Finding]
   793   C2825490:Positive [Qualitative Concept]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "that"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "both interaction-dependent growth on selection media"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0010454:growth media [Indicator, Reagent, or Diagnostic Aid]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "interaction-dependent expression of LacZ activity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.166: Of these initial clones, DNA sequencing revealed that 28of the clones contained various sized cDNA fragments of previously identified RalGDS family proteins including RalGDS (18clones) (29), RLF (7clones) (30), and RGL (3clones) (31). 

Phrase: "Of these initial clones,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "DNA sequencing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162326:DNA sequencing [Nucleotide Sequence]
  1000   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1553778:Sequencing [Intellectual Product]
   861   C1561491:Sequencing [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that 28of"

Phrase: "the clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0009013:Clones [Cell]
   966 E C1522642:Clone [Tissue]
   916 E C1704387:Clonal [Qualitative Concept]
   893 E C0796368:clonality [Diagnostic Procedure]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "various sized cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "fragments of previously identified RalGDS family proteins"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   757   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   748   C0015576:Family [Family Group]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205396:Identified [Qualitative Concept]
   748   C0332255:fragment [Functional Concept]
   748   C0378212:ral-GDS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0486805:Fragments [Body Substance]
   748   C1335588:RALGDS [Gene or Genome]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   748   C1704727:Family [Conceptual Entity]
   748   C1708096:Fragment [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "RalGDS (18clones"

Phrase: ")"

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "RLF (7clones"

Phrase: ")"

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "RGL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428954:RGL [Gene or Genome]

Phrase: "(3clones"

Phrase: ")"

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.167: However, four clones contained an open reading frame of 108amino acids encoding the C-terminal region of a novel protein with high sequence homology to the RalGDS gene family (RalGDS, RLF, RGL, and RGL-2) (20, 29-31). 

Phrase: "However,"

Phrase: "four clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "an open reading frame of 108amino acids"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0079941:Open Reading Frame [Gene or Genome]
   778   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   748   C0034754:Reading [Daily or Recreational Activity]
   748   C0175566:Open [Spatial Concept]
   748   C0180979:Frame [Medical Device]
   748   C1705179:Reading [Finding]
   748   C1705858:Frame [Manufactured Object]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the C-terminal region of a novel protein"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C1707271:C-Terminal [Amino Acid Sequence]
   767   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   767   C1168438:Protein C [Laboratory Procedure]
   767   C1418943:PROTEIN C [Gene or Genome]
   767   C1514562:Protein Region [Amino Acid Sequence]
   767   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0017446:Region [Geographic Area]
   744   C0205088:Terminal [Temporal Concept]
   744   C0205147:Region [Spatial Concept]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]

Phrase: "with high sequence homology"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0162775:Sequence Homology [Quantitative Concept]
   851 E C0162774:Sequence Homolog [Molecular Sequence]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1334043:Homology [Gene or Genome]
   827   C1519249:Sequence [Functional Concept]
   827   C2697616:Homology [Qualitative Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "to the RalGDS gene family"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C1517488:Gene Family [Gene or Genome]
   827   C0015576:Family [Family Group]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]
   734   C1335588:RALGDS gene [Gene or Genome]

Phrase: "(RalGDS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0378212:ral-GDS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335588:RALGDS [Gene or Genome]

Phrase: "RLF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035344:RLF [Disease or Syndrome]
  1000   C1416453:RLF [Gene or Genome]
  1000   C1419392:RLF [Gene or Genome]

Phrase: "RGL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428954:RGL [Gene or Genome]

Phrase: "and"

Phrase: "RGL-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428954:RGL [Gene or Genome]

Phrase: ")"

Phrase: "(20,"

Phrase: "29-31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.168: Based on this similarity we have named this protein RGL3 (Ral GDS-like 3). 

Phrase: "Based on this similarity"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   770   C2348205:Similarity [Qualitative Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "we"

Phrase: "have"

Phrase: "named"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027365:named [Intellectual Product]
   966 E C1547383:Name [Intellectual Product]

Phrase: "this protein RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428955:RGL3 [Gene or Genome]

Phrase: "(Ral GDS-like 3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0378212:ral-GDS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0451184:GDS [Intellectual Product]
   770   C0812284:RAL [Gene or Genome]
   770   C1149049:GDS [Molecular Function]
   770   C1418244:GdS [Gene or Genome]
   770   C1704992:RAL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.169: Analysis of the remaining clones will be described elsewhere. 

Phrase: "Analysis of the remaining clones"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   744   C1880109:Clonality Analysis [Molecular Biology Research Technique]

Phrase: "will"

Phrase: "be"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "elsewhere."
Processing 00000000.tx.170: The 288-bp RGL3 cDNA was used as a probe to isolate several longer cDNAs from a mouse kidney cDNA library (21). 

Phrase: "The 288-bp RGL3 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "used as a probe to"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0182400:Probe [Medical Device]
   760   C1273517:used [Finding]
   760   C1704681:Probe [Gene or Genome]
   760   C2347609:Probe [Chemical Viewed Functionally]
   760   C3536729:Probe [Manufactured Object]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "isolate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370215:Isolate [Substance]
  1000   C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "several longer cDNAs from a mouse kidney cDNA library"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   745   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   708   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.171: Although the largest clone obtained after repeated library screening encoded an open reading frame of 688amino acids, it was incomplete at the 5' end. 

Phrase: "Although"

Phrase: "the largest clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009013:Clone [Cell]
   861   C1522642:Clone [Tissue]
   789 E C1704387:Clonal [Qualitative Concept]
   761 E C0796368:clonality [Diagnostic Procedure]

Phrase: "obtained after repeated library screening"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   760   C0023621:Library [Manufactured Object,Organization]
   760   C0205341:Repeated [Functional Concept]
   760   C0220908:Screening [Health Care Activity]
   760   C0220909:screening [Functional Concept]
   760   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1301820:Obtained [Functional Concept]
   760   C1698960:screening [Intellectual Product]
   760   C1710031:Screening [Diagnostic Procedure]
   760   C1710477:SCREENING [Research Activity]
   726 E C1706701:Obtain [Activity]

Phrase: "encoded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0679058:encoded [Mental Process]
  1000   C2700640:Encoded [Activity]

Phrase: "an open reading frame of 688amino acids,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0079941:Open Reading Frame [Gene or Genome]
   778   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   748   C0034754:Reading [Daily or Recreational Activity]
   748   C0175566:Open [Spatial Concept]
   748   C0180979:Frame [Medical Device]
   748   C1705179:Reading [Finding]
   748   C1705858:Frame [Manufactured Object]

Phrase: "it"

Phrase: "was"

Phrase: "incomplete at the 5' end."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205257:Incomplete [Quantitative Concept]
   760   C0728938:incomplete [Quantitative Concept]
   760   C1548386:incomplete [Idea or Concept]
Processing 00000000.tx.172: Therefore, the 5'-RACE procedure was used to obtain the sequence at the 5' end of the open reading frame. 

Phrase: "Therefore,"

Phrase: "the 5'-RACE procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C1948041:Procedure [Therapeutic or Preventive Procedure]
   827   C2700391:Procedure [Activity]
   827   C3274430:PROCEDURE [Health Care Activity]
   827   C3538935:Procedure [Idea or Concept]
   827   C3539779:Procedure [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the sequence at the 5' end of the open reading frame."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0004793:Sequence [Nucleotide Sequence]
   738   C0162326:Sequence [Nucleotide Sequence]
   738   C0162327:Sequence [Nucleotide Sequence]
   738   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.173: Two independently isolated RACE clones, containing approximately 90bp of new 5' sequence, were used to confirm the 5' end of the RGL3 cDNA. 

Phrase: "Two independently isolated RACE clones,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0009013:Clones [Cell]
   771 E C1522642:Clone [Tissue]
   721 E C1704387:Clonal [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "approximately 90bp of new 5' sequence,"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the 5' end of the RGL3 cDNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0444930:End [Spatial Concept]
   748   C2746065:End [Temporal Concept]
Processing 00000000.tx.174: The full-length RGL3 cDNA was then generated by splicing together the RACE product with the remainder of the cDNA through a unique BglII restriction site. 

Phrase: "The full-length RGL3 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "generated by splicing together"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0035687:Splicing [Genetic Function]
   770   C1883357:Together [Qualitative Concept]
   770   C2610186:splicing [Genetic Function]
   770   C3146294:Generated [Activity]

Phrase: "the RACE product with the remainder of the cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1514468:product [Entity]
   742   C1704444:Product [Quantitative Concept]

Phrase: "through a unique BglII restriction site."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1882940:Restriction Site [Nucleotide Sequence]
   812   C0205145:Site [Spatial Concept]
   812   C0443288:Restriction [Functional Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]
Processing 00000000.tx.175: The 2.8-kb cDNA sequence includes a portion of the 5'-untranslated region, a 2127-nucleotide open reading frame followed by a termination codon, and a large 3'-untranslated region. 

Phrase: "The 2.8-kb cDNA sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   804   C0004793:Sequence [Nucleotide Sequence]
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0162326:Sequence [Nucleotide Sequence]
   804   C0162327:Sequence [Nucleotide Sequence]
   804   C1519249:Sequence [Functional Concept]
   733 E C1548958:Sequential [Idea or Concept]
   733 E C1705294:Sequential [Qualitative Concept]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "a portion of the 5'-untranslated region,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449719:Portion [Spatial Concept]

Phrase: "a 2127-nucleotide open reading frame"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   884   C0079941:Open Reading Frame [Gene or Genome]
   840   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   804   C0034754:Reading [Daily or Recreational Activity]
   804   C0175566:Open [Spatial Concept]
   804   C0180979:Frame [Medical Device]
   804   C1705179:Reading [Finding]
   804   C1705858:Frame [Manufactured Object]
   733 E C0547049:Openness [Spatial Concept]

Phrase: "followed by a termination codon,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0242611:Codon, Termination [Nucleotide Sequence]
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0009221:Codon [Nucleotide Sequence]
   760   C1095825:Codon [Plant]
   760   C1549081:Termination [Intellectual Product]
   760   C1692758:termination [Idea or Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "a large 3'-untranslated region."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.176: The putative initiating methionine lies within a favorable context for translation initiation according to Kozak's consensus (32). 

Phrase: "The putative initiating methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "lies within a favorable context"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0449255:Context [Finding]
   760   C0542559:Context [Functional Concept]
   760   C3640814:Favorable [Qualitative Concept]

Phrase: "for translation initiation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1519613:Translation Initiation [Genetic Function]
   861   C0589507:Initiation [Mental Process]
   861   C1158830:Initiation [Genetic Function]
   861   C1704686:Initiation [Functional Concept]

Phrase: "according to Kozak's consensus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0376298:Consensus [Social Behavior]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.177: Analysis of the open reading frame revealed significant identity at the nucleotide level with the RalGDS gene family (Fig. 1). 

Phrase: "Analysis of the open reading frame revealed significant identity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "at the nucleotide level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "with the RalGDS gene family"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C1517488:Gene Family [Gene or Genome]
   827   C0015576:Family [Family Group]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]
   734   C1335588:RALGDS gene [Gene or Genome]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.178: View larger version (81K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(81K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.179: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.180: RGL3 is a new member of the RalGDS family. 

Phrase: "RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "is"

Phrase: "a new member of the RalGDS family."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0086282:Family member [Family Group]
   774   C1611821:Family Member [Intellectual Product]
   748   C0680022:member [Population Group]
   748   C2698041:Member [Professional or Occupational Group]
Processing 00000000.tx.181: Comparison of the amino acid sequences of murine RGL3, RalGDS, RLF, and RGL. 

Phrase: "Comparison of the amino acid sequences of murine RGL3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1707455:Comparison [Activity]

Phrase: "RalGDS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0378212:ral-GDS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335588:RALGDS [Gene or Genome]

Phrase: "RLF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035344:RLF [Disease or Syndrome]
  1000   C1416453:RLF [Gene or Genome]
  1000   C1419392:RLF [Gene or Genome]

Phrase: "and"

Phrase: "RGL."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428954:RGL [Gene or Genome]
Processing 00000000.tx.182: The alignment was performed with the Clustal W1.6 program (62). 

Phrase: "The alignment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706765:Alignment [Quantitative Concept]

Phrase: "was"

Phrase: "performed with the Clustal W1.6 program"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0884358:Performed [Functional Concept]
   748   C1709697:Program [Conceptual Entity]
   748   C2728259:Program [Pharmacologic Substance]
   748   C3484370:Program [Functional Concept]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(62"

Phrase: ")."
Processing 00000000.tx.183: Hyphens represent gaps introduced for optimal alignment. 

Phrase: "Hyphens"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "gaps"

Phrase: "introduced for optimal alignment."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1706765:Alignment [Quantitative Concept]
   770   C2698651:Optimal [Qualitative Concept]
   737   C1292748:introduce [Functional Concept]
Processing 00000000.tx.184: Amino acid residues that are conserved in at least two of the four proteins in the alignment are placed in shaded boxes. 

Phrase: "Amino acid residues"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "that"

Phrase: "are"

Phrase: "conserved in"

Phrase: "at least two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205448:Two [Quantitative Concept]

Phrase: "of the four proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the alignment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706765:Alignment [Quantitative Concept]

Phrase: "are"

Phrase: "placed in shaded boxes."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0179400:boxes [Manufactured Object]
   770   C1638312:Boxes [Quantitative Concept]
   737   C0442504:Place [Spatial Concept]
   737 E C1533124:Box [Medical Device]
   737   C1704765:Place [Functional Concept]
   737   C1882509:Place [Activity]
   737   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.185: The consensus CDC25 homology domains (amino acids 87-507 of RGL3) and Rit/Ras-binding domains (RBD) (amino acids 611-709 of RGL3) are indicated by black arrows. 

Phrase: "The consensus CDC25 homology domains"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C1334043:Homology [Gene or Genome]
   812   C2697616:Homology [Qualitative Concept]
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]

Phrase: "(amino acids 87-507 of RGL3"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   753   C0450381:507 [Intellectual Product]
   753   C1428955:RGL3 [Gene or Genome]
   719 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "and"

Phrase: "Rit/Ras-binding domains"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0034678:RAS [Gene or Genome]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]

Phrase: "(RBD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: ")"

Phrase: "(amino acids 611-709 of RGL3"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   753   C1428955:RGL3 [Gene or Genome]
   719 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "are"

Phrase: "indicated by black arrows."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0005680:Black [Population Group]
   770   C0027567:Black [Population Group]
   770   C0085756:Black [Population Group]
   770   C0336721:arrows [Manufactured Object]
   770   C0439541:Black [Qualitative Concept]
   770   C1444656:Indicated [Finding]
Processing 00000000.tx.186: The RGL3 cDNA encodes a putative open reading frame encoding a protein of 709amino acids with a predicted molecular mass of 77,968Da (Fig. 1). 

Phrase: "The RGL3 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a putative open reading frame"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   923   C0079941:Open Reading Frame [Gene or Genome]
   861   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   812   C0034754:Reading [Daily or Recreational Activity]
   812   C0175566:Open [Spatial Concept]
   812   C0180979:Frame [Medical Device]
   812   C1705179:Reading [Finding]
   812   C1705858:Frame [Manufactured Object]
   741 E C0547049:Openness [Spatial Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a protein of 709amino acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0038164:a protein [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with a predicted molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]

Phrase: "of 77,"

Phrase: "968Da"

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.187: A search of the GenBankTM and Swiss-Protein data banks revealed significant homology to the known members of the RalGDS family. 

Phrase: "A search of the GenBankTM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1552603:search [Intellectual Product]
   760   C1706202:Search [Activity]

Phrase: "and"

Phrase: "Swiss-Protein data banks revealed significant homology to the known members"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C1334043:Homology [Gene or Genome]
   738   C2697616:Homology [Qualitative Concept]
   704   C1512488:Protein Homolog [Amino Acid, Peptide, or Protein]

Phrase: "of the RalGDS family."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.188: The greatest amount of similarity was found with RalGDS (34.5%), RLF (34.4%), and RGL (37.5%). 

Phrase: "The greatest amount of similarity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "found with RalGDS (34.5%"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0150312:Found [Quantitative Concept]
   760   C0378212:ral-GDS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1335588:RALGDS [Gene or Genome]
   726 E C0243095:Find [Finding]

Phrase: ")"

Phrase: ","

Phrase: "RLF (34.4%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0035344:RLF [Disease or Syndrome]
   827   C1416453:RLF [Gene or Genome]
   827   C1419392:RLF [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "RGL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428954:RGL [Gene or Genome]

Phrase: "(37.5%"

Phrase: ")."
Processing 00000000.tx.189: Like other RalGDS family members, RGL3 contains an N-terminal domain (amino acids 40-507) that is similar to the catalytic domain of the yeast CDC25 protein, which functions as a Ras GEF (29, 31, 33, 34). 

Phrase: "Like other RalGDS family members,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0086282:Family Members [Family Group]
   867 E C1611821:Family Member [Intellectual Product]
   827   C0015576:Family [Family Group]
   827   C0680022:members [Population Group]
   827   C1704727:Family [Conceptual Entity]
   793 E C2698041:Member [Professional or Occupational Group]
   755 E C0241888:Familial [Functional Concept]

Phrase: "RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an N-terminal domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(amino acids 40-507"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   812   C0439509:/40 [Temporal Concept]
   812   C0450381:507 [Intellectual Product]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "that"

Phrase: "is"

Phrase: "similar to the catalytic domain of the yeast CDC25 protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C2348205:Similar [Qualitative Concept]

Phrase: "which"

Phrase: "functions as a Ras GEF (29,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0210149:ras-GEF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0031843:function [Physiologic Function]
   753   C0034678:RAS [Gene or Genome]
   753   C0120465:GEF [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1149049:GEF [Molecular Function]
   753   C1423839:GEF [Gene or Genome]
   753   C1705273:Function [Intellectual Product]
   753   C3539611:GEF [Gene or Genome]

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "33,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.190: Among the proteins bearing CDC25 homology domains, the CDC25 domain of RGL3 shares most identity with the CDC25 domains of RGL (39.6%) and RLF (38.4%), whereas RGL3 possessed only 23-25% identity when compared with the CDC25 domains present in the mammalian Ras exchange factors GRF and SOS1. 

Phrase: "Among the proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "CDC25 homology domains,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1334043:Homology [Gene or Genome]
   827   C2697616:Homology [Qualitative Concept]
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: "the CDC25 domain of RGL3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "shares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "most identity with the CDC25 domains of RGL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0424215:Identity [Mental Process]
   744   C2003939:Identity [Finding]

Phrase: "(39.6%"

Phrase: ")"

Phrase: "and"

Phrase: "RLF (38.4%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0035344:RLF [Disease or Syndrome]
   827   C1416453:RLF [Gene or Genome]
   827   C1419392:RLF [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "possessed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0850310:Possessed [Mental or Behavioral Dysfunction]
   966 E C3154893:Possess [Idea or Concept]

Phrase: "only 23-25% identity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0424215:Identity [Mental Process]
   812   C2003939:Identity [Finding]

Phrase: "when"

Phrase: "compared with the CDC25 domains"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C1707455:Compared [Activity]
   760   C3538850:CDC25 [Gene or Genome]
   726   C1880389:Domain [Functional Concept]
   726   C1883221:Domain [Conceptual Entity]
   726   C3541951:Domain [Intellectual Product]

Phrase: "present in the mammalian Ras exchange factors GRF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   767   C0379310:ras-GRF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0023610:GRF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   744   C0024660:Mammalian [Mammal]
   744   C0034678:RAS [Gene or Genome]
   744   C0150312:Present [Quantitative Concept]
   744   C0449450:Present [Idea or Concept]
   744   C0678640:exchange [Social Behavior]
   744   C1706512:GRF [Gene or Genome]
   737   C0120465:exchange factor [Amino Acid, Peptide, or Protein,Enzyme]
   711   C1521761:Factor [Functional Concept]
   711   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "SOS1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420314:SOS1 [Gene or Genome]
Processing 00000000.tx.191: A high degree of amino acid sequence identity was also seen in the C-terminal portion of RGL3 when compared with RalGDS and RLF (43and 44%, respectively). 

Phrase: "A high degree of amino acid sequence identity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0441889:Degree [Qualitative Concept]
   744   C0449286:Degree [Quantitative Concept]
   744   C0542560:Degree [Intellectual Product]
   744   C1561545:degree [Quantitative Concept]
   744   C2348088:Degree [Quantitative Concept]

Phrase: "was"

Phrase: "also"

Phrase: "seen in the C-terminal portion of RGL3"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C1707271:C-Terminal [Amino Acid Sequence]
   744   C0205088:Terminal [Temporal Concept]
   744   C0205397:Seen [Qualitative Concept]
   744   C0449719:Portion [Spatial Concept]
   744   C1428955:RGL3 [Gene or Genome]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]
   711 E C0042789:see [Organism Function]
   711 E C1947903:See [Activity]

Phrase: "when"

Phrase: "compared with RalGDS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0378212:ral-GDS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1335588:RALGDS [Gene or Genome]
   790   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "RLF (43and 44%,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0035344:RLF [Disease or Syndrome]
   827   C1416453:RLF [Gene or Genome]
   827   C1419392:RLF [Gene or Genome]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.192: This domain represents the Ras-binding domain (RBD) of RalGDS, RLF, and RGL (35). 

Phrase: "This domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the Ras-binding domain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0034678:RAS [Gene or Genome]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(RBD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: ")"

Phrase: "of RalGDS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0378212:ral-GDS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335588:RALGDS [Gene or Genome]

Phrase: "RLF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035344:RLF [Disease or Syndrome]
  1000   C1416453:RLF [Gene or Genome]
  1000   C1419392:RLF [Gene or Genome]

Phrase: "and"

Phrase: "RGL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428954:RGL [Gene or Genome]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.193: RGL3 did not show any obvious sequence identity with any other known Ras interaction domains. 

Phrase: "RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "any obvious sequence identity with any"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0424215:Identity [Mental Process]
   753   C2003939:Identity [Finding]

Phrase: "other known Ras interaction domains."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.194: The RasGEFs SOS1 and CDC25 contain different SH3-binding sites. 

Phrase: "The RasGEFs SOS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420314:SOS1 [Gene or Genome]

Phrase: "and"

Phrase: "CDC25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538850:CDC25 [Gene or Genome]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "different SH3-binding sites."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0005456:Binding Sites [Receptor]
   827 E C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Sites [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.195: A search for potential SH3-binding motifs, PXXP (36), revealed a proline-rich region in RGL3 between residues 114and 123that may serve as an SH3-binding site. 

Phrase: "A search for potential SH3-binding motifs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1552603:search [Intellectual Product]
   748   C1706202:Search [Activity]

Phrase: "PXXP"

Phrase: "(36"

Phrase: ")"

Phrase: ","

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a proline-rich region in RGL3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1514490:Proline-Rich Region [Amino Acid Sequence]
   753   C0017446:Region [Geographic Area]
   753   C0033382:Proline [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205147:Region [Spatial Concept]
   753   C0699759:Rich [Qualitative Concept]

Phrase: "between residues 114and 123that"

Phrase: "may"

Phrase: "serve as an SH3-binding site."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0005456:Binding Site [Receptor]
   790   C0682969:Binding Site [Amino Acid Sequence]
   753   C0205145:Site [Spatial Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]
Processing 00000000.tx.196: Taken together, these sequence similarities indicate that RGL3, like other RalGEFs, is composed of N-terminal CDC25 homology domain and a C-terminal RBD. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these sequence similarities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1710052:Sequence Similarity [Quantitative Concept]
   827   C2348205:Similarity [Qualitative Concept]

Phrase: "indicate"

Phrase: "that RGL3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "like other RalGEFs,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C0378212:ral Guanine Nucleotide Exchange Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C0120465:Guanine Nucleotide Exchange Factors [Amino Acid, Peptide, or Protein,Enzyme]
           exchange factor
   840   C0018328:guanine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0678640:exchange [Social Behavior]
   804   C0812284:RAL [Gene or Genome]
   804   C1704992:RAL [Gene or Genome]
   771   C1521761:Factor [Functional Concept]
   771   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "composed of N-terminal CDC25 homology domain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0205088:Terminal [Temporal Concept]
   748   C1334043:Homology [Gene or Genome]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C2697616:Homology [Qualitative Concept]
   748   C3538850:CDC25 [Gene or Genome]
   748   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "a C-terminal RBD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C1880389:Domain [Functional Concept]
   799   C1883221:Domain [Conceptual Entity]
   799   C3541951:Domain [Intellectual Product]
   700   C1149341:C-terminal binding [Molecular Function]
Processing 00000000.tx.197: Northern blot analysis was used to investigate the expression of the RGL3 gene (Fig. 2). 

Phrase: "Northern blot analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C1621557:Northern Blot [Research Device]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the expression of the RGL3 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0017262:Gene Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.198: An mRNA of approximately 2.9kilobase pairs was detected in every mouse organ examined and is consistent with the size of the largest RGL3 cDNA isolated during library screening. 

Phrase: "An mRNA of approximately 2.9kilobase pairs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "detected in every mouse organ"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0178784:Organ [Body Part, Organ, or Organ Component]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "and"

Phrase: "is"

Phrase: "consistent with the size of the largest RGL3 cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "isolated during library screening."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   770   C0023621:Library [Manufactured Object,Organization]
   770   C0205409:Isolated [Functional Concept]
   770   C0220908:Screening [Health Care Activity]
   770   C0220909:screening [Functional Concept]
   770   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1548221:Isolated [Idea or Concept]
   770   C1698960:screening [Intellectual Product]
   770   C1710031:Screening [Diagnostic Procedure]
   770   C1710477:SCREENING [Research Activity]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.199: The highest basal levels of RGL3 message were detected in liver and kidney with lower levels of the message in testis, brain, cardiac and skeletal muscle. 

Phrase: "The highest basal levels of RGL3 message"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "detected in liver"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0023884:Liver [Body Part, Organ, or Organ Component]
   790   C0442726:Detected [Finding]
   790   C0736268:LIVER [Body Part, Organ, or Organ Component]
   790   C1278929:Liver [Body Part, Organ, or Organ Component]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   790   C2346688:LIVER [Food]
   734 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "kidney with lower levels of the message"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0022646:Kidney [Body Part, Organ, or Organ Component]
   748   C0227665:kidney [Body Part, Organ, or Organ Component]
   748   C1278978:Kidney [Body Part, Organ, or Organ Component]
   748   C1514845:KIDNEY [Tissue]

Phrase: "in testis,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039597:Testis [Body Part, Organ, or Organ Component]
  1000   C1278981:Testis [Body Part, Organ, or Organ Component]
   916 E C0021358:Testes [Body Part, Organ, or Organ Component]
   907 E C0205070:Testicular [Spatial Concept]
   888 E C1284096:Testicle [Body Part, Organ, or Organ Component]

Phrase: "brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "cardiac"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018787:Cardiac [Body Part, Organ, or Organ Component]
  1000   C1522601:Cardiac [Spatial Concept]

Phrase: "and"

Phrase: "skeletal muscle."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.200: Although the RGL3 mRNA is widely expressed, it exhibits a different distribution pattern from that of RLF (which is weakly expressed in the liver) (30) and RalGDS (which is poorly expressed in liver, kidney, and testis) (29). 

Phrase: "Although"

Phrase: "the RGL3 mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "widely"

Phrase: "expressed"

Phrase: ","

Phrase: "it"

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a different distribution pattern from that of RLF ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449775:Distribution pattern [Spatial Concept]
   744   C0449774:Pattern [Spatial Concept]

Phrase: "which"

Phrase: "is"

Phrase: "weakly"

Phrase: "expressed in the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: ")"

Phrase: "(30"

Phrase: ")"

Phrase: "and"

Phrase: "RalGDS ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0378212:ral-GDS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335588:RALGDS [Gene or Genome]

Phrase: "which"

Phrase: "is"

Phrase: "poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "expressed in liver,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0023884:Liver [Body Part, Organ, or Organ Component]
   790   C0736268:LIVER [Body Part, Organ, or Organ Component]
   790   C1278929:Liver [Body Part, Organ, or Organ Component]
   790   C2346688:LIVER [Food]
   734 E C0205054:Hepatic [Body Location or Region]

Phrase: "kidney,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "and"

Phrase: "testis"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039597:Testis [Body Part, Organ, or Organ Component]
  1000   C1278981:Testis [Body Part, Organ, or Organ Component]
   916 E C0021358:Testes [Body Part, Organ, or Organ Component]
   907 E C0205070:Testicular [Spatial Concept]
   888 E C1284096:Testicle [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.201: View larger version (59K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(59K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.202: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.203: Tissue distribution of mouse RGL3 mRNA. 

Phrase: "Tissue distribution of mouse RGL3 mRNA."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0040287:Tissue Distribution [Quantitative Concept]
   790   C0220927:tissue distribution [Functional Concept]
   753   C0040300:Tissue [Tissue]
   753   C0520511:distribution [Idea or Concept]
   753   C1547928:Tissue [Intellectual Product]
   753   C1704711:Distribution [Functional Concept]
Processing 00000000.tx.204: A multiple tissue Northern blot, containing ~2 g/lane poly(A)+ mRNA from each indicated mouse tissue, was hybridized with a 32P-labeled RGL3 probe (nucleotides 1863-2162) as described under "Experimental Procedures." 

Phrase: "A multiple tissue Northern blot,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005861:Northern Blot [Molecular Biology Research Technique]
   861   C1621557:Northern Blot [Research Device]
   812   C1709269:Northern [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "~2 g/lane poly(A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0032400:Poly A [Nucleic Acid, Nucleoside, or Nucleotide]
           poly
   804   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0747726:POLY [Conceptual Entity]

Phrase: ")"

Phrase: "+ mRNA from each indicated mouse tissue,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "hybridized with a 32P-labeled RGL3 probe"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   748   C0182400:Probe [Medical Device]
   748   C1428955:RGL3 [Gene or Genome]
   748   C1553631:32p [Medical Device]
   748   C1704681:Probe [Gene or Genome]
   748   C1708632:Labeled [Qualitative Concept]
   748   C2347609:Probe [Chemical Viewed Functionally]
   748   C3536729:Probe [Manufactured Object]
   714 E C0181496:Label [Manufactured Object]
   714 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(nucleotides 1863-2162"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.205: The blot was exposed with an intensifying screen to film for 12h at 70C. 

Phrase: "The blot"

Phrase: "was"

Phrase: "exposed with an intensifying screen to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0332157:Exposed to [Clinical Attribute]
           Exposed
   753   C0220908:screen [Health Care Activity]
   753   C1305399:screen [Functional Concept]
   753   C1705053:Screen [Medical Device]

Phrase: "film for 12h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0086296:Film [Manufactured Object]
   790   C0456695:/12h [Temporal Concept]
   790   C1561571:film [Biomedical or Dental Material]
   790   C1561572:film [Substance]

Phrase: "at 70C."
Processing 00000000.tx.206: The position of RNA mass standards is shown on the right. 

Phrase: "The position of RNA mass standards"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0733755:Position [Spatial Concept]

Phrase: "is"

Phrase: "shown on the right."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205090:Right [Spatial Concept]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.207: Kb, kilobase pairs. 

Phrase: "Kb,"

Phrase: "kilobase pairs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0582520:kilobase pairs [Quantitative Concept]
   861   C0582519:kilobase [Quantitative Concept]
   861   C1709450:Pair [Qualitative Concept]
Processing 00000000.tx.208: RGL3 Exhibits Properties of an Effector Protein for Rit and Ras-- Although the known candidate Ras effector proteins comprise a set of structurally and functionally distinct molecules, they all interact preferentially with GTP-bound Ras, through the effector domain. 

Phrase: "RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "Exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "Properties of an Effector Protein"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]

Phrase: "for Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "and"

Phrase: "Ras--"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "Although"

Phrase: "the known candidate Ras effector proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0242853:ras Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "comprise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "a set of structurally"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0036849:Set [Mental Process]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]

Phrase: "and"

Phrase: "functionally distinct molecules,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "they"

Phrase: "all"

Phrase: "interact"

Phrase: "preferentially with GTP-bound Ras,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0034678:RAS [Gene or Genome]
   760   C0332297:bound [Spatial Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "through the effector domain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0682970:effector domain [Gene or Genome]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.209: To determine if RGL3 possessed the properties of a binding protein for Ras, Rit, or other Ras-related proteins, the two-hybrid interaction of RGL3-RBD with wild type and mutant small GTPases was tested. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "possessed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0850310:Possessed [Mental or Behavioral Dysfunction]
   966 E C3154893:Possess [Idea or Concept]

Phrase: "the properties of a binding protein"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]

Phrase: "for Ras,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "Rit,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "or"

Phrase: "other Ras-related proteins,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   988   C1335596:ras-related protein [Gene or Genome]
   988   C1335599:Ras-Related Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   988   C1704396:RAS-Related Protein [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0242853:ras Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the two-hybrid interaction of RGL3-RBD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1704675:Interaction [Functional Concept]

Phrase: "with wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "mutant small GTPases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0751984:Small GTPases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "tested."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.210: C-terminally truncated versions of wild type and constitutively activated Rit (either Rit G30V or Rit Q79L) or wild type Rin and Ha-Ras (37) and full-length wild type Rap1A and Rap1B but not RalA were found to interact with RGL3-RBD (Table I). 

Phrase: "C-terminally truncated versions of wild type"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0333052:versions [Functional Concept]
   714 E C2607870:Version [Spatial Concept]

Phrase: "and"

Phrase: "constitutively activated Rit (either Rit G30V"

Phrase: "or"

Phrase: "Rit Q79L"

Phrase: ")"

Phrase: "or"

Phrase: "wild type Rin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1419388:RIN [Gene or Genome]
   827   C1882531:RIN [Qualitative Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "Ha-Ras (37"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034678:RAS [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "full-length wild type Rap1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0967718:RAP1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1335590:RAP1A [Gene or Genome]

Phrase: "and"

Phrase: "Rap1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419266:RAP1B [Gene or Genome]

Phrase: "but"

Phrase: "not RalA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0765159:RALA [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812284:RALA [Gene or Genome]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with RGL3-RBD"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0243122:binding [Functional Concept]
   753   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1419390:RIT [Gene or Genome]
   753   C1428955:RGL3 [Gene or Genome]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.211: The effector domain mutants Rit Q79LT53S and Rit Q79LY58C were unable to interact with RGL3-RBD (Table I). 

Phrase: "The effector domain mutants Rit Q79LT53S"

Phrase: "and"

Phrase: "Rit Q79LY58C"

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "interact with RGL3-RBD"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0243122:binding [Functional Concept]
   753   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1419390:RIT [Gene or Genome]
   753   C1428955:RGL3 [Gene or Genome]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.212: These results suggest that, as for previously described effector proteins, RGL3 binding requires an intact effector domain. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that,"

Phrase: "as for previously described effector proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "RGL3 binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "requires"

Phrase: "an intact effector domain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0682970:effector domain [Gene or Genome]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.213: Interestingly, the effector domain mutant Rit Q79LE55G did interact with RGL3-RBD. 

Phrase: "Interestingly,"

Phrase: "the effector domain mutant Rit Q79LE55G"

Phrase: "did"

Phrase: "interact with RGL3-RBD."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0243122:binding [Functional Concept]
   753   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1419390:RIT [Gene or Genome]
   753   C1428955:RGL3 [Gene or Genome]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.214: Since the equivalent E37G mutant in Ras inhibits its ability to bind Raf and PI-3K, but not RalGDS, it is predicted that Rit and Ras have similar structural requirements for binding to RGL3 and other RalGDS-RBDs (38). 

Phrase: "Since"

Phrase: "the equivalent E37G mutant in Ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "its ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "Raf"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425569:RAF [Gene or Genome]
  1000   C1706586:RAF [Gene or Genome]

Phrase: "and"

Phrase: "PI-3K,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "but"

Phrase: "not RalGDS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0378212:ral-GDS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1335588:RALGDS [Gene or Genome]

Phrase: "it"

Phrase: "is"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "that Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "and"

Phrase: "Ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "have"

Phrase: "similar structural requirements for binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1514873:Requirement [Functional Concept]

Phrase: "to RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "and"

Phrase: "other RalGDS-RBDs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522002:RBD [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.215: As shown in Table I, RitS35N, which corresponds to the RasS17N dominant negative mutant and would be expected to be predominantly GDP-bound, showed no detectable interaction with RGL3-RBD, suggesting that RGL3 showed preferential binding to the active GTP-bound form of Rit.  

Phrase: "As"

Phrase: "shown in Table I,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0021966:I- [Inorganic Chemical]
   770   C0039224:Table [Manufactured Object]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "RitS35N,"

Phrase: "which"

Phrase: "corresponds to the RasS17N dominant negative mutant"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C1512032:Dominant-Negative Mutant [Cell or Molecular Dysfunction]
           Dominant Negative
   748   C0205160:Negative [Qualitative Concept]
   748   C0596988:Mutant [Cell or Molecular Dysfunction]
   748   C1513916:Negative [Finding]
   748   C1527180:Dominant [Functional Concept]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]

Phrase: "and"

Phrase: "would"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "predominantly GDP-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "bound,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no detectable interaction with RGL3-RBD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1704675:Interaction [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "preferential binding to the active GTP-bound form of Rit."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1149035:GTP Binding [Molecular Function]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
Processing 00000000.tx.216: View this table: [in this window] [in a new window]  Table I Interaction of Rit and small GTPases with RGL3 in the yeast two-hybrid system To confirm and extend the observations from the two-hybrid system, we generated both His6 epitope-tagged and GST fusion proteins containing the RGL3-RBD for in vitro binding experiments. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table I Interaction of Rit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "small GTPases with RGL3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0751984:Small GTPases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in the yeast two-hybrid system To"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   937   C0599647:Yeast Two Hybrid System [Molecular Biology Research Technique]
           Two Hybrid
   937   C1961118:Yeast Two-Hybrid System [Molecular Biology Research Technique]
   804   C0020205:Hybrid [Organism]
   804   C0036025:yeast [Fungus]
   804   C0043392:Yeast [Food]
   804   C0043393:Yeast [Fungus]
   804   C0205448:Two [Quantitative Concept]
   804   C0449913:System [Functional Concept]
   804   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "and"

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "the observations from the two-hybrid system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0302523:observations [Research Activity]
   748   C0700325:observations [Health Care Activity]
   748   C3244290:observations [Functional Concept]
   714 E C1964257:Observation [Diagnostic Procedure]

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "both His6 epitope-tagged"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C1505208:his6 tag [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   827   C1708632:Tagged [Qualitative Concept]
   793 E C0037293:Tag [Neoplastic Process]
   793 E C0181496:Tag [Manufactured Object]
   793 E C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "GST fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   867   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the RGL3-RBD for in vitro binding experiments."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C1880389:Domain [Functional Concept]
   739   C1883221:Domain [Conceptual Entity]
   739   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.217: These fusion proteins were used to test the specificity of binding between RGL3-RBD and a series of Ras-like small GTPases. 

Phrase: "These fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the specificity of binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037791:Specificity [Quantitative Concept]
   770   C1511884:Specificity [Quantitative Concept]

Phrase: "between RGL3-RBD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "a series of Ras-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205549:Series [Quantitative Concept]
   770   C2348044:Series [Intellectual Product]

Phrase: "like small GTPases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751984:Small GTPases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.218: Ras, Rit, Rin, Rap1, TC21, R-Ras, RheB, and Ral all share extensive sequence identity within their respective effector domains, and several have been shown to interact with RalGEF proteins (39, 40). 

Phrase: "Ras,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "Rit,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "Rin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419388:RIN [Gene or Genome]
  1000   C1882531:RIN [Qualitative Concept]

Phrase: "Rap1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1426113:RAP1 [Gene or Genome]

Phrase: "TC21,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1335647:TC21 [Gene or Genome]
  1000   C1447284:TC21 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1704999:TC21 [Gene or Genome]

Phrase: "R-Ras,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034678:RAS [Gene or Genome]

Phrase: "RheB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419383:RHEB [Gene or Genome]
  1000   C1419384:RHEB [Gene or Genome]

Phrase: "and"

Phrase: "Ral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812284:RAL [Gene or Genome]
  1000   C1704992:RAL [Gene or Genome]

Phrase: "all"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "extensive sequence identity within their respective effector domains,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0424215:Identity [Mental Process]
   744   C2003939:Identity [Finding]

Phrase: "and"

Phrase: "several"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439064:Several [Quantitative Concept]
  1000   C0443302:Several [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with RalGEF proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0378212:RALGEF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1335588:RalGEF [Gene or Genome]
   770   C1706345:RalGEF [Gene or Genome]

Phrase: "(39,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.219: To examine the nucleotide-dependent interaction of these proteins with RGL3-RBD, the GTPases were preloaded with either [35S]GTPS or [3H]GDP, incubated in the presence of recombinant RGL3-RBD pre-bound to affinity resin, the reactions washed and pelleted, and the amount of Ras-like protein bound to RGL3-RBD determined by scintillation counting (Fig. 3A). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the nucleotide-dependent interaction of these proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0872234:nucleotide protein interaction [Physiologic Function]
   757   C0872079:interaction protein [Molecular Function]
   748   C1704675:Interaction [Functional Concept]

Phrase: "with RGL3-RBD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "the GTPases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "preloaded with either"

Phrase: "[35S"

Phrase: "]GTPS or [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442460:3H [Temporal Concept]

Phrase: "]GDP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "incubated in the presence of recombinant RGL3-RBD"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   739   C0243122:binding [Functional Concept]
   739   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1419390:RIT [Gene or Genome]
   739   C1428955:RGL3 [Gene or Genome]
   739   C1439852:Incubated [Laboratory Procedure]
   739   C1514798:recombinant [Organism]
   739   C1880389:Domain [Functional Concept]
   739   C1883221:Domain [Conceptual Entity]
   739   C3541951:Domain [Intellectual Product]

Phrase: "pre-bound to affinity resin,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0035191:Resin [Biomedical or Dental Material]
   760   C0332152:Pre [Temporal Concept]
   760   C0332297:bound [Spatial Concept]
   760   C0740175:Pre [Qualitative Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1510827:Affinity [Natural Phenomenon or Process]
   760   C1689898:% bound [Quantitative Concept]
   760   C2257086:PRE [Genetic Function]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "the reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "pelleted,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0441436:Pellet [Manufactured Object]
   966   C0993610:Pellet [Biomedical or Dental Material]
   966   C1998480:Pellet [Quantitative Concept]

Phrase: "and"

Phrase: "the amount of Ras-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "like protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bound to RGL3-RBD"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   753   C0243122:binding [Functional Concept]
   753   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   753   C0332297:bound [Spatial Concept]
   753   C1145667:Binding [Activity]
           Bound
   753   C1167622:Binding [Molecular Function]
           Bound
   753   C1419390:RIT [Gene or Genome]
   753   C1428955:RGL3 [Gene or Genome]
   753   C1689898:% bound [Quantitative Concept]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C2349209:Bound [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "determined by scintillation counting"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0036406:Scintillation Counting [Laboratory Procedure]
   770   C0678573:scintillation [Natural Phenomenon or Process]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.220: RGL3-RBD bound preferentially to the active GTP-bound form of the majority of these GTPases and to GTP-Rit and GTP-Ha-Ras in a concentration-dependent manner (Fig. 3, B and C). 

Phrase: "RGL3-RBD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "preferentially to the active GTP-bound form of the majority of these GTPases"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   735   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]
   735   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   735   C0205177:Active [Functional Concept]
   735   C0332297:bound [Spatial Concept]
   735   C0348078:Form [Qualitative Concept]
   735   C0376315:Form [Manufactured Object]
   735   C0680220:majority [Social Behavior]
   735   C1145667:Bound [Activity]
   735   C1167622:Bound [Molecular Function]
   735   C1522492:Form [Functional Concept]
   735   C1689898:% bound [Quantitative Concept]
   735   C2349209:Bound [Conceptual Entity]

Phrase: "and to GTP-Rit"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   770   C1419390:RIT [Gene or Genome]
   770   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "GTP-Ha-Ras in a concentration-dependent manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0034678:RAS [Gene or Genome]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.221: However, RGL3-RBD did not interact with Rab1A, RalA, or RheB (Fig. 3A). 

Phrase: "However,"

Phrase: "RGL3-RBD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interact with Rab1A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1419187:RAB1A [Gene or Genome]

Phrase: "RalA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0765159:RALA [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812284:RALA [Gene or Genome]

Phrase: "or"

Phrase: "RheB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419383:RHEB [Gene or Genome]
  1000   C1419384:RHEB [Gene or Genome]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.222: Thus, RGL3-RBD showed strong preferential binding to the GTP-bound forms of the majority of the Ras branch of the small GTPases. 

Phrase: "Thus,"

Phrase: "RGL3-RBD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "strong preferential binding to the GTP-bound forms of the majority"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   754   C1149035:GTP Binding [Molecular Function]
   738   C0243122:binding [Functional Concept]
   738   C1145667:Binding [Activity]
   738   C1167622:Binding [Molecular Function]

Phrase: "of the Ras branch"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1253959:Branch [Body Part, Organ, or Organ Component]
   861   C1881507:Branch [Chemical Viewed Structurally]
   861   C2700383:Branch [Plant]
   861   C2826234:BRANCH [Intellectual Product]

Phrase: "of the small GTPases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751984:Small GTPases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.223: Taken together, these studies suggest a pattern of RGL3 interactions that is characteristic of a Rit- and Ras-binding protein. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a pattern of RGL3 interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Pattern [Spatial Concept]

Phrase: "that"

Phrase: "is"

Phrase: "characteristic of a Rit-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521970:Characteristic [Qualitative Concept]

Phrase: "and"

Phrase: "Ras-binding protein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0242853:Ras protein [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
Processing 00000000.tx.224: These results are consistent with the two-hybrid analysis and comparable with the interactions of other RalGEFs with Rit and Ras (17, 30, 31). 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with the two-hybrid analysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "and"

Phrase: "comparable with the interactions of other RalGEFs"

Phrase: "with Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "and"

Phrase: "Ras (17,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034678:RAS [Gene or Genome]

Phrase: "30,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.225: Because recent studies have demonstrated that RalGEFs are genuine Ras effectors (reviewed in Ref. 1), the ability of Rit and Ha-Ras to bind and activate RGL3 was compared throughout the remainder of this study. 

Phrase: "Because"

Phrase: "recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that RalGEFs"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C0378212:ral Guanine Nucleotide Exchange Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C0120465:Guanine Nucleotide Exchange Factors [Amino Acid, Peptide, or Protein,Enzyme]
           exchange factor
   840   C0018328:guanine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0678640:exchange [Social Behavior]
   804   C0812284:RAL [Gene or Genome]
   804   C1704992:RAL [Gene or Genome]
   771   C1521761:Factor [Functional Concept]
   771   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "genuine Ras effectors"

Phrase: "("

Phrase: "reviewed in Ref. 1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0140145:REF-1 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1332102:REF-1 [Gene or Genome]
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "the ability of Rit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "and"

Phrase: "Ha-Ras to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034678:RAS [Gene or Genome]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "was"

Phrase: "compared throughout the remainder of this study."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0557651:Study [Manufactured Object]
   748   C1707455:Compared [Activity]
   748   C2603343:Study [Research Activity]
Processing 00000000.tx.226: View larger version (23K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.227: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.228: Interaction of RGL3-RBD domain with Rit and Ras. 

Phrase: "Interaction of RGL3-RBD domain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1704675:Interaction [Functional Concept]

Phrase: "with Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "and"

Phrase: "Ras."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]
Processing 00000000.tx.229: A, binding of a series of GST-fused Ras-like small GTPases to RGL3-RBD complexed beads. 

Phrase: "A,"

Phrase: "binding of a series of GST-fused Ras-"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   744   C0034678:RAS [Gene or Genome]
   744   C0205549:Series [Quantitative Concept]
   744   C0243122:binding [Functional Concept]
   744   C0699952:Fused [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C2348044:Series [Intellectual Product]
   711 E C1414861:FUSE [Gene or Genome]
   711 E C1708111:Fuse [Manufactured Object]

Phrase: "like small GTPases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751984:Small GTPases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "to RGL3-RBD complexed beads."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0991566:Beads [Biomedical or Dental Material]
   766 E C2346972:Bead [Spatial Concept]
Processing 00000000.tx.230: Each assay contained recombinant epitope-tagged RGL3-RBD (20g), 20l of a 1:1 (v/v) suspension of affinity resin, and 20g of [35S]GTPS or [3H]GDP-loaded small GTPases in a volume of 200l. 

Phrase: "Each assay contained recombinant epitope-tagged RGL3-RBD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C1880389:Domain [Functional Concept]
   791   C1883221:Domain [Conceptual Entity]
   791   C3541951:Domain [Intellectual Product]

Phrase: "(20g"

Phrase: ")"

Phrase: ","

Phrase: "20l of a 1"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(v/v) suspension of affinity resin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0038960:Suspension [Biomedical or Dental Material]
   753   C1382107:Suspension [Substance]
   753   C1705537:Suspension [Functional Concept]

Phrase: "and"

Phrase: "20g of [35S"

Phrase: "]GTPS or [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442460:3H [Temporal Concept]

Phrase: "]GDP-loaded small GTPases in a volume of 200l."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0751984:Small GTPases [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.231: After incubation for 1h at 4C, the RGL3-RBD complexed affinity beads were pelleted, washed extensively, and the amount of nucleotide bound Ras-like protein in the pellet fraction determined by scintillation counting as described under "Experimental Procedures." 

Phrase: "After incubation"

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "the RGL3-RBD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "complexed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439855:Complex [Qualitative Concept]
   966   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "affinity beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0991566:Beads [Biomedical or Dental Material]
   827 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "pelleted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0441436:Pellet [Manufactured Object]
   966   C0993610:Pellet [Biomedical or Dental Material]
   966   C1998480:Pellet [Quantitative Concept]

Phrase: ","

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "extensively,"

Phrase: "and"

Phrase: "the amount of nucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "Ras-like protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0812284:RAS-LIKE PROTEIN [Gene or Genome]
   858   C0242853:Ras protein [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0034678:RAS [Gene or Genome]

Phrase: "in the pellet fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "determined by scintillation counting"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0036406:Scintillation Counting [Laboratory Procedure]
   770   C0678573:scintillation [Natural Phenomenon or Process]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.232: Binding is represented as the fraction of [35S]GTPS or [3H]GDP-loaded Ras-like protein in the pellet fraction relative to the total radiolabeled Ras-like protein added to each reaction (for [35S]GTPS-bound proteins this ranged from 1.25to 3.7105 cpm/reaction whereas [3H]GDP-bound protein reactions contained from 8to 40103 cpm/reaction). 

Phrase: "Binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "represented as the fraction of [35S"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1264633:Fraction of [Quantitative Concept]
           Fraction
   753   C1554103:Fraction [Idea or Concept]
   719   C1882932:Represent [Activity]

Phrase: "]GTPS or [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442460:3H [Temporal Concept]

Phrase: "]GDP-loaded Ras-like protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C0812284:RAS-LIKE PROTEIN [Gene or Genome]
   797   C0242853:Ras protein [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0034678:RAS [Gene or Genome]

Phrase: "in the pellet fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "relative to the total radiolabeled Ras-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "like protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "added to each reaction"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0443286:Reaction [Functional Concept]
   770   C1114821:Reaction [Clinical Attribute]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "("

Phrase: "for"

Phrase: "[35S"

Phrase: "]GTPS-bound proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "this"

Phrase: "ranged from 1.25to 3.7105 cpm/reaction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0443286:Reaction [Functional Concept]
   744   C1114821:Reaction [Clinical Attribute]
   711   C1514721:Range [Quantitative Concept]
   711   C2348147:Range [Quantitative Concept]
   711   C3542016:Range [Intellectual Product]

Phrase: "whereas"

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]GDP-bound protein reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0443286:Reaction [Functional Concept]
   779   C1114821:Reaction [Clinical Attribute]

Phrase: "contained from 8to 40103 cpm/reaction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0332256:contained [Functional Concept]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C2700400:Contained [Activity]

Phrase: ")."
Processing 00000000.tx.233: B, binding curves comparing GST-RGL3-RBD binding to the indicated amounts of [35S]GTPS-loaded Rit or [3H]GDP-loaded Rit. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "curves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205134:Curve [Spatial Concept]

Phrase: "comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Compare [Activity]

Phrase: "GST-RGL3-RBD binding"

Phrase: "to the indicated amounts of [35S"

Phrase: "]GTPS-loaded Rit or [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1442460:3H [Temporal Concept]

Phrase: "]GDP-loaded Rit."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   827   C1419390:RIT [Gene or Genome]
Processing 00000000.tx.234: Each assay contained recombinant epitope-tagged RGL3-RBD (2nmol), 30l of a 1:1 (v/v) suspension of affinity resin, and [35S]GTPS or [3H]GDP-loaded small GTPases in a volume of 300l. 

Phrase: "Each assay contained recombinant epitope-tagged RGL3-RBD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C1880389:Domain [Functional Concept]
   791   C1883221:Domain [Conceptual Entity]
   791   C3541951:Domain [Intellectual Product]

Phrase: "(2nmol"

Phrase: ")"

Phrase: ","

Phrase: "30l of a 1"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(v/v) suspension of affinity resin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0038960:Suspension [Biomedical or Dental Material]
   753   C1382107:Suspension [Substance]
   753   C1705537:Suspension [Functional Concept]

Phrase: "and ["

Phrase: "35S"

Phrase: "]GTPS or [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442460:3H [Temporal Concept]

Phrase: "]GDP-loaded small GTPases in a volume of 300l."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0751984:Small GTPases [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.235: After incubation for 1h at 4C, the RGL3-RBD complexed affinity beads were pelleted and washed extensively, and the amount of nucleotide bound Rit in the pellet fraction was determined by scintillation counting as described under "Experimental Procedures." 

Phrase: "After incubation"

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "the RGL3-RBD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "complexed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439855:Complex [Qualitative Concept]
   966   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "affinity beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0991566:Beads [Biomedical or Dental Material]
   827 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "pelleted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0441436:Pellet [Manufactured Object]
   966   C0993610:Pellet [Biomedical or Dental Material]
   966   C1998480:Pellet [Quantitative Concept]

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "extensively,"

Phrase: "and"

Phrase: "the amount of nucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "Rit in the pellet fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   760   C1419390:RIT [Gene or Genome]

Phrase: "was"

Phrase: "determined by scintillation counting"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0036406:Scintillation Counting [Laboratory Procedure]
   770   C0678573:scintillation [Natural Phenomenon or Process]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.236: C, binding curves comparing RGL3-RBD binding to the indicated amounts of [35S]GTPS-loaded Ras or [3H]GDP-loaded Ras. 

Phrase: "C,"

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "curves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205134:Curve [Spatial Concept]

Phrase: "comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Compare [Activity]

Phrase: "RGL3-RBD binding to the indicated amounts of [35S"

Phrase: "]GTPS-loaded Ras or [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1442460:3H [Temporal Concept]

Phrase: "]GDP-loaded Ras."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034678:RAS [Gene or Genome]
Processing 00000000.tx.237: Binding was determined as described above. 

Phrase: "Binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "determined as described above."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1552738:described [Idea or Concept]
Processing 00000000.tx.238: The results are representative of three independent experiments done in duplicate. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "representative of three independent experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "done in duplicate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205173:Duplicate [Functional Concept]
   790   C1272695:Done [Qualitative Concept]
   790   C2746065:Done [Temporal Concept]
   790   C3539942:Duplicate [Intellectual Product]
Processing 00000000.tx.239: Interaction of Full-length RGL3 with Ras-like GTPases-- Since the RBD of RGL3 only represents the C-terminal one-third of the entire protein, the interaction of full-length RGL3 with Rit and Ha-Ras was examined. 

Phrase: "Interaction of Full-length RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "with Ras-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "like GTPases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "-"

Phrase: "-"

Phrase: "Since"

Phrase: "the RBD of RGL3 only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the C-terminal one-third of the entire protein,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C1707271:C-Terminal [Amino Acid Sequence]
   762   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C1168438:Protein C [Laboratory Procedure]
   762   C1418943:PROTEIN C [Gene or Genome]
   762   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0205088:Terminal [Temporal Concept]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]

Phrase: "the interaction of full-length RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]

Phrase: "with Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "and"

Phrase: "Ha-Ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034678:RAS [Gene or Genome]

Phrase: "was"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.240: The ability of full-length RGL3, transcribed and translated in vitro in the presence of [35S]methionine, to bind several GST-Ras-related fusion proteins immobilized to glutathione-agarose beads and loaded with GTPS or GDP was examined. 

Phrase: "The ability of full-length RGL3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "transcribed"

Phrase: "and"

Phrase: "translated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040710:translated [Occupational Activity]

Phrase: "in vitro in the presence of [35S"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0021135:In Vitro [Intellectual Product]
   778   C1533691:in vitro [Qualitative Concept]
           vitro
   778   C2827718:In Vitro [Functional Concept]

Phrase: "]methionine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "several GST-Ras-related fusion proteins"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   858   C0242853:ras Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   856   C1335596:ras-related protein [Gene or Genome]
   856   C1335599:Ras-Related Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   856   C1704396:RAS-Related Protein [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0332466:Fusion [Functional Concept]
   799   C1293131:Fusion [Therapeutic or Preventive Procedure]
   793   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "immobilized to glutathione-agarose beads"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0036681:Agarose [Carbohydrate]
   760   C0991566:Beads [Biomedical or Dental Material]
   726 E C2346972:Bead [Spatial Concept]

Phrase: "and"

Phrase: "loaded with GTPS"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1708715:Loaded [Activity]
   756   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   756 E C1550025:Load [Idea or Concept]
   756 E C1704782:Load [Manufactured Object]

Phrase: "or"

Phrase: "GDP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.241: As seen with the isolated RBD domain, full-length RGL3 interacted with active GTP-bound Rit and Ha-Ras but not with GTP-RheB (Fig. 4). 

Phrase: "As"

Phrase: "seen with the isolated RBD domain,"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   744   C0205397:Seen [Qualitative Concept]
   744   C0205409:Isolated [Functional Concept]
   744   C0243122:binding [Functional Concept]
   744   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1419390:RIT [Gene or Genome]
   744   C1548221:Isolated [Idea or Concept]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]
   711 E C0042789:see [Organism Function]
   711 E C1947903:See [Activity]

Phrase: "full-length RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1428955:RGL3 [Gene or Genome]

Phrase: "interacted with active GTP-bound Rit"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205177:Active [Functional Concept]
   753   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   753   C0332297:bound [Spatial Concept]
   753   C1145667:Bound [Activity]
   753   C1167622:Bound [Molecular Function]
   753   C1419390:RIT [Gene or Genome]
   753   C1689898:% bound [Quantitative Concept]
   753   C2349209:Bound [Conceptual Entity]

Phrase: "and"

Phrase: "Ha-Ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034678:RAS [Gene or Genome]

Phrase: "but"

Phrase: "not with GTP-RheB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1419383:RHEB [Gene or Genome]
   770   C1419384:RHEB [Gene or Genome]
   770   C1518422:Not [Functional Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.242: Although some weak interaction of RGL3 was seen with GDP-bound Rit and Ras in certain experiments, it was always much weaker than that observed with their GTP-bound forms (Fig. 4). 

Phrase: "Although"

Phrase: "some weak interaction of RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "was"

Phrase: "seen with GDP-bound Rit"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   760   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205397:Seen [Qualitative Concept]
   760   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   760   C0332297:bound [Spatial Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1419390:RIT [Gene or Genome]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "and"

Phrase: "Ras in certain experiments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0034678:RAS [Gene or Genome]

Phrase: "it"

Phrase: "was"

Phrase: "always much weaker than that"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0004093:Weak [Sign or Symptom]
   726   C1762617:Weak [Qualitative Concept]

Phrase: "observed with their GTP-bound forms"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   753   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0332297:bound [Spatial Concept]
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   753   C1145667:Bound [Activity]
   753   C1167622:Bound [Molecular Function]
   753   C1441672:Observed [Functional Concept]
   753   C1689898:% bound [Quantitative Concept]
   753   C2349209:Bound [Conceptual Entity]
   719 E C1522492:Form [Functional Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.243: View larger version (38K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(38K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.244: 4.  

Phrase: "4."
Processing 00000000.tx.245: Interaction of full-length RGL3 with Rit and Ras in vitro. 

Phrase: "Interaction of full-length RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "with Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "and"

Phrase: "Ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.246: Full-length RGL3 was transcribed and translated in vitro in the presence of [35S]methionine and incubated with GST (control) or with Rit, RheB, or Ras proteins fused to GST and loaded with either GTPS or GDP. 

Phrase: "Full-length RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1428955:RGL3 [Gene or Genome]

Phrase: "was"

Phrase: "transcribed"

Phrase: "and"

Phrase: "translated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040710:translated [Occupational Activity]

Phrase: "in vitro in the presence of [35S"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0021135:In Vitro [Intellectual Product]
   778   C1533691:in vitro [Qualitative Concept]
           vitro
   778   C2827718:In Vitro [Functional Concept]

Phrase: "]methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "incubated with GST (control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "or with Rit,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   790   C1419390:RIT [Gene or Genome]

Phrase: "RheB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419383:RHEB [Gene or Genome]
  1000   C1419384:RHEB [Gene or Genome]

Phrase: "or"

Phrase: "Ras proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242853:ras Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "fused to GST"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0699952:Fused [Functional Concept]
   756 E C1414861:FUSE [Gene or Genome]
   756 E C1708111:Fuse [Manufactured Object]

Phrase: "and"

Phrase: "loaded with either GTPS"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C1708715:Loaded [Activity]
   737   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]

Phrase: "or"

Phrase: "GDP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.247: After incubation for 2h at 4C in the presence of 20l of a 1:1 (v/v) suspension of glutathione-agarose beads, the samples were sedimented and washed as described under "Experimental Procedures." 

Phrase: "After incubation"

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 20l"

Phrase: "of a 1"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(v/v) suspension of glutathione-agarose beads,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0038960:Suspension [Biomedical or Dental Material]
   748   C1382107:Suspension [Substance]
   748   C1705537:Suspension [Functional Concept]

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "sedimented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550099:Sediment [Body Substance]

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.248: Bound proteins were eluted by boiling in SDS-PAGE sample buffer and resolved by 8% SDS-polyacrylamide gel electrophoresis. 

Phrase: "Bound proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "eluted by boiling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0242301:Boil [Disease or Syndrome]
   756   C1546559:Boil [Intellectual Product]

Phrase: "in SDS-PAGE sample buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "resolved by 8% SDS-polyacrylamide gel electrophoresis."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   853   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   814   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   778   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   778   C0596607:Gel Electrophoresis [Laboratory Procedure]
   774 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   748   C0013855:Electrophoresis [Laboratory Procedure]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   748   C1382104:Gel [Substance]
   748   C1514893:Resolved [Idea or Concept]
   748   C2699488:Resolved [Conceptual Entity]
Processing 00000000.tx.249: The gel was treated with Amplify (Amersham Pharmacia Biotech), dried, and exposed to Kodak X-Omat AR film for 24h at 70C to detect bound protein. 

Phrase: "The gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]

Phrase: "was"

Phrase: "treated with"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C1522326:Treated [Functional Concept]
   799 E C1292734:TREAT [Functional Concept]

Phrase: "Amplify"

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: ","

Phrase: "dried"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1512080:Dried [Qualitative Concept]
  1000   C2827485:Dried [Body Substance]
   966 E C0011682:Dry [Natural Phenomenon or Process]
   966 E C0205222:Dry [Qualitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "exposed to Kodak X-Omat AR film"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0332157:Exposed to [Clinical Attribute]
           Exposed
   748   C0086296:Film [Manufactured Object]
   748   C1561571:film [Biomedical or Dental Material]
   748   C1561572:film [Substance]
   748   C2986463:AR+ [Finding]

Phrase: "for 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "at 70C to"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "bound protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.250: Lane RGL3, one-fifth of the input radiolabeled RGL3 protein. 

Phrase: "Lane RGL3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428955:RGL3 [Gene or Genome]

Phrase: "one-fifth of the input"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205439:Fifth [Quantitative Concept]

Phrase: "radiolabeled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527121:Radiolabeled [Qualitative Concept]
   966 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "RGL3 protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.251: To investigate whether RGL3 interacts with active Rit or Ha-Ras in vivo, HEK293 cells were co-transfected with expression vectors for Myc- and His6 epitope-tagged RGL3 and the HA epitope-tagged activated forms of either Rit (RitQ79L) or Ras (RasQ61L). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "interacts with active Rit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205177:Active [Functional Concept]
   770   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   770   C1419390:RIT [Gene or Genome]

Phrase: "or"

Phrase: "Ha-Ras in vivo, HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C2936239:HEK293 Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with expression vectors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0599566:expression vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0442335:Vectors [Spatial Concept]
   726 E C1705099:Vector [Idea or Concept]

Phrase: "for Myc-"

Phrase: "and"

Phrase: "His6 epitope-tagged RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1428955:RGL3 [Gene or Genome]

Phrase: "and"

Phrase: "the HA epitope-tagged activated forms of either Rit (RitQ79L"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   739   C0348078:forms [Qualitative Concept]
   739   C0376315:Forms [Manufactured Object]
   706 E C1522492:Form [Functional Concept]

Phrase: ")"

Phrase: "or"

Phrase: "Ras (RasQ61L"

Phrase: ")."
Processing 00000000.tx.252: Although it is not known whether subcellular localization is critical to Rit function, as seen with Ras, epitope-tagged Rit has been shown to localize to the plasma membrane (41). 

Phrase: "Although"

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "whether"

Phrase: "subcellular localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "is"

Phrase: "critical to Rit function,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511545:Critical [Qualitative Concept]

Phrase: "as"

Phrase: "seen with Ras,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0034678:RAS [Gene or Genome]
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "epitope-tagged Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   827   C1419390:RIT [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "localize to the plasma membrane"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0007603:Plasma membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0392752:localize [Spatial Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.253: In order to establish that any RGL3 complexes involved the mature and membrane-associated Rit or Ras proteins, the particulate fraction of transfected cells was isolated by ultracentrifugation prior to the isolation of RGL3 using Ni-NTA resin (see "Experimental Procedures"). 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "that"

Phrase: "any RGL3 complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "the mature"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205286:Mature [Temporal Concept]
   928 E C0449989:Maturity [Qualitative Concept]
   928 E C0700597:Maturity [Temporal Concept]

Phrase: "and"

Phrase: "membrane-associated Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   827   C1419390:RIT [Gene or Genome]

Phrase: "or"

Phrase: "Ras proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242853:ras Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the particulate fraction of transfected cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1264633:Fraction of [Quantitative Concept]
           Fraction
   767   C0805525:Cell Fraction [Cell Component]
   753   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "isolated by ultracentrifugation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0041609:Ultracentrifugation [Laboratory Procedure]
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "prior to the isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0204727:Isolation [Therapeutic or Preventive Procedure]
  1000   C0205409:Isolation [Functional Concept]
  1000   C0220862:isolation [Laboratory Procedure]
   928 E C1548221:Isolated [Idea or Concept]

Phrase: "of RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Ni-NTA resin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035191:Resin [Biomedical or Dental Material]

Phrase: "(see ""Experimental Procedures"""
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.254: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.255: 5, constitutively active Rit and Ras proteins both co-precipitated with His6-tagged RGL3 from the solubilized membranes of co-transfected cells. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "constitutively active Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   827   C1419390:RIT [Gene or Genome]

Phrase: "and"

Phrase: "Ras proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242853:ras Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "both"

Phrase: "co-precipitated with His6-tagged RGL3"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   773   C1505208:his6 tag [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   753   C1428955:RGL3 [Gene or Genome]
   753   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   753   C1708632:Tagged [Qualitative Concept]
   719 E C0037293:Tag [Neoplastic Process]
   719 E C0181496:Tag [Manufactured Object]
   719 E C1710492:TAG [Gene or Genome]
   719   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "from the solubilized membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "of"

Phrase: "co-transfected"

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.256: In HEK293 cells transfected with RitQ79L or RasQ61L expression constructs alone, there is no precipitation of the active proteins by Ni-NTA resin. 

Phrase: "In HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with RitQ79L"

Phrase: "or"

Phrase: "RasQ61L expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "alone, there"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]

Phrase: "is"

Phrase: "no precipitation of the active proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0032931:Precipitation [Natural Phenomenon or Process]
   753   C0032932:Precipitation [Molecular Function]
   753   C1642401:% precipitation [Quantitative Concept]
   753   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "by Ni-NTA resin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035191:Resin [Biomedical or Dental Material]
Processing 00000000.tx.257: Thus, RGL3 can interact with activated Rit and Ras when overexpressed in vivo. 

Phrase: "Thus,"

Phrase: "RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "can"

Phrase: "interact with activated Rit"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   770   C1419390:RIT [Gene or Genome]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "Ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "when"

Phrase: "overexpressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.258: View larger version (45K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(45K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.259: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.260: Interaction of RGL3 with the active form of Rit and Ras in the particulate fraction of HEK293 cells. 

Phrase: "Interaction of RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704675:Interaction [Functional Concept]

Phrase: "with the active form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "of Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "and"

Phrase: "Ras in the particulate fraction of HEK293 cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0034678:RAS [Gene or Genome]
Processing 00000000.tx.261: HEK293 cells were co-transfected with expression vectors encoding HA-tagged constitutively active Rit (RitQ79L) or Ras (RasQ61L) with or without a vector encoding Myc- and His6 epitope-tagged full-length RGL3 as described under "Experimental Procedures." 

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with expression vectors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0599566:expression vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0442335:Vectors [Spatial Concept]
   726 E C1705099:Vector [Idea or Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "HA-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018909:Haemagglutinin, NOS [Immunologic Factor]

Phrase: "tagged"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
  1000   C1708632:Tagged [Qualitative Concept]
   966 E C0037293:Tag [Neoplastic Process]
   966 E C0181496:Tag [Manufactured Object]
   966 E C1710492:TAG [Gene or Genome]

Phrase: "constitutively active Rit (RitQ79L"

Phrase: ")"

Phrase: "or"

Phrase: "Ras (RasQ61L"

Phrase: ")"

Phrase: "with"

Phrase: "or without a vector encoding Myc-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1547699:Encoding [Idea or Concept]
   753   C1705099:Vector [Idea or Concept]
   753   C2700640:Encoding [Activity]

Phrase: "and"

Phrase: "His6 epitope-tagged full-length RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1428955:RGL3 [Gene or Genome]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.262: Cells were collected and mechanically lysed in hypotonic buffer 48h after transfection. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "mechanically"

Phrase: "lysed in hypotonic buffer 48h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0024348:lysed [Pathologic Function]
   760   C0241938:Hypotonic [Pathologic Function]
   760   C1442464:48H [Temporal Concept]

Phrase: "after transfection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
Processing 00000000.tx.263: The homogenate was subjected to centrifugation at 105g, and the pellet fraction (P100) was washed and solubilized in lysis buffer containing 1% Nonidet P-40. 

Phrase: "The homogenate"

Phrase: "was"

Phrase: "subjected to centrifugation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0007703:Centrifugation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "at 105g,"

Phrase: "and"

Phrase: "the pellet fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "(P100"

Phrase: ")"

Phrase: "was"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "solubilized in lysis buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:Lysis [Pathologic Function]
   770   C1536403:lysis [Cell Function]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% Nonidet P-40."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.264: Aliquots of the P100 fraction were removed and tested for expression of transfected constructs by immunoblotting using anti-Myc (RGL3) or anti-HA (Rit and Ras) antibodies. 

Phrase: "Aliquots of the P100 fraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "tested for expression of transfected constructs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0392366:tested [Intellectual Product]
   719 E C0022885:Test [Laboratory Procedure]
   719 E C0039593:Test [Functional Concept]
   719   C2827421:Construct [Classification]

Phrase: "by immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-Myc (RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1428955:RGL3 [Gene or Genome]

Phrase: ")"

Phrase: "or"

Phrase: "anti-HA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018909:Haemagglutinin, NOS [Immunologic Factor]

Phrase: "(Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "and"

Phrase: "Ras) antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.265: Ni-NTA beads were added to 200g of the remaining P100 fraction and incubated for 2h at 4C, and the samples were pelleted and washed as described under "Experimental Procedures." 

Phrase: "Ni-NTA beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0991566:Beads [Biomedical or Dental Material]
   793 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "added to 200g of the remaining P100 fraction"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   767   C1264633:Fraction of [Quantitative Concept]
           Fraction
   744   C1524062:Added [Functional Concept]
   744   C1527428:Remaining [Qualitative Concept]
   744   C1554103:Fraction [Idea or Concept]
   711 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "incubated for 2h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292425:2H [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "and"

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "pelleted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0441436:Pellet [Manufactured Object]
   966   C0993610:Pellet [Biomedical or Dental Material]
   966   C1998480:Pellet [Quantitative Concept]

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.266: Protein in the pellet fraction was eluted by boiling in SDS-PAGE sample buffer and resolved by 8% SDS-PAGE. 

Phrase: "Protein in the pellet fraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "eluted by boiling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0242301:Boil [Disease or Syndrome]
   756   C1546559:Boil [Intellectual Product]

Phrase: "in SDS-PAGE sample buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "resolved by 8% SDS-PAGE."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C1514893:Resolved [Idea or Concept]
   760   C1704732:Page [Intellectual Product]
   760   C2699488:Resolved [Conceptual Entity]
Processing 00000000.tx.267: The presence of RitQ79L or RasQ61L in these complexes was detected by immunoblot analysis using anti-HA antibody. 

Phrase: "The presence of RitQ79L"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "RasQ61L in these complexes"

Phrase: "was"

Phrase: "detected by immunoblot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C0936012:Analysis [Research Activity]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-HA antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.268: RGL3 Has Properties Consistent with a RalGEF-- Since the N-terminal domain of RGL3 reveals significant homology to CDC25, we next examined the GEF activity of RGL3 for several Ras-like proteins in vitro. 

Phrase: "RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "Has"

Phrase: "Properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0871161:properties [Qualitative Concept]
  1000   C1292721:properties [Functional Concept]
   966 E C1882134:Property [Conceptual Entity]
   966 E C2347695:Property [Entity]

Phrase: "Consistent with a RalGEF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "-"

Phrase: "-"

Phrase: "Since"

Phrase: "the N-terminal domain of RGL3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205088:Terminal [Temporal Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "significant homology to CDC25,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1334043:Homology [Gene or Genome]
   770   C2697616:Homology [Qualitative Concept]

Phrase: "we next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the GEF activity of RGL3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "for several Ras-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034678:RAS [Gene or Genome]

Phrase: "like proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.269: In order to evaluate potential target GTPases for RGL3, a His6-tagged RGL3 protein containing amino acids 1-557 (RGL3RBD), which includes the CDC25 homology domain, was constructed and used for in vitro nucleotide release and binding studies. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "potential target GTPases for RGL3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a His6-tagged RGL3 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "amino acids 1-557"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "(RGL3RBD"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the CDC25 homology domain,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1334043:Homology [Gene or Genome]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C2697616:Homology [Qualitative Concept]
   827   C3541951:Domain [Intellectual Product]

Phrase: "was"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "used for in vitro nucleotide release"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]
   753   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1273517:used [Finding]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "binding studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
Processing 00000000.tx.270: A property common to CDC25-related GEF domains is their relatively high affinity for the nucleotide-free form of their target GTPase (42). 

Phrase: "A property"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0871161:Property [Qualitative Concept]
  1000   C1882134:Property [Conceptual Entity]
  1000   C2347695:Property [Entity]

Phrase: "common to CDC25-related GEF domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205214:Common [Quantitative Concept]
   753   C1522138:Common [Functional Concept]
   753   C3245511:common [Intellectual Product]

Phrase: "is"

Phrase: "their relatively high affinity for the nucleotide-free form of their target GTPase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   735   C0205250:High [Qualitative Concept]
   735   C1299351:High [Qualitative Concept]
   735   C1510827:Affinity [Natural Phenomenon or Process]
   735   C2700149:HIGH [Intellectual Product]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.271: The ability of RGL3RBD to modulate Ras-like proteins by direct interaction was first studied by the binding of epitope-tagged RGL3RBD to various Ras-related proteins fused to GST, immobilized to glutathione-agarose beads, and treated with EDTA to prevent stable nucleotide association. 

Phrase: "The ability of RGL3RBD to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "Ras-like proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C0812284:RAS-LIKE PROTEIN [Gene or Genome]
   858   C0242853:ras Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0034678:RAS [Gene or Genome]

Phrase: "by direct interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704675:Interaction [Functional Concept]

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "studied by the binding of epitope-tagged RGL3RBD"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   744   C0003316:Epitope [Immunologic Factor]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   744   C1708632:Tagged [Qualitative Concept]
   711 E C0037293:Tag [Neoplastic Process]
   711 E C0181496:Tag [Manufactured Object]
   711   C0557651:Study [Manufactured Object]
   711 E C1710492:TAG [Gene or Genome]
   711   C2603343:Study [Research Activity]

Phrase: "to various Ras-related proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   912   C1335596:ras-related protein [Gene or Genome]
   912   C1335599:Ras-Related Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   912   C1704396:RAS-Related Protein [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0242853:ras Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "fused to GST,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0699952:Fused [Functional Concept]
   756 E C1414861:FUSE [Gene or Genome]
   756 E C1708111:Fuse [Manufactured Object]

Phrase: "immobilized to glutathione-agarose beads,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0036681:Agarose [Carbohydrate]
   760   C0991566:Beads [Biomedical or Dental Material]
   726 E C2346972:Bead [Spatial Concept]

Phrase: "and"

Phrase: "treated with EDTA to"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "stable nucleotide association."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
Processing 00000000.tx.272: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.273: 6A, when RGL3RBD was incubated with GST beads, no RGL3RBD was recovered in the pellet fraction. 

Phrase: "6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553638:6a [Medical Device]

Phrase: "when"

Phrase: "RGL3RBD"

Phrase: "was"

Phrase: "incubated with GST beads,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0991566:Beads [Biomedical or Dental Material]
   770   C1439852:Incubated [Laboratory Procedure]
   737 E C2346972:Bead [Spatial Concept]

Phrase: "no RGL3RBD"

Phrase: "was"

Phrase: "recovered in the pellet fraction."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0441436:Pellet [Manufactured Object]
   760   C0521108:recovered [Qualitative Concept]
   760   C0993610:Pellet [Biomedical or Dental Material]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
   760   C1998480:Pellet [Quantitative Concept]
   726 E C2004454:recover [Organism Function]
Processing 00000000.tx.274: GST-RalB beads did bind RGL3RBD, suggesting that RGL3RBD recognizes Ral GTPases. 

Phrase: "GST-RalB beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0991566:Beads [Biomedical or Dental Material]
   793 E C2346972:Bead [Spatial Concept]

Phrase: "did"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "RGL3RBD,"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that RGL3RBD"

Phrase: "recognizes"

Phrase: "Ral GTPases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.275: GST-RalB proteins that were bound to GDP or the nonhydrolyzable GTP analog GTPS did not bind to RGL3RBD (Fig. 6B), suggesting that a stable interaction occurred only with the apo form of Ral. 

Phrase: "GST-RalB proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0767970:RALB Protein [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "were"

Phrase: "bound to GDP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "or"

Phrase: "the nonhydrolyzable GTP analog GTPS"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind to RGL3RBD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "(Fig. 6B"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a stable interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704675:Interaction [Functional Concept]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "only with the apo form of Ral."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0205171:Only [Quantitative Concept]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C0812284:RAL [Gene or Genome]
   748   C1522492:Form [Functional Concept]
   748   C1704992:RAL [Gene or Genome]
   748   C1720467:Only [Intellectual Product]
Processing 00000000.tx.276: Whereas GST-RalA protein also bound RGL3RBD (data not shown), no other Ras-related protein was found to consistently bind (Fig. 6A). 

Phrase: "Whereas"

Phrase: "GST-RalA protein also bound RGL3RBD"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "no"

Phrase: "other Ras-related protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1335596:ras-related protein [Gene or Genome]
  1000   C1335599:Ras-Related Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1704396:RAS-Related Protein [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0242853:Ras protein [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to consistently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")."
Processing 00000000.tx.277: These results indicate that RGL3RBD has a greater affinity for the nucleotide-free form of RalA and RalB than for any of the other Ras-like GTPases tested and suggest that RGL3 may act as a RalGEF. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that RGL3RBD"

Phrase: "has"

Phrase: "a greater affinity for the nucleotide-free form of RalA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "RalB than"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0767970:RALB [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0812283:RALB [Gene or Genome]

Phrase: "for any"

Phrase: "of the"

Phrase: "other Ras-like GTPases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   898   C1538770:Ras like GTPase [Gene or Genome]
   770   C0034678:RAS [Gene or Genome]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "may"

Phrase: "act as a RalGEF."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0079613:ACT [Therapeutic or Preventive Procedure]
   770   C0378212:RALGEF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1335588:RalGEF [Gene or Genome]
   770   C1706345:RalGEF [Gene or Genome]
Processing 00000000.tx.278: View larger version (36K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.279: 6.  

Phrase: "6."
Processing 00000000.tx.280: In vitro activation of Ral by RGL3. 

Phrase: "In vitro activation of Ral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "by RGL3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]
Processing 00000000.tx.281: A, association of RGL3RBD with nucleotide-free Ras-related GTPases. 

Phrase: "A,"

Phrase: "association of RGL3RBD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004083:Association [Mental Process]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "with nucleotide-free Ras-related GTPases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0751983:ras-Related GTPases [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.282: GST or a series of nucleotide-free GST-Ras-related fusion proteins (5g each protein) pretreated with EDTA and immobilized on glutathione-agarose beads were incubated for 2h at 4C with His6-T7tag-RGL3RBD (5g) as described under "Experimental Procedures." 

Phrase: "GST"

Phrase: "or"

Phrase: "a series of nucleotide-free GST-Ras-related fusion proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0205549:Series [Quantitative Concept]
   739   C2348044:Series [Intellectual Product]

Phrase: "(5g"

Phrase: "each protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "pretreated with EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "immobilized on glutathione-agarose beads"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0036681:Agarose [Carbohydrate]
   760   C0991566:Beads [Biomedical or Dental Material]
   726 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 2h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292425:2H [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "with His6-T7tag-RGL3RBD"

Phrase: "(5g"

Phrase: ")"

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.283: Pelleted samples were washed extensively, and bound His6-T7tag-RGL3RBD was released by boiling in SDS-PAGE sample buffer. 

Phrase: "Pelleted samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "extensively,"

Phrase: "and"

Phrase: "bound His6-T7tag-RGL3RBD"

Phrase: "was"

Phrase: "released by boiling"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0391871:Released [Functional Concept]
   790   C1283071:Released [Functional Concept]
   756 E C0030685:Release [Health Care Activity]
   756   C0242301:Boil [Disease or Syndrome]
   756 E C0439180:% release [Quantitative Concept]
   756 E C0680255:release [Health Care Activity]
   756   C1546559:Boil [Intellectual Product]
   756 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "in SDS-PAGE sample buffer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.284: Samples were resolved by 8% SDS-polyacrylamide gel electrophoresis, and co-precipitated His6-T7-RGL3RBD was detected by immunoblotting with anti-T7 antibody. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "resolved by 8% SDS-polyacrylamide gel electrophoresis,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   853   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   814   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   778   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   778   C0596607:Gel Electrophoresis [Laboratory Procedure]
   774 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   748   C0013855:Electrophoresis [Laboratory Procedure]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   748   C1382104:Gel [Substance]
   748   C1514893:Resolved [Idea or Concept]
   748   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "co-precipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "His6-T7-RGL3RBD"

Phrase: "was"

Phrase: "detected by immunoblotting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "with anti-T7 antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.285: B, association of RGL3RBD with nucleotide-free RalB. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "association of RGL3RBD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004083:Association [Mental Process]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "with nucleotide-free RalB."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0767970:RALB [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812283:RALB [Gene or Genome]
Processing 00000000.tx.286: GST or GST-RalB (5g) immobilized on glutathione-agarose beads and bound to GDP, GTPS, or pretreated with EDTA were incubated with His6-T7tag-RGL3RBD, the beads washed, and the bound protein detected by immunoblot using anti-T7 antisera as described under "Experimental Procedures." 

Phrase: "GST"

Phrase: "or"

Phrase: "GST-RalB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0767970:RALB [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812283:RALB [Gene or Genome]

Phrase: "(5g"

Phrase: ")"

Phrase: "immobilized on glutathione-agarose beads"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0036681:Agarose [Carbohydrate]
   760   C0991566:Beads [Biomedical or Dental Material]
   726 E C2346972:Bead [Spatial Concept]

Phrase: "and"

Phrase: "bound to GDP,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "GTPS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "pretreated with EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "incubated with His6-T7tag-RGL3RBD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "the beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "and"

Phrase: "the bound protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "detected by immunoblot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020985:Immunoblot [Laboratory Procedure]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-T7 antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.287: C, RGL3RBD stimulates RalA guanine nucleotide exchange in vitro. 

Phrase: "C,"

Phrase: "RGL3RBD"

Phrase: "stimulates"

Phrase: "RalA guanine nucleotide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0018328:guanine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "exchange"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678640:exchange [Social Behavior]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.288: Purified His6-RGL3RBD (filled squares), His6-RLFRBD (open circles), or buffer (filled circles) were incubated with [3H]GDP-bound His6-RalA (11,700cpm/2.5 g of protein) for the indicated times. 

Phrase: "Purified His6-RGL3RBD"

Phrase: "(filled squares"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205120:Square [Spatial Concept]
   827   C1552595:Square [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "His6-RLFRBD"

Phrase: "(open circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(filled circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "were"

Phrase: "incubated with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]GDP-bound His6-RalA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0765159:RALA [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0812284:RALA [Gene or Genome]

Phrase: "(11,"

Phrase: "700cpm/2.5 g of protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0060916:protein g [Amino Acid, Peptide, or Protein]
   783   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "for the indicated times."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.289: Nucleotide release reactions contained 2M RalA, 5M RalGEF, and 1mM unlabeled GDP. 

Phrase: "Nucleotide release reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0443286:Reaction [Functional Concept]
   793   C1114821:Reaction [Clinical Attribute]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "2M RalA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0765159:RALA [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812284:RALA [Gene or Genome]

Phrase: "5M RalGEF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0378212:RALGEF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1335588:RalGEF [Gene or Genome]
   861   C1706345:RalGEF [Gene or Genome]

Phrase: "and"

Phrase: "1mM unlabeled GDP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.290: Nucleotide release rates from Ha-Ras (3500cpm/2.5 g of protein) were also determined in the absence (open triangles) or presence (filled triangles) of RGL3RBD. 

Phrase: "Nucleotide release rates from Ha-Ras (3500cpm/2.5 g"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   777   C1548189:Release 2.5 [Intellectual Product]
   739   C0030685:Release [Health Care Activity]
   739   C0391871:Release [Functional Concept]
   739   C0439180:% release [Quantitative Concept]
   739   C0680255:release [Health Care Activity]
   739   C1283071:Release [Functional Concept]
   739   C1963578:Release [Therapeutic or Preventive Procedure]
   706   C0871208:Rate [Activity]
   706   C1521828:Rate [Quantitative Concept]

Phrase: "of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "were"

Phrase: "also"

Phrase: "determined in the absence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "(open triangles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205119:triangles [Conceptual Entity]

Phrase: ")"

Phrase: "or"

Phrase: "presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "(filled triangles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205119:triangles [Conceptual Entity]

Phrase: ")"

Phrase: "of RGL3RBD."
Processing 00000000.tx.291: Values are expressed as the percentage of the average zero time point. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "expressed as the percentage of the average zero time point."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C2348792:Time Point [Temporal Concept]
   739   C0040223:Time [Temporal Concept]
   739   C0439165:Percentage [Quantitative Concept]
   739   C0919414:Zero [Quantitative Concept]
   739   C1510992:Average [Quantitative Concept]
   739   C1549488:Percentage [Idea or Concept]
   739   C1552961:Point [Quantitative Concept]
   739   C1561533:Percentage [Idea or Concept]
   739   C2347617:point [Quantitative Concept]
   739   C2825518:AVERAGE [Quantitative Concept]
   739   C3541383:Time [Temporal Concept]
Processing 00000000.tx.292: Each value is the average of duplicate incubations and is representative of a typical experiment repeated five times. 

Phrase: "Each value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "is"

Phrase: "the average of duplicate incubations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1510992:Average [Quantitative Concept]
   760   C2825518:AVERAGE [Quantitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "representative of a typical experiment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "five times."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.293: To extend this analysis, HA-tagged RGL3RBD was used for in vitro nucleotide exchange assays. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "this analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "HA-tagged RGL3RBD"

Phrase: "was"

Phrase: "used for in vitro nucleotide exchange assays."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   788   C1515653:In Vitro Assay [Research Activity]
   778   C0021135:In Vitro [Intellectual Product]
   778   C1533691:in vitro [Qualitative Concept]
           vitro
   778   C2827718:In Vitro [Functional Concept]
   748   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0678640:exchange [Social Behavior]
   748   C1273517:used [Finding]
   714   C0005507:Assay [Laboratory Procedure]
   714 E C0042153:use [Functional Concept]
   714   C0243073:assay [Qualitative Concept]
   714 E C0457083:Use [Functional Concept]
   714   C1510438:Assay [Laboratory Procedure]
   714 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.294: Because RLF has proven Ral-specific nucleotide exchange activity, the activity of the bacterially expressed RLF CDC25 homology domain was also examined (30). 

Phrase: "Because"

Phrase: "RLF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035344:RLF [Disease or Syndrome]
  1000   C1416453:RLF [Gene or Genome]
  1000   C1419392:RLF [Gene or Genome]

Phrase: "has"

Phrase: "proven Ral-specific nucleotide exchange activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]

Phrase: "the activity of the bacterially expressed RLF CDC25 homology domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "also"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.295: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.296: 6C, recombinant RGL3RBD and RLFRBD (amino acids 1-518 of RLF, which include its CDC25 domain), but not buffer alone, stimulated the dissociation of [3H]GDP from RalA but not Ha-Ras. 

Phrase: "6C,"

Phrase: "recombinant RGL3RBD"

Phrase: "and"

Phrase: "RLFRBD"

Phrase: "(amino acids 1-518 of RLF,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   753   C0035344:RLF [Disease or Syndrome]
   753   C1416453:RLF [Gene or Genome]
   753   C1419392:RLF [Gene or Genome]
   719 E C0202406:Acid [Laboratory Procedure]

Phrase: "which"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "its CDC25 domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "the dissociation of [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442460:3H [Temporal Concept]

Phrase: "]GDP from RalA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "but"

Phrase: "not Ha-Ras."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034678:RAS [Gene or Genome]
Processing 00000000.tx.297: Similar results were seen with RalB (data not shown). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "seen with RalB"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205397:Seen [Qualitative Concept]
   790   C0767970:RALB [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0812283:RALB [Gene or Genome]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.298: These data demonstrate that the isolated RGL3-CDC25 homology domain has RalGEF activity in vitro. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the isolated RGL3-CDC25 homology domain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1334043:Homology [Gene or Genome]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C2697616:Homology [Qualitative Concept]
   804   C3541951:Domain [Intellectual Product]

Phrase: "has"

Phrase: "RalGEF activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.299: To determine if RGL3 can activate Ral in vivo, we used an affinity precipitation assay to examine the activation status of endogenous cellular Ral. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "Ral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812284:RAL [Gene or Genome]
  1000   C1704992:RAL [Gene or Genome]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an affinity precipitation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0032931:Precipitation [Natural Phenomenon or Process]
   861   C0032932:Precipitation [Molecular Function]
   861   C1642401:% precipitation [Quantitative Concept]
   861   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the activation status of endogenous cellular Ral."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449438:Status [Qualitative Concept]
Processing 00000000.tx.300: This assay is based on the ability of the Ral effector RLIP76 to interact specifically with the activated, GTP-bound form of Ral (27, 43). 

Phrase: "This assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "is"

Phrase: "based on the ability of the Ral effector RLIP76 to"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   739   C0085732:Ability [Organism Attribute]
   739   C0812284:RAL [Gene or Genome]
   739   C1419253:RLIP76 [Gene or Genome]
   739   C1527178:Based [Functional Concept]
   739   C1704992:RAL [Gene or Genome]
   739   C1705938:Based [Idea or Concept]
   739   C3539807:RLIP76 [Gene or Genome]
   706 E C0002055:base [Inorganic Chemical]
   706 E C0178499:Base [Chemical Viewed Functionally]
   706 E C1880279:Base [Biomedical or Dental Material]

Phrase: "interact"

Phrase: "specifically with the activated, GTP-bound form of Ral (27,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   739   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0332297:bound [Spatial Concept]
   739   C0348078:Form [Qualitative Concept]
   739   C0376315:Form [Manufactured Object]
   739   C0812284:RAL [Gene or Genome]
   739   C1145667:Bound [Activity]
   739   C1167622:Bound [Molecular Function]
   739   C1522492:Form [Functional Concept]
   739   C1689898:% bound [Quantitative Concept]
   739   C1704992:RAL [Gene or Genome]
   739   C1879547:Activated [Activity]
   739   C2349209:Bound [Conceptual Entity]
   706 E C1515877:Activate [Functional Concept]

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.301: We generated GST-RalBD (a GST fusion protein containing the Ral binding domain of RLIP76 (amino acids 397-518)), and we used it to detect Ral-GTP in cell lysates (44-46). 

Phrase: "We"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "GST-RalBD"

Phrase: "("

Phrase: "a GST fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the Ral binding domain of RLIP76"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "(amino acids 397-518"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "it to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "Ral-GTP in cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   823   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "(44-46"

Phrase: ")."
Processing 00000000.tx.302: The validity of this method, including the use of GST-RalBD, has been previously demonstrated (27, 43). 

Phrase: "The validity of this method,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2349101:Validity [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the use of GST-RalBD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1524063:Use of [Functional Concept]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "previously"

Phrase: "demonstrated"

Phrase: "(27,"

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.303: The RalGEF activity of RGL3 was examined by transient transfection assays in HEK293 (Fig. 7). 

Phrase: "The RalGEF activity of RGL3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "examined by transient transfection assays"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   760   C0040704:Transient [Population Group]
   760   C0205374:Transient [Temporal Concept]
   760   C0332128:Examined [Finding]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "in HEK293"

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.304: The transfection of epitope-tagged RGL3 substantially increased the amount of precipitated endogenous Ral-GTP (Fig. 7, compare lanes 1and 2). 

Phrase: "The transfection of epitope-tagged RGL3 substantially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the amount of precipitated endogenous Ral-GTP (Fig. 7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1265611:Amount [Quantitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lanes 1and 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.305: Transfection with increasing amounts of RGL3 led to increased levels of Ral-GTP, and these increases correlated with the amount of expressed RGL3 detected by immunoblotting (data not shown). 

Phrase: "Transfection with increasing amounts of RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "led to increased levels of Ral-GTP,"
Meta Candidates (Total=19; Excluded=9; Pruned=0; Remaining=10)
   789   C1318746:increased lead levels [Finding]
   757   C0428255:lead levels [Laboratory or Test Result]
   757   C0861064:increased lead [Finding]
   748   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205217:Increased [Quantitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0812284:RAL [Gene or Genome]
   748   C1704992:RAL [Gene or Genome]
   748   C1708698:LED [Manufactured Object]
   741 E C0524167:Lead level [Laboratory Procedure]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C0456079:Level [Classification]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C1522538:Lead [Functional Concept]
   714 E C1547707:Level [Geographic Area]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C2946261:Level [Pharmacologic Substance]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "these increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:increases [Functional Concept]

Phrase: "correlated with the amount of expressed RGL3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1265611:Amount [Quantitative Concept]
   748   C1428955:RGL3 [Gene or Genome]
   748   C1707520:Correlated [Qualitative Concept]

Phrase: "detected by immunoblotting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.306: We next examined the ability of an RGL3 mutant (RGL3RBD) lacking the Rit/Ras-interaction domain to activate Ral in vivo. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the ability of an RGL3 mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "(RGL3RBD"

Phrase: ")"

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the Rit/Ras-interaction domain to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "Ral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812284:RAL [Gene or Genome]
  1000   C1704992:RAL [Gene or Genome]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.307: Overexpression of RGL3RBD only modestly stimulated the cellular levels of Ral-GTP (Fig. 7, lane 3). 

Phrase: "Overexpression of RGL3RBD only modestly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "the cellular levels of Ral-GTP (Fig. 7,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.308: These results demonstrate that RGL3 acts as a Ral exchange factor in vivo and suggest that the C-terminal RBD is required for effective GDP/GTP exchange. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "acts as a Ral exchange factor"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0120465:exchange factor [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0960756:factor A [Organic Chemical]
   753   C0079613:ACT [Therapeutic or Preventive Procedure]
   753   C0678640:exchange [Social Behavior]
   753   C0812284:RAL [Gene or Genome]
   753   C1521761:Factor [Functional Concept]
   753   C1704992:RAL [Gene or Genome]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the C-terminal RBD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]
   722   C1149341:C-terminal binding [Molecular Function]

Phrase: "is"

Phrase: "required for effective GDP/GTP exchange."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0678640:exchange [Social Behavior]
   753   C1280519:effective [Qualitative Concept]
   753   C1514873:Required [Functional Concept]
   753   C1704419:Effective [Qualitative Concept]
Processing 00000000.tx.309: View larger version (38K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(38K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.310: 7.  

Phrase: "7."
Processing 00000000.tx.311: RGL3-induced Ral activation. 

Phrase: "RGL3-induced Ral activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]
Processing 00000000.tx.312: Whole cell lysates were prepared from HEK293 cells transiently transfected with expression vector alone (lane 1) or with vectors expressing HA-RGL3 (lane 2) or HA-RGL3RBD cDNAs (lane 3) (10g each plasmid). 

Phrase: "Whole cell lysates"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate
   827   C0007634:Cell [Cell]
   827   C0444667:Whole [Quantitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "prepared from HEK293 cells transiently"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C2936239:HEK293 Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726   C1521827:Prepare [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with expression vector"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or with vectors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0442335:Vectors [Spatial Concept]
   756 E C1705099:Vector [Idea or Concept]

Phrase: "expressing"

Phrase: "HA-RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428955:RGL3 [Gene or Genome]

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "HA-RGL3RBD cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "(10g"

Phrase: "each plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")."
Processing 00000000.tx.313: Each reaction contained (in a final volume of 500l) 1.5mg of clarified cell lysate, 20g of GST-RalBD, and 20l of a 1:1 (v/v) suspension of glutathione-agarose. 

Phrase: "Each reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "("

Phrase: "in a final volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "of 500l"

Phrase: ")"

Phrase: "1.5mg of clarified cell lysate,"

Phrase: "20g of GST-RalBD,"

Phrase: "and"

Phrase: "20l of a 1"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(v/v) suspension of glutathione-agarose."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0038960:Suspension [Biomedical or Dental Material]
   753   C1382107:Suspension [Substance]
   753   C1705537:Suspension [Functional Concept]
Processing 00000000.tx.314: After incubation for 2h at 4C, the samples were pelleted and washed as described under "Experimental Procedures." 

Phrase: "After incubation"

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "pelleted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0441436:Pellet [Manufactured Object]
   966   C0993610:Pellet [Biomedical or Dental Material]
   966   C1998480:Pellet [Quantitative Concept]

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.315: The GTP-Ral precipitated by glutathione-agarose-bound GST-RalBD was identified by immunoblot analysis with a monoclonal anti-RalA antibody (top panel). 

Phrase: "The GTP-Ral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0812284:RAL [Gene or Genome]
   861   C1704992:RAL [Gene or Genome]

Phrase: "precipitated by glutathione-agarose-bound GST-RalBD"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0036681:Agarose [Carbohydrate]
   748   C0332297:bound [Spatial Concept]
           Bounded by
   748   C1145667:Bound [Activity]
   748   C1167622:Bound [Molecular Function]
   748   C1689898:% bound [Quantitative Concept]
   748   C2349209:Bound [Conceptual Entity]
   714   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "was"

Phrase: "identified by immunoblot analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0205396:Identified [Qualitative Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "with a monoclonal anti-RalA antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.316: Endogenous RalA present in the lysate (bottom panel) and the expression of the transfected constructs was determined by immunoblot analysis with anti-RalA and anti-HA monoclonal antibodies, respectively. 

Phrase: "Endogenous RalA present in the lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "(bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "the expression of the transfected constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "determined by immunoblot analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "with anti-RalA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0765159:RALA [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812284:RALA [Gene or Genome]

Phrase: "and"

Phrase: "anti-HA monoclonal antibodies,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0746619:monoclonal [Finding]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "respectively."
Processing 00000000.tx.317: The data are representative of a typical experiment repeated four times. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "representative of a typical experiment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "four times."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.318: Rit Leads to the In Vivo Activation of Ral GTPases-- Because Rit is capable of interacting with a series of RalGEFs (17), we next asked if Rit can activate the exchange activity of endogenous RalGDS proteins in vivo. 

Phrase: "Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "Leads to the In Vivo Activation of Ral GTPases"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   773   C2246178:Ral GTPase activation [Organism Function]
   764   C1515655:In Vivo [Spatial Concept]
           vivo
   742   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   742   C0181586:leads [Medical Device]
   742   C0812284:RAL [Gene or Genome]
   742   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   742   C1522538:Lead [Functional Concept]
   742   C1704992:RAL [Gene or Genome]
   742   C1879547:Activation [Activity]
   742   C2348269:Lead [Element, Ion, or Isotope]
   742   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "-"

Phrase: "-"

Phrase: "Because"

Phrase: "Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "is"

Phrase: "capable of interacting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C2698977:Capability [Qualitative Concept]

Phrase: "with a series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: "of RalGEFs"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C0378212:ral Guanine Nucleotide Exchange Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C0120465:Guanine Nucleotide Exchange Factors [Amino Acid, Peptide, or Protein,Enzyme]
           exchange factor
   840   C0018328:guanine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0678640:exchange [Social Behavior]
   804   C0812284:RAL [Gene or Genome]
   804   C1704992:RAL [Gene or Genome]
   771   C1521761:Factor [Functional Concept]
   771   C2827422:Factor [Conceptual Entity]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "we next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "asked"

Phrase: "if"

Phrase: "Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the exchange activity of endogenous RalGDS proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C1537044:protein activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.319: Increasing amounts of RitQ79L were transfected to HEK293 cells together with epitope-tagged RalA and analyzed for cellular Ral-GTP levels. 

Phrase: "Increasing amounts of RitQ79L"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "transfected to HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C2936239:HEK293 Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "together with epitope-tagged RalA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0765159:RALA [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812284:RALA [Gene or Genome]

Phrase: "and"

Phrase: "analyzed for cellular Ral-GTP levels."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   753   C0007634:Cellular [Cell]
   753   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0178539:Cellular [Functional Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C0812284:RAL [Gene or Genome]
   753   C0936012:Analyzed [Research Activity]
   753   C1704992:RAL [Gene or Genome]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.320: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.321: 8, following transient co-expression of HA-tagged RalA with 10g of constitutively active or wild type Rit in HEK293 cells, RitQ79L but not wild type Rit elevated the cellular levels of RalA-GTP. 

Phrase: "8,"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "transient co-expression of HA-tagged RalA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "with 10g"

Phrase: "of constitutively active"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205177:Active [Functional Concept]

Phrase: "or"

Phrase: "wild type Rit in HEK293 cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   753   C1419390:RIT [Gene or Genome]

Phrase: "RitQ79L"

Phrase: "but"

Phrase: "not wild type Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   812   C1419390:RIT [Gene or Genome]

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "the cellular levels of RalA-GTP."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.322: The activation of Ral presumably results from the activation of endogenous RalGEFs, since the expression of Rit79L58C, a Rit effector mutant that fails to interact with RalGEFs (17), did not induce Ral activation (Fig. 8, lane 4). 

Phrase: "The activation of Ral presumably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "results from the activation of endogenous RalGEFs,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   797   C0120465:Guanine Nucleotide Exchange Factors [Amino Acid, Peptide, or Protein,Enzyme]
           exchange factor
   787   C0378212:ral Guanine Nucleotide Exchange Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0018328:guanine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   754   C1516853:Endogenous Factors [Functional Concept]
   738   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0205227:Endogenous [Functional Concept]
   738   C0678640:exchange [Social Behavior]
   738   C0812284:RAL [Gene or Genome]
   738   C1274040:Result [Functional Concept]
   738   C1546471:Result [Idea or Concept]
   738   C1704992:RAL [Gene or Genome]
   738   C1879547:Activation [Activity]
   738   C2825142:Result [Finding]
   704   C1521761:Factor [Functional Concept]
   704   C2827422:Factor [Conceptual Entity]

Phrase: "since"

Phrase: "the expression of Rit79L58C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "a Rit effector mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with RalGEFs"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   864   C0378212:ral Guanine Nucleotide Exchange Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C0120465:Guanine Nucleotide Exchange Factors [Amino Acid, Peptide, or Protein,Enzyme]
           exchange factor
   778   C0018328:guanine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0678640:exchange [Social Behavior]
   748   C0812284:RAL [Gene or Genome]
   748   C1704992:RAL [Gene or Genome]
   714   C1521761:Factor [Functional Concept]
   714   C2827422:Factor [Conceptual Entity]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Ral activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "(Fig. 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.323: Increasing the amount of transfected RitQ79L did not further enhance the observed Ral-GTP levels, indicating that the endogenous levels of RalGEFs are limiting under these conditions (data not shown). 

Phrase: "Increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the amount of transfected RitQ79L"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "did"

Phrase: "not further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1518422:Not [Functional Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the observed Ral-GTP levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "indicating"

Phrase: "that"

Phrase: "the endogenous levels of RalGEFs"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "limiting under these conditions"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0439801:limiting [Functional Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737 E C1549649:Limit [Idea or Concept]
   737   C1705253:Condition [Conceptual Entity]
   737 E C2349209:Limit [Conceptual Entity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.324: View larger version (42K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(42K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.325: 8.  

Phrase: "8."
Processing 00000000.tx.326: In vivo activation of Ral by activated Rit. 

Phrase: "In vivo activation of Ral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "by activated Rit."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   861   C1419390:RIT [Gene or Genome]
Processing 00000000.tx.327: Whole cell lysates were prepared from HEK293 cells transiently co-transfected with 5g of a vector expressing HA-RalA and 10g of either an empty expression vector (lane 1) or with vectors expressing HA-RitWT (lane 2), HA-RitQ79L (lane 3), or HA-Rit79L58C (lane 4) as indicated. 

Phrase: "Whole cell lysates"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate
   827   C0007634:Cell [Cell]
   827   C0444667:Whole [Quantitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "prepared from HEK293 cells transiently"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C2936239:HEK293 Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726   C1521827:Prepare [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "co-transfected with 5g of a vector expressing HA-RalA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0018909:Haemagglutinin, NOS [Immunologic Factor]
   739   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0442335:Vector [Spatial Concept]
   739   C0765159:RALA [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0812284:RALA [Gene or Genome]
   739   C1705099:Vector [Idea or Concept]

Phrase: "and"

Phrase: "10g of either"

Phrase: "an empty expression vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or with vectors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0442335:Vectors [Spatial Concept]
   756 E C1705099:Vector [Idea or Concept]

Phrase: "expressing"

Phrase: "HA-RitWT"

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "HA-RitQ79L"

Phrase: "(lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "HA-Rit79L58C"

Phrase: "(lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.328: Each reaction contained (in a final volume of 500l) 1.5mg of clarified cell lysate, 20g of GST-RalBD, and 20l of a 1:1 (v/v) suspension of glutathione-agarose. 

Phrase: "Each reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "("

Phrase: "in a final volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "of 500l"

Phrase: ")"

Phrase: "1.5mg of clarified cell lysate,"

Phrase: "20g of GST-RalBD,"

Phrase: "and"

Phrase: "20l of a 1"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(v/v) suspension of glutathione-agarose."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0038960:Suspension [Biomedical or Dental Material]
   753   C1382107:Suspension [Substance]
   753   C1705537:Suspension [Functional Concept]
Processing 00000000.tx.329: After incubation for 2h at 4C, the samples were pelleted and washed as described under "Experimental Procedures," and the GTP-Ral precipitated by glutathione-agarose-bound GST-RalBD was identified by immunoblot analysis with a monoclonal anti-RalA antibody (top panel). 

Phrase: "After incubation"

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "pelleted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0441436:Pellet [Manufactured Object]
   966   C0993610:Pellet [Biomedical or Dental Material]
   966   C1998480:Pellet [Quantitative Concept]

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "as"

Phrase: "described under ""Experimental Procedures,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]

Phrase: """"

Phrase: "and"

Phrase: "the GTP-Ral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0812284:RAL [Gene or Genome]
   861   C1704992:RAL [Gene or Genome]

Phrase: "precipitated by glutathione-agarose-bound GST-RalBD"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0036681:Agarose [Carbohydrate]
   748   C0332297:bound [Spatial Concept]
           Bounded by
   748   C1145667:Bound [Activity]
   748   C1167622:Bound [Molecular Function]
   748   C1689898:% bound [Quantitative Concept]
   748   C2349209:Bound [Conceptual Entity]
   714   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "was"

Phrase: "identified by immunoblot analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0205396:Identified [Qualitative Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "with a monoclonal anti-RalA antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.330: Aliquots of each cell lysate (10g) were subjected to SDS-PAGE on a 10% polyacrylamide gel, transferred to nitrocellulose, and subjected to immunoblot analysis with anti-RalA antibody to determine the amount of endogenous RalA (middle panel) and with anti-Rit polyclonal antibody to detect transfected Rit protein expression (bottom panel). 

Phrase: "Aliquots of each cell lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1510844:Aliquot [Quantitative Concept]

Phrase: "(10g"

Phrase: ")"

Phrase: "were"

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "on a 10% polyacrylamide gel,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   812   C1382104:Gel [Substance]

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   777 E C0009357:Collodion Cotton [Biomedical or Dental Material,Pharmacologic Substance]

Phrase: "and"

Phrase: "subjected to immunoblot analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "with anti-RalA antibody to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "determine"

Phrase: "the amount of endogenous RalA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "(middle panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and with anti-Rit polyclonal antibody to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   748   C1419390:RIT [Gene or Genome]
   748   C1515981:And [Idea or Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "transfected Rit protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1171362:protein expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.331: The data are representative of a typical experiment repeated two times. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "representative of a typical experiment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "two times."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1948050:Two Times [Quantitative Concept]
   861   C0040223:times [Temporal Concept]
   861   C0205448:Two [Quantitative Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.332: To determine whether Rit can activate the exchange activity of RGL3 in vivo, HEK293 cells were transfected with epitope-tagged RitQ79L or RGL3 alone or with RitQ79L and RGL3 together, and the levels of endogenous Ral-GTP were determined using the GST-RalBD association assay. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the exchange activity of RGL3 in vivo, HEK293 cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "transfected with epitope-tagged RitQ79L"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0003316:Epitope [Immunologic Factor]
   760   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   760   C1708632:Tagged [Qualitative Concept]
   726 E C0037293:Tag [Neoplastic Process]
   726 E C0181496:Tag [Manufactured Object]
   726 E C1710492:TAG [Gene or Genome]

Phrase: "or"

Phrase: "RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or with RitQ79L"

Phrase: "and"

Phrase: "RGL3 together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428955:RGL3 [Gene or Genome]

Phrase: "and"

Phrase: "the levels of endogenous Ral-GTP"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the GST-RalBD association assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.333: Since the expression of either active Rit or RGL3 is sufficient to induce Ral GDP/GTP exchange, the amount of individual expression vectors was adjusted to limit endogenous Ral activation by either RitQ79L or RGL3 expression alone. 

Phrase: "Since"

Phrase: "the expression of either active Rit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "is"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Ral GDP/GTP exchange,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0678640:exchange [Social Behavior]

Phrase: "the amount of individual expression vectors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "adjusted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456081:Adjusted [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "limit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439801:limit [Functional Concept]
  1000   C1549649:Limit [Idea or Concept]
  1000   C2349209:Limit [Conceptual Entity]

Phrase: "endogenous Ral activation by either RitQ79L"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "or"

Phrase: "RGL3 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.334: The expression of RGL3 together with activated Rit modestly stimulated endogenous Ral activation (~2.3-fold ) above the levels of Ral-GTP achieved by either protein alone (~1.4-fold for RGL3 and ~1.1-fold with RitQ79L alone) (Fig. 9, compare lanes 1-4). 

Phrase: "The expression of RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "together with activated Rit modestly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   827   C1419390:RIT [Gene or Genome]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "endogenous Ral activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]

Phrase: "(~2.3-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C1519042:2-3 [Research Activity]

Phrase: ")"

Phrase: "above the levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "of Ral-GTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "achieved by either protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(~1.4-fold for RGL3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332462:Fold [Spatial Concept]
   760   C1880834:FOLD [Phenomenon or Process]

Phrase: "and ~"

Phrase: "1.1-fold with RitQ79L"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332462:Fold [Spatial Concept]
   760   C1880834:FOLD [Phenomenon or Process]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: ")"

Phrase: "(Fig. 9,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lanes 1-4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.335: This activation presumably resulted from the direct interaction of RGL3 with Rit because co-expression of RGL3RBD with activated Rit, or the effector mutant Rit79L58C with RGL3, failed to induce endogenous Ral activation above the levels achieved by either RitQ79L or RGL3 expression alone (Fig. 9). 

Phrase: "This activation presumably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "resulted from the direct interaction of RGL3"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0439851:Direct [Qualitative Concept]
   748   C1428955:RGL3 [Gene or Genome]
   748   C1704675:Interaction [Functional Concept]
   748   C1947931:Direct [Qualitative Concept]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "with Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "because"

Phrase: "co-expression of RGL3RBD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "with activated Rit,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   861   C1419390:RIT [Gene or Genome]

Phrase: "or"

Phrase: "the effector mutant Rit79L58C with RGL3,"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "endogenous Ral activation above the levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "achieved by either RitQ79L"

Phrase: "or"

Phrase: "RGL3 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(Fig. 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.336: Taken together, these findings suggest that GTP-bound Rit can activate cellular RalGEFs including RGL3. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that GTP-bound Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   827   C1419390:RIT [Gene or Genome]

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "cellular RalGEFs"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   914   C0378212:ral Guanine Nucleotide Exchange Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0120465:Guanine Nucleotide Exchange Factors [Amino Acid, Peptide, or Protein,Enzyme]
           exchange factor
   827   C0018328:guanine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0678640:exchange [Social Behavior]
   799   C0812284:RAL [Gene or Genome]
   799   C1704992:RAL [Gene or Genome]
   766   C1521761:Factor [Functional Concept]
   766   C2827422:Factor [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "RGL3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]
Processing 00000000.tx.337: View larger version (49K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(49K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.338: 9.  

Phrase: "9."
Processing 00000000.tx.339: Rit-induced Ral activation is stimulated by RGL3. 

Phrase: "Rit-induced Ral activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "stimulated by RGL3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1428955:RGL3 [Gene or Genome]
   790   C1948023:Stimulated [Natural Phenomenon or Process]
Processing 00000000.tx.340: HEK293 cells were transiently transfected with vectors expressing RGL3 (3g), RGL3RBD (3g), RitQ79L (5g), or Rit79L58C (5g) cDNAs as indicated. 

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with vectors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0442335:Vectors [Spatial Concept]
   756 E C1705099:Vector [Idea or Concept]

Phrase: "expressing"

Phrase: "RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "(3g"

Phrase: ")"

Phrase: ","

Phrase: "RGL3RBD"

Phrase: "(3g"

Phrase: ")"

Phrase: ","

Phrase: "RitQ79L"

Phrase: "(5g"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "Rit79L58C"

Phrase: "(5g"

Phrase: ")"

Phrase: "cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.341: Whole cell lysates (1.5mg) were prepared and incubated with 20g of GST-RalBD and 20l of a 1:1 (v/v) suspension of glutathione-agarose to recover Ral-GTP. 

Phrase: "Whole cell lysates"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate
   827   C0007634:Cell [Cell]
   827   C0444667:Whole [Quantitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "(1.5mg"

Phrase: ")"

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "incubated with 20g of GST-RalBD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "20l of a 1"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(v/v) suspension of glutathione-agarose to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0038960:Suspension [Biomedical or Dental Material]
   748   C1382107:Suspension [Substance]
   748   C1705537:Suspension [Functional Concept]

Phrase: "recover"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0521108:recover [Qualitative Concept]
  1000   C2004454:recover [Organism Function]

Phrase: "Ral-GTP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.342: After incubation for 2h at 4C, the samples were pelleted and washed as described under "Experimental Procedures." 

Phrase: "After incubation"

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "pelleted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0441436:Pellet [Manufactured Object]
   966   C0993610:Pellet [Biomedical or Dental Material]
   966   C1998480:Pellet [Quantitative Concept]

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.343: The GTP-Ral precipitated by glutathione-agarose-bound GST-RalBD was identified by immunoblot analysis with a monoclonal anti-RalA antibody (top panel). 

Phrase: "The GTP-Ral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0812284:RAL [Gene or Genome]
   861   C1704992:RAL [Gene or Genome]

Phrase: "precipitated by glutathione-agarose-bound GST-RalBD"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0036681:Agarose [Carbohydrate]
   748   C0332297:bound [Spatial Concept]
           Bounded by
   748   C1145667:Bound [Activity]
   748   C1167622:Bound [Molecular Function]
   748   C1689898:% bound [Quantitative Concept]
   748   C2349209:Bound [Conceptual Entity]
   714   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "was"

Phrase: "identified by immunoblot analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0205396:Identified [Qualitative Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "with a monoclonal anti-RalA antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.344: Aliquots of each cell lysate (10g) were subjected to SDS-PAGE on a 10% polyacrylamide gel, transferred to nitrocellulose, and subjected to immunoblot analysis with anti-RalA and anti-HA monoclonal antibodies to determine the amount of endogenous RalA and transfected Rit and RGL3 protein expression (bottom panels). 

Phrase: "Aliquots of each cell lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1510844:Aliquot [Quantitative Concept]

Phrase: "(10g"

Phrase: ")"

Phrase: "were"

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "on a 10% polyacrylamide gel,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   812   C1382104:Gel [Substance]

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   777 E C0009357:Collodion Cotton [Biomedical or Dental Material,Pharmacologic Substance]

Phrase: "and"

Phrase: "subjected to immunoblot analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "with anti-RalA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0765159:RALA [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812284:RALA [Gene or Genome]

Phrase: "and"

Phrase: "anti-HA monoclonal antibodies to"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   875   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0746619:monoclonal [Finding]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "determine"

Phrase: "the amount of endogenous RalA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "transfected Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   861   C1419390:RIT [Gene or Genome]

Phrase: "and"

Phrase: "RGL3 protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1171362:protein expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(bottom panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.345: The graph shows data from three independent experiments (results are mean valuesS.D.), and the immunoblots are representative of a typical experiment. 

Phrase: "The graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681493:Graph [Intellectual Product]
  1000   C2698021:Graph [Conceptual Entity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "data from three independent experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "mean valuesS."

Phrase: "D."

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "are"

Phrase: "representative of a typical experiment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.346: Ras Activates RGL3-- The strong in vivo association of RGL3 and activated Ras and previous studies that have shown that Ras is capable of activating RalGEFs (47, 48) led us to assess whether Ras could activate the exchange activity of RGL3 in vivo. 

Phrase: "Ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "Activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "-"

Phrase: "-"

Phrase: "The strong in vivo association of RGL3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "activated Ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034678:RAS [Gene or Genome]

Phrase: "and"

Phrase: "previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that Ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "is"

Phrase: "capable of activating RalGEFs"

Phrase: "(47,"

Phrase: "48"

Phrase: ")"

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "whether"

Phrase: "Ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "could"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the exchange activity of RGL3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.347: HEK293 cells were transfected with expression plasmids encoding epitope-tagged RGL3 or Ras61L alone, or co-transfected with Ras61L and RGL3. 

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with expression plasmids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "epitope-tagged RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1428955:RGL3 [Gene or Genome]

Phrase: "or"

Phrase: "Ras61L"

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or"

Phrase: "co-transfected with Ras61L"

Phrase: "and"

Phrase: "RGL3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]
Processing 00000000.tx.348: Transient expression of RGL3 or activated Ras alone induced modest Ral activation (~1.5-fold) (Fig. 10, compare lanes 1,2,and 4). 

Phrase: "Transient expression of RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "activated Ras alone induced modest Ral activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1879547:Activation [Activity]

Phrase: "(~1.5-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0450316:1/5 [Quantitative Concept]

Phrase: ")"

Phrase: "(Fig. 10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lanes 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.349: However, expression of constitutively active Ras together with RGL3 strongly stimulated Ral activation, resulting in Ral-GTP levels that were ~7-fold higher than those of untransfected cells (Fig. 10, compare lanes 1and 5). 

Phrase: "However,"

Phrase: "expression of constitutively active Ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "together with RGL3 strongly stimulated Ral activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1879547:Activation [Activity]

Phrase: "resulting in Ral-GTP levels"
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   806   C0332294:Resulting in [Functional Concept]
   760   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0441889:Levels [Qualitative Concept]
   760   C0678226:resulting [Functional Concept]
   760   C0812284:RAL [Gene or Genome]
   760   C1704992:RAL [Gene or Genome]
   726 E C0456079:Level [Classification]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C1547707:Level [Geographic Area]
   726 E C2825142:Result [Finding]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "were"

Phrase: "~7-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "higher than those of untransfected cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "(Fig. 10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lanes 1and 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.350: As seen with Rit, co-expression of Ras61L and RGL3RBD failed to stimulate Ral-GTP levels above that of activated Ras alone, suggesting that the interaction of Ras and RGL3 is necessary for synergistic stimulation of Ral-GTP levels. 

Phrase: "As"

Phrase: "seen with Rit,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205397:Seen [Qualitative Concept]
   790   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   790   C1419390:RIT [Gene or Genome]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "co-expression of Ras61L"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "RGL3RBD"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stimulate"

Phrase: "Ral-GTP levels above that of activated Ras"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the interaction of Ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "is"

Phrase: "necessary for synergistic stimulation of Ral-GTP levels."
Processing 00000000.tx.351: View larger version (49K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(49K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.352: 10.  

Phrase: "10."
Processing 00000000.tx.353: Ras-induced Ral-activation is stimulated by RGL3. 

Phrase: "Ras-induced Ral-activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "stimulated by RGL3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1428955:RGL3 [Gene or Genome]
   790   C1948023:Stimulated [Natural Phenomenon or Process]
Processing 00000000.tx.354: Whole cell lysates were prepared from HEK293 cells transiently transfected with expression vector alone (3g) (lane 1) or with vectors expressing HA-RasQ61L (2g), HA-RGL3 (3g), or HA-RGL3RBD (3g) as indicated. 

Phrase: "Whole cell lysates"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate
   827   C0007634:Cell [Cell]
   827   C0444667:Whole [Quantitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "prepared from HEK293 cells transiently"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C2936239:HEK293 Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726   C1521827:Prepare [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with expression vector"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(3g"

Phrase: ")"

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or with vectors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0442335:Vectors [Spatial Concept]
   756 E C1705099:Vector [Idea or Concept]

Phrase: "expressing"

Phrase: "HA-RasQ61L"

Phrase: "(2g"

Phrase: ")"

Phrase: ","

Phrase: "HA-RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428955:RGL3 [Gene or Genome]

Phrase: "(3g"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "HA-RGL3RBD"

Phrase: "(3g"

Phrase: ")"

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.355: Each reaction contained (in a final volume of 500l) 1.5mg of clarified cell lysate, 20g of GST-RalBD, and 20l of a 1:1 (v/v) suspension of glutathione-agarose. 

Phrase: "Each reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "("

Phrase: "in a final volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "of 500l"

Phrase: ")"

Phrase: "1.5mg of clarified cell lysate,"

Phrase: "20g of GST-RalBD,"

Phrase: "and"

Phrase: "20l of a 1"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(v/v) suspension of glutathione-agarose."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0038960:Suspension [Biomedical or Dental Material]
   753   C1382107:Suspension [Substance]
   753   C1705537:Suspension [Functional Concept]
Processing 00000000.tx.356: After incubation for 2h at 4C, the samples were pelleted and washed as described under "Experimental Procedures," and collected GTP-Ral was identified by immunoblot analysis with a monoclonal anti-RalA antibody (top panel). 

Phrase: "After incubation"

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "pelleted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0441436:Pellet [Manufactured Object]
   966   C0993610:Pellet [Biomedical or Dental Material]
   966   C1998480:Pellet [Quantitative Concept]

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "as"

Phrase: "described under ""Experimental Procedures,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]

Phrase: """"

Phrase: "and"

Phrase: "collected GTP-Ral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0812284:RAL [Gene or Genome]
   827   C1704992:RAL [Gene or Genome]

Phrase: "was"

Phrase: "identified by immunoblot analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0205396:Identified [Qualitative Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "with a monoclonal anti-RalA antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.357: Aliquots of each cell lysate (10g) were subjected to SDS-PAGE on a 10% polyacrylamide gel, transferred to nitrocellulose, and subjected to immunoblot analysis with anti-RalA and anti-HA monoclonal antibodies to determine the amount of endogenous RalA and expressed Ras and RGL3 protein (bottom panels). 

Phrase: "Aliquots of each cell lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1510844:Aliquot [Quantitative Concept]

Phrase: "(10g"

Phrase: ")"

Phrase: "were"

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "on a 10% polyacrylamide gel,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   812   C1382104:Gel [Substance]

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   777 E C0009357:Collodion Cotton [Biomedical or Dental Material,Pharmacologic Substance]

Phrase: "and"

Phrase: "subjected to immunoblot analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "with anti-RalA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0765159:RALA [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812284:RALA [Gene or Genome]

Phrase: "and"

Phrase: "anti-HA monoclonal antibodies to"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   875   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0746619:monoclonal [Finding]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "determine"

Phrase: "the amount of endogenous RalA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "expressed Ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034678:RAS [Gene or Genome]

Phrase: "and"

Phrase: "RGL3 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(bottom panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.358: The graph shows data from three independent experiments (results are mean valuesS.D.) and the immunoblots are representative of a typical experiment.  

Phrase: "The graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681493:Graph [Intellectual Product]
  1000   C2698021:Graph [Conceptual Entity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "data from three independent experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "mean valuesS."

Phrase: "D.)"

Phrase: "and"

Phrase: "the immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "are"

Phrase: "representative of a typical experiment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.359: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES In the present study, yeast two-hybrid screening was used to identify RGL3, a novel Rit-interacting protein and the newest member of the rapidly expanding RalGEF family (Fig. 1). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES In the present study,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C2985663:Study Reference [Intellectual Product]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1514811:Reference [Idea or Concept]
   760   C1706462:Reference [Conceptual Entity]
   760   C2603343:Study [Research Activity]

Phrase: "yeast two-hybrid screening"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   861   C0599647:Two Hybrid [Molecular Biology Research Technique]
   812   C0020205:Hybrid [Organism]
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0205448:Two [Quantitative Concept]
   812   C0220908:Screening [Health Care Activity]
   812   C0220909:screening [Functional Concept]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   812   C1698960:screening [Intellectual Product]
   812   C1710031:Screening [Diagnostic Procedure]
   812   C1710477:SCREENING [Research Activity]
   779 E C1305399:screen [Functional Concept]
   779 E C1705053:Screen [Medical Device]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "RGL3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "a novel Rit-interacting protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "the newest member of the rapidly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0680022:member [Population Group]
   753   C2698041:Member [Professional or Occupational Group]

Phrase: "expanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:Expanding [Spatial Concept]

Phrase: "RalGEF family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.360: Rit must therefore be added to the growing list of Ras-like GTPases to be shown to interact with members of the RalGEF gene family. 

Phrase: "Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "added to the growing list of Ras-"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0034678:RAS [Gene or Genome]
   748   C0745732:List [Conceptual Entity]
   748   C1524062:Added [Functional Concept]
   748   C3272378:LIST [Intellectual Product]
   714 E C1883712:Add [Functional Concept]

Phrase: "like GTPases to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "be"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with members of the RalGEF gene family."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C1517488:Gene Family [Gene or Genome]
   767   C0086282:Family Members [Family Group]
   750 E C1611821:Family Member [Intellectual Product]
   744   C0015576:Family [Family Group]
   744   C0017337:Gene [Gene or Genome]
   744   C0378212:RALGEF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0680022:members [Population Group]
   744   C1335588:RalGEF [Gene or Genome]
   744   C1704727:Family [Conceptual Entity]
   744   C1706345:RalGEF [Gene or Genome]
   711 E C2698041:Member [Professional or Occupational Group]
Processing 00000000.tx.361: As seen with other RalGEFs, the C-terminal Rit/Ras binding domain of RGL3 (RGL3-RBD) was both necessary and sufficient to direct interactions with Rit, Ras, and Rap but not with several other Ras-related GTPases (Table I and Fig. 3A). 

Phrase: "As"

Phrase: "seen with other RalGEFs,"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   836   C0378212:ral Guanine Nucleotide Exchange Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0120465:Guanine Nucleotide Exchange Factors [Amino Acid, Peptide, or Protein,Enzyme]
           exchange factor
   770   C0018328:guanine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0205397:Seen [Qualitative Concept]
   744   C0678640:exchange [Social Behavior]
   744   C0812284:RAL [Gene or Genome]
   744   C1704992:RAL [Gene or Genome]
   711 E C0042789:see [Organism Function]
   711   C1521761:Factor [Functional Concept]
   711 E C1947903:See [Activity]
   711   C2827422:Factor [Conceptual Entity]

Phrase: "the C-terminal Rit/Ras binding domain of RGL3 (RGL3-RBD)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   784   C1149341:C-terminal binding [Molecular Function]
   742   C0034678:RAS [Gene or Genome]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]

Phrase: "was"

Phrase: "both necessary"

Phrase: "and"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "interactions with Rit,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1704675:Interaction [Functional Concept]

Phrase: "Ras,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "and"

Phrase: "Rap"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416920:RAP [Gene or Genome]

Phrase: "but"

Phrase: "not with several"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1518422:Not [Functional Concept]

Phrase: "other Ras-related GTPases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751983:ras-Related GTPases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Fig. 3A"

Phrase: ")."
Processing 00000000.tx.362: Qualitative yeast two-hybrid and in vitro binding assays demonstrate that the interaction of RGL3 with Rit requires an intact effector domain and that RGL3 shows preferential binding to the active, GTP-bound forms of Rit, Ras, and the majority of the Ras subgroup of the Ras GTPase superfamily (Figs. 3-5). 

Phrase: "Qualitative yeast"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "two-hybrid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599647:Two Hybrid [Molecular Biology Research Technique]
   861   C0020205:Hybrid [Organism]
   861   C0205448:Two [Quantitative Concept]

Phrase: "and"

Phrase: "in vitro binding assays"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   906   C1515653:In Vitro Assay [Research Activity]
   861   C0021135:In Vitro [Intellectual Product]
   861   C1533691:in vitro [Qualitative Concept]
           vitro
   861   C2827718:In Vitro [Functional Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the interaction of RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "with Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "requires"

Phrase: "an intact effector domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0682970:effector domain [Gene or Genome]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "that RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "preferential binding to the active, GTP-bound forms of Rit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1149035:GTP Binding [Molecular Function]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]

Phrase: "Ras,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "and"

Phrase: "the majority of the Ras subgroup of the Ras GTPase superfamily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0680220:majority [Social Behavior]

Phrase: "(Figs. 3-5"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0349966:Figs [Food]
   793 E C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.363: These results are consistent with the observed properties of other RalGEF proteins, which share a common structural arrangement consisting of a C-terminal Ras-binding domain and N-terminal CDC25-like homology domain (29-31, 33, 34). 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with the observed properties of other RalGEF proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "which"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "a common structural arrangement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449830:Arrangement [Spatial Concept]

Phrase: "consisting of a C-terminal Ras-binding domain"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   793   C1149341:C-terminal binding [Molecular Function]
   770   C1707271:C-Terminal [Amino Acid Sequence]
   744   C0034678:RAS [Gene or Genome]
   744   C0205088:Terminal [Temporal Concept]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]
   711   C0332529:CONSIST [Qualitative Concept]

Phrase: "and"

Phrase: "N-terminal CDC25-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3538850:CDC25 [Gene or Genome]

Phrase: "like homology domain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1334043:Homology [Gene or Genome]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C2697616:Homology [Qualitative Concept]
   861   C3541951:Domain [Intellectual Product]

Phrase: "(29-31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "33,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.364: By using co-immunoprecipitation assays, we detected the in vivo interaction of RGL3 with activated Rit and Ras in HEK293 cells. 

Phrase: "By"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "co-immunoprecipitation assays,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]
   734   C1449705:Co-Immunoprecipitation [Laboratory Procedure]

Phrase: "we"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "the in vivo interaction of RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]

Phrase: "with activated Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   861   C1419390:RIT [Gene or Genome]

Phrase: "and"

Phrase: "Ras in HEK293 cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0034678:RAS [Gene or Genome]
Processing 00000000.tx.365: This result suggests that RGL3 may act as a binding partner for these proteins. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "may"

Phrase: "act as a binding partner"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0243122:binding [Functional Concept]
   760   C0682323:Partner [Family Group]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "for these proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.366: However, although RalGEF family members have been found to interact with many Ras-related proteins, only the in vivo activation of their RalGEF activity by Ras has been reported (47-49). 

Phrase: "However,"

Phrase: "although"

Phrase: "RalGEF family members"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0086282:Family Members [Family Group]
   867 E C1611821:Family Member [Intellectual Product]
   827   C0015576:Family [Family Group]
   827   C0680022:members [Population Group]
   827   C1704727:Family [Conceptual Entity]
   793 E C2698041:Member [Professional or Occupational Group]
   755 E C0241888:Familial [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with many Ras-related proteins,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   822   C1335596:ras-related protein [Gene or Genome]
   822   C1335599:Ras-Related Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   822   C1704396:RAS-Related Protein [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0242853:ras Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0034678:RAS [Gene or Genome]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the in vivo activation of their RalGEF activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1879547:Activation [Activity]

Phrase: "by Ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(47-49"

Phrase: ")."
Processing 00000000.tx.367: Here we show that expression of activated Rit causes an increase in Ral-GTP levels in vivo (Figs. 8 and 9). 

Phrase: "Here"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that expression of activated Rit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "an increase in Ral-GTP levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(Figs. 8"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.368: Rit-mediated Ral activation is likely to depend upon RalGEFs, because expression of Rit79L58C, an effector domain mutant that does not associate with RalGEFs (17), fails to stimulate GDP/GTP exchange of Ral in vivo (Fig. 9). 

Phrase: "Rit-mediated Ral activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "depend upon RalGEFs,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   864   C0378212:ral Guanine Nucleotide Exchange Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C0120465:Guanine Nucleotide Exchange Factors [Amino Acid, Peptide, or Protein,Enzyme]
           exchange factor
   778   C0018328:guanine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0678640:exchange [Social Behavior]
   748   C0725813:depend [Medical Device]
   748   C0812284:RAL [Gene or Genome]
   748   C1704992:RAL [Gene or Genome]
   714   C1521761:Factor [Functional Concept]
   714   C2827422:Factor [Conceptual Entity]

Phrase: "because"

Phrase: "expression of Rit79L58C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "an effector domain mutant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]
   734   C0682970:effector domain [Gene or Genome]

Phrase: "that"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associate with RalGEFs"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   864   C0378212:ral Guanine Nucleotide Exchange Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C0120465:Guanine Nucleotide Exchange Factors [Amino Acid, Peptide, or Protein,Enzyme]
           exchange factor
   778   C0018328:guanine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0678640:exchange [Social Behavior]
   748   C0750490:Associate [Idea or Concept]
   748   C0812284:RAL [Gene or Genome]
   748   C1704992:RAL [Gene or Genome]
   748   C1706221:Associate [Professional or Occupational Group]
   714   C1521761:Factor [Functional Concept]
   714   C2827422:Factor [Conceptual Entity]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stimulate"

Phrase: "GDP/GTP exchange of Ral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0678640:exchange [Social Behavior]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(Fig. 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.369: These results indicate that Rit is capable of stimulating the exchange factor activity of endogenous RalGEFs and support the potential for a cellular Rit-RalGEF-Ral signaling pathway. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "is"

Phrase: "capable of stimulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C2698977:Capability [Qualitative Concept]

Phrase: "the exchange factor activity of endogenous RalGEFs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0205177:Activity [Functional Concept]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the potential for a cellular Rit-RalGEF-Ral signaling pathway."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.370: Thus, Rit appears to be the second member of the Ras superfamily capable of activating RalGEF proteins. 

Phrase: "Thus,"

Phrase: "Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the second member of the Ras superfamily"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0680022:member [Population Group]
   748   C2698041:Member [Professional or Occupational Group]

Phrase: "capable of activating RalGEF proteins."
Processing 00000000.tx.371: Like Ras, constitutively activated mutants of Rit cause tumorigenic transformation of NIH3T3 cells. 

Phrase: "Like Ras,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "constitutively activated mutants of Rit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "tumorigenic transformation of NIH3T3 cells."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0007621:Tumorigenic Transformation [Neoplastic Process]
   781   C0040682:cell transformation [Cell Function]
           Transformation
   781   C1510411:Cell Transformation [Pathologic Function]
           Transformation
   760   C1705163:Transformation [Research Activity]
Processing 00000000.tx.372: However, Rit does not cause the activation of Raf kinases seen with Ras-mediated transformation2 and appears to utilize Raf-independent signaling pathways to cause transformation (17). 

Phrase: "However,"

Phrase: "Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "the activation of Raf kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "seen with Ras-mediated transformation2"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0034678:RAS [Gene or Genome]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0205397:Seen [Qualitative Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "and"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "utilize"

Phrase: "Raf-independent signaling pathways to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   823   C0037080:Signal Pathways [Molecular Function]
   823   C0037083:signaling pathway [Cell Function]
   823   C0086982:Signaling Pathway [Molecular Function]
   804   C1704259:Pathways [Molecular Function]
   804   C1705987:Pathways [Conceptual Entity]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "transformation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040682:Transformation [Cell Function]
  1000   C1510411:Transformation [Pathologic Function]
  1000   C1705163:Transformation [Research Activity]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.373: Future investigation will need to examine whether RalGEF proteins and Ral GTPases may represent downstream targets of Rit mediated signal transduction. 

Phrase: "Future investigation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C1261322:Investigation [Health Care Activity]
   861   C1552578:investigation [Idea or Concept]
   789 E C1517586:Investigational [Qualitative Concept]
   789 E C3245491:investigational [Intellectual Product]

Phrase: "will"

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "RalGEF proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Ral GTPases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "downstream targets of Rit mediated signal transduction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1521840:Target [Functional Concept]
   714   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.374: We have also demonstrated that the isolated CDC25 domain of RGL3 functions as a RalGEF in vitro. 

Phrase: "We"

Phrase: "have"

Phrase: "also"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the isolated CDC25 domain of RGL3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "functions as a RalGEF"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0031843:function [Physiologic Function]
   770   C0378212:RALGEF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1335588:RalGEF [Gene or Genome]
   770   C1705273:Function [Intellectual Product]
   770   C1706345:RalGEF [Gene or Genome]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.375: Interestingly, the in vitro stimulation of net nucleotide exchange on Ral by the CDC25 domain of RLF was more dramatic (Fig. 6C). 

Phrase: "Interestingly,"

Phrase: "the in vitro stimulation of net nucleotide exchange"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   744   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "on Ral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812284:RAL [Gene or Genome]
  1000   C1704992:RAL [Gene or Genome]

Phrase: "by the CDC25 domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "of RLF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035344:RLF [Disease or Syndrome]
  1000   C1416453:RLF [Gene or Genome]
  1000   C1419392:RLF [Gene or Genome]

Phrase: "was"

Phrase: "more dramatic"

Phrase: "(Fig. 6C"

Phrase: ")."
Processing 00000000.tx.376: This may suggest that the isolated RGL3 CDC25 domain is inherently less stable than the same domain from RLF or that a more elaborate reconstitution mixture, for example including membrane-bound Ral and full-length RGL3, may be required to demonstrate more efficient activation of Ral by this protein. 

Phrase: "This"

Phrase: "may"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the isolated RGL3 CDC25 domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "inherently less stable than the same domain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205360:Stable [Qualitative Concept]
   748   C1547311:Stable [Intellectual Product]

Phrase: "from RLF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035344:RLF [Disease or Syndrome]
  1000   C1416453:RLF [Gene or Genome]
  1000   C1419392:RLF [Gene or Genome]

Phrase: "or"

Phrase: "that"

Phrase: "a more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "elaborate"

Phrase: "reconstitution mixture,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]

Phrase: "for example"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "membrane-bound Ral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0812284:RAL [Gene or Genome]
   827   C1704992:RAL [Gene or Genome]

Phrase: "and"

Phrase: "full-length RGL3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1428955:RGL3 [Gene or Genome]

Phrase: "may"

Phrase: "be"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "more efficient activation of Ral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "by this protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.377: Indeed, it is known that the post-translational modifications of Ras-like GTPases are important for the actions of their GDP/GTP exchange proteins (50-52), including the ability of RalGDS and RGL to activate Ral (48). 

Phrase: "Indeed,"

Phrase: "it"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that"

Phrase: "the post-translational modifications of Ras-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0033666:Post-Translational Modifications [Molecular Function]
   753   C0687676:Post [Temporal Concept]
   753   C1519614:Translational [Genetic Function]
   753   C1704687:Post [Manufactured Object]
   719   C0392747:Modification [Functional Concept]
   719   C1554963:modification [Qualitative Concept]

Phrase: "like GTPases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "important for the actions of their GDP/GTP exchange proteins"

Phrase: "(50-52"

Phrase: ")"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the ability of RalGDS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "and"

Phrase: "RGL to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428954:RGL [Gene or Genome]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "Ral (48"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0812284:RAL [Gene or Genome]
   861   C1704992:RAL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.378: In addition, regions outside the CDC25-like domain of RGL are crucial for its RalGEF activity (48). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "outside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205101:Outside [Spatial Concept]

Phrase: "the CDC25-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538850:CDC25 [Gene or Genome]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "of RGL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428954:RGL [Gene or Genome]

Phrase: "are"

Phrase: "crucial for its RalGEF activity"

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.379: Finally, a property common to CDC25-related GEF domains is their relatively high affinity for the nucleotide-free form of their target GTPase. 

Phrase: "Finally,"

Phrase: "a property"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0871161:Property [Qualitative Concept]
  1000   C1882134:Property [Conceptual Entity]
  1000   C2347695:Property [Entity]

Phrase: "common to CDC25-related GEF domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205214:Common [Quantitative Concept]
   753   C1522138:Common [Functional Concept]
   753   C3245511:common [Intellectual Product]

Phrase: "is"

Phrase: "their relatively high affinity for the nucleotide-free form"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0205250:High [Qualitative Concept]
   742   C1299351:High [Qualitative Concept]
   742   C1510827:Affinity [Natural Phenomenon or Process]
   742   C2700149:HIGH [Intellectual Product]

Phrase: "of their target GTPase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018296:GTPase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.380: We found that RGL3RBD was able to bind nucleotide-free Ral but not to a series of related Ras family GTPases (Fig. 6A). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that RGL3RBD"

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "nucleotide-free Ral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0812284:RAL [Gene or Genome]
   827   C1704992:RAL [Gene or Genome]

Phrase: "but"

Phrase: "not to a series of related Ras family GTPases (Fig. 6A)."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   781   C0751983:ras-Related GTPases [Amino Acid, Peptide, or Protein,Enzyme]
   762   C1546988:Not related [Idea or Concept]
   742   C0015576:Family [Family Group]
   742   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0034678:RAS [Gene or Genome]
   742   C0205549:Series [Quantitative Concept]
   742   C0439849:Related [Qualitative Concept]
   742   C0445223:Related [Finding]
   742   C1518422:Not [Functional Concept]
   742   C1704727:Family [Conceptual Entity]
   742   C2348044:Series [Intellectual Product]
   726   C0015608:Family Relations [Social Behavior]
   726   C0015609:family relations [Social Behavior]
Processing 00000000.tx.381: The interaction of RGL3 with apoRal (Fig. 6B), that recombinant RGL3 exhibits guanine nucleotide exchange activity for RalA and RalB in vitro (Fig. 6C) and that overexpression of RGL3 in HEK293 cells increases cellular Ral-GTP levels (Fig. 7), demonstrates that RGL3 functions as a GEF for Ral. 

Phrase: "The interaction of RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "with apoRal"

Phrase: "(Fig. 6B"

Phrase: ")"

Phrase: ","

Phrase: "that recombinant RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428955:RGL3 [Gene or Genome]

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "guanine nucleotide exchange activity for RalA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "RalB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0767970:RALB [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812283:RALB [Gene or Genome]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(Fig. 6C"

Phrase: ")"

Phrase: "and"

Phrase: "that overexpression of RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "in HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "cellular Ral-GTP levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "demonstrates"

Phrase: "that RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "functions as a GEF"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0031843:function [Physiologic Function]
   770   C0120465:GEF [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1149049:GEF [Molecular Function]
   770   C1423839:GEF [Gene or Genome]
   770   C1705273:Function [Intellectual Product]
   770   C3539611:GEF [Gene or Genome]

Phrase: "for Ral."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812284:RAL [Gene or Genome]
  1000   C1704992:RAL [Gene or Genome]
Processing 00000000.tx.382: Regulation of RGL3 exchange activity in vivo appears to rely, in part, on its interaction with Ras-like GTPases (13, 47-49). 

Phrase: "Regulation of RGL3 exchange activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "rely"

Phrase: ","

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "on its interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "with Ras-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "like GTPases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(13,"

Phrase: "47-49"

Phrase: ")."
Processing 00000000.tx.383: We have shown that the RBD of RGL3 is necessary and sufficient for the association of RGL3 with activated Rit and Ras but that it is not directly required for the stimulation of GDP/GTP exchange of Ral in vitro. 

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the RBD of RGL3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "necessary"

Phrase: "and"

Phrase: "sufficient for the association of RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205410:Sufficient [Qualitative Concept]

Phrase: "with activated Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   861   C1419390:RIT [Gene or Genome]

Phrase: "and"

Phrase: "Ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "but"

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "not directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Not [Functional Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "required for the stimulation of GDP/GTP exchange of Ral"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   739   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0678640:exchange [Social Behavior]
   739   C0812284:RAL [Gene or Genome]
   739   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   739   C1514873:Required [Functional Concept]
   739   C1704992:RAL [Gene or Genome]
   739   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.384: However, in vivo studies indicate that the RBD domain plays a central role in the activation of Ral GDP/GTP exchange activity. 

Phrase: "However,"

Phrase: "in vivo studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0681829:in vivo study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "indicate"

Phrase: "that"

Phrase: "the RBD domain"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a central role in the activation of Ral GDP/GTP exchange activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0035820:Role [Social Behavior]
   736   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.385: Whereas the overexpression of full-length RGL3 significantly increased the cellular levels of Ral-GTP in HEK293 cells, expression of RGL3RBD only weakly activated Ral (Fig. 7). 

Phrase: "Whereas"

Phrase: "the overexpression of full-length RGL3 significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514559:Overexpression [Genetic Function]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the cellular levels of Ral-GTP"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in HEK293 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expression of RGL3RBD only weakly activated Ral (Fig. 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ")."
Processing 00000000.tx.386: These results indicate that the CDC25 domain of RGL3 is not sufficient to stimulate potently Ral GDP/GTP exchange in vivo, although the isolated CDC25 domain supports the in vitro exchange reaction. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the CDC25 domain of RGL3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "not sufficient to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205410:Sufficient [Qualitative Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "stimulate"

Phrase: "potently Ral GDP/GTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "exchange"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678640:exchange [Social Behavior]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "although"

Phrase: "the isolated CDC25 domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the in vitro exchange reaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.387: We have also demonstrated that RitQ79L but not Rit79L58C stimulates RGL3-mediated GDP/GTP exchange of Ral in HEK293 cells. 

Phrase: "We"

Phrase: "have"

Phrase: "also"

Phrase: "demonstrated"

Phrase: "that RitQ79L"

Phrase: "but"

Phrase: "not Rit79L58C"

Phrase: "stimulates"

Phrase: "RGL3-mediated GDP/GTP exchange of Ral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0678640:exchange [Social Behavior]

Phrase: "in HEK293 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.388: In addition, the GEF activity of RGL3RBD is not rescued by co-expression of constitutively active Rit or Ras proteins (Figs. 9 and 10). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the GEF activity of RGL3RBD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "rescued by co-expression of constitutively active Rit"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0205177:Active [Functional Concept]
   744   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   744   C1419390:RIT [Gene or Genome]

Phrase: "or"

Phrase: "Ras proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242853:ras Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Figs. 9"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.389: These results suggest that Rit- and Ras-induced RGL3 activation is dependent upon a direct binding interaction and that Rit and Ras may mediate the redistribution of RGL3 to membrane-localized Ral (53). 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Rit-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "and"

Phrase: "Ras-induced RGL3 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "dependent upon a direct binding interaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "that Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
  1000   C1419390:RIT [Gene or Genome]

Phrase: "and"

Phrase: "Ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "may"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the redistribution of RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332620:Redistribution [Functional Concept]

Phrase: "to membrane-localized Ral (53"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0025255:Membrane [Tissue]
   812   C0392752:Localized [Spatial Concept]
   812   C0596901:Membrane [Cell Component]
   812   C0812284:RAL [Gene or Genome]
   812   C1704992:RAL [Gene or Genome]
   812   C1706182:Membrane [Manufactured Object]
   741 E C0205287:Membranous [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.390: This characteristic is found in other members of the RalGEF family (47, 54). 

Phrase: "This characteristic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521970:Characteristic [Qualitative Concept]

Phrase: "is"

Phrase: "found in other members of the RalGEF family"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   767   C0086282:Family Members [Family Group]
   750 E C1611821:Family Member [Intellectual Product]
   744   C0015576:Family [Family Group]
   744   C0150312:Found [Quantitative Concept]
   744   C0378212:RALGEF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0680022:members [Population Group]
   744   C1335588:RalGEF [Gene or Genome]
   744   C1704727:Family [Conceptual Entity]
   744   C1706345:RalGEF [Gene or Genome]
   711 E C0243095:Find [Finding]
   711 E C2698041:Member [Professional or Occupational Group]

Phrase: "(47,"

Phrase: "54"

Phrase: ")."
Processing 00000000.tx.391: Indeed previous studies have shown that RalGDS and RLF translocate from the cytosol to specific membrane compartments upon recruitment by active GTPases (55). 

Phrase: "Indeed previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that RalGDS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0378212:ral-GDS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335588:RALGDS [Gene or Genome]

Phrase: "and"

Phrase: "RLF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035344:RLF [Disease or Syndrome]
  1000   C1416453:RLF [Gene or Genome]
  1000   C1419392:RLF [Gene or Genome]

Phrase: "translocate from the cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1383501:Cytosol [Cell Component]

Phrase: "to specific membrane compartments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1185625:Compartments [Body Space or Junction]
   827   C1382196:Compartments [Natural Phenomenon or Process]
   793 E C2986730:Compartment [Spatial Concept]

Phrase: "upon recruitment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2949735:Recruitment [Activity]

Phrase: "by active GTPases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.392: Therefore, it is possible that differences in the ability of Ras (7-fold) and Rit (2.3-fold) to induce RGL3 activation may result from differences in their binding affinities for RGL3 or from the subcellular location to which active Ras and Rit recruit RGL3. 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that differences in the ability of Ras (7-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C1705241:*Difference [Quantitative Concept]
   708   C1705242:Difference [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "Rit (2.3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332462:Fold [Spatial Concept]
   812   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "RGL3 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "may"

Phrase: "result from differences"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "in their binding affinities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "for RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "or from the subcellular location"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0450429:Location [Spatial Concept]
   760   C1515974:Location [Body Location or Region]

Phrase: "to which active Ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034678:RAS [Gene or Genome]

Phrase: "and"

Phrase: "Rit recruit RGL3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1428955:RGL3 [Gene or Genome]
Processing 00000000.tx.393: However, we cannot exclude the possibility that the interaction of GTP-bound Rit or Ras with RGL3 serves to stimulate its intrinsic GEF activity or that interaction with a membrane bound factor(s) serves to activate RGL3. 

Phrase: "However,"

Phrase: "we"

Phrase: "cannot"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the interaction of GTP-bound Rit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]

Phrase: "or"

Phrase: "Ras with RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0034678:RAS [Gene or Genome]

Phrase: "serves"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stimulate"

Phrase: "its intrinsic GEF activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "or"

Phrase: "that interaction with a membrane bound factor(s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1704675:Interaction [Functional Concept]

Phrase: ")"

Phrase: "serves"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "RGL3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]
Processing 00000000.tx.394: Additional studies, including characterization of the subcellular localization of Rit, RGL3, and the putative Rit-RGL3 complex are currently under investigation. 

Phrase: "Additional studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "characterization of the subcellular localization of Rit,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880022:Characterization [Activity]

Phrase: "RGL3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "and"

Phrase: "the putative Rit-RGL3 complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "are"

Phrase: "currently under investigation."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0521116:Currently [Temporal Concept]
   790   C1261322:Investigation [Health Care Activity]
   790   C1552578:investigation [Idea or Concept]
   718 E C1517586:Investigational [Qualitative Concept]
   718 E C3245491:investigational [Intellectual Product]
Processing 00000000.tx.395: Although we have demonstrated that Ral is activated by RGL3, the physiological role of Ral proteins remains poorly defined (13). 

Phrase: "Although"

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that Ral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812284:RAL [Gene or Genome]
  1000   C1704992:RAL [Gene or Genome]

Phrase: "is"

Phrase: "activated by RGL3,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1428955:RGL3 [Gene or Genome]
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "the physiological role of Ral proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "remains"

Phrase: "poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.396: Ral is constitutively bound to phospholipase D and is required for Src- and Ras-dependent activation of PLD (56). 

Phrase: "Ral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812284:RAL [Gene or Genome]
  1000   C1704992:RAL [Gene or Genome]

Phrase: "is"

Phrase: "constitutively"

Phrase: "bound to phospholipase D"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0332297:bound [Spatial Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1689898:% bound [Quantitative Concept]
   770   C2349209:Bound [Conceptual Entity]

Phrase: "and"

Phrase: "is"

Phrase: "required for Src-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514873:Required [Functional Concept]

Phrase: "and"

Phrase: "Ras-dependent activation of PLD (56"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: ")."
Processing 00000000.tx.397: Furthermore, it has been reported that Ral is involved in Ras-dependent transformation in NIH3T3 cells and that Ral GTPases regulate developmental cell shape changes through the c-Jun N-terminal kinase pathway in Drosophila (49, 57-59). 

Phrase: "Furthermore,"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that Ral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812284:RAL [Gene or Genome]
  1000   C1704992:RAL [Gene or Genome]

Phrase: "is"

Phrase: "involved in Ras-dependent transformation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0034678:RAS [Gene or Genome]
   760   C0040682:Transformation [Cell Function]
   760   C0851827:Dependent [Qualitative Concept]
   760   C1314939:Involved [Functional Concept]
   760   C1510411:Transformation [Pathologic Function]
   760   C1701901:Dependent [Qualitative Concept]
   760   C1705163:Transformation [Research Activity]
   760   C3244310:dependent [Functional Concept]

Phrase: "in NIH3T3 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "that Ral GTPases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "regulate"

Phrase: "developmental cell shape changes through the c-Jun N-terminal kinase pathway"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   736   C0392747:changes [Functional Concept]
   736   C0443172:changes [Quantitative Concept]
   703 E C1705241:Change [Quantitative Concept]

Phrase: "in Drosophila"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013138:Drosophila [Eukaryote]
  1000   C1028876:Drosophila [Fungus]
  1000   C1504613:Drosophila [Eukaryote]

Phrase: "(49,"

Phrase: "57-59"

Phrase: ")."
Processing 00000000.tx.398: RalGDS and Raf synergistically stimulate cellular proliferation and gene expression (60). 

Phrase: "RalGDS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0378212:ral-GDS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335588:RALGDS [Gene or Genome]

Phrase: "and"

Phrase: "Raf synergistically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1425569:RAF [Gene or Genome]
   861   C1706586:RAF [Gene or Genome]

Phrase: "stimulate"

Phrase: "cellular proliferation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020507:Cellular proliferation [Pathologic Function]
  1000   C0596290:Cellular Proliferation [Cell Function]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(60"

Phrase: ")."
Processing 00000000.tx.399: Moreover, exposure of cells to epidermal growth factor, lysophosphatidic acid, or insulin increases the GTP-bound active form of Ral, acting through both Ras-dependent and Ras-independent signaling pathways (27). 

Phrase: "Moreover,"

Phrase: "exposure of cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0274281:Exposure, NOS [Injury or Poisoning]
   790   C0332157:Exposure [Clinical Attribute]

Phrase: "to epidermal growth factor,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1323367:epidermal growth factor [Molecular Function]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0014520:Epidermal [Tissue]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0221920:Epidermal [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   711 E C3496194:Epidermis [Cell]

Phrase: "lysophosphatidic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0066772:lysophosphatidic acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "or"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the GTP-bound active form of Ral,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "acting through both Ras-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0034678:RAS [Gene or Genome]
   737   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "Ras-independent signaling pathways"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   912   C1514731:Ras Signaling Pathway [Molecular Function]
   844   C0037080:Signal Pathways [Molecular Function]
   844   C0037083:signaling pathway [Cell Function]
   844   C0086982:Signaling Pathway [Molecular Function]
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.400: RalGEFs and Ral have also been implicated in Ras-induced DNA synthesis, gene expression, and oncogenic transformation (27, 43, 49, 57, 61). 

Phrase: "RalGEFs"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C0378212:ral Guanine Nucleotide Exchange Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C0120465:Guanine Nucleotide Exchange Factors [Amino Acid, Peptide, or Protein,Enzyme]
           exchange factor
   840   C0018328:guanine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0678640:exchange [Social Behavior]
   804   C0812284:RAL [Gene or Genome]
   804   C1704992:RAL [Gene or Genome]
   771   C1521761:Factor [Functional Concept]
   771   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "Ral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812284:RAL [Gene or Genome]
  1000   C1704992:RAL [Gene or Genome]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "implicated in Ras-induced DNA synthesis,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0598312:DNA Synthesis [Genetic Function]
   790   C1328870:DNA synthesis [Laboratory Procedure]
   790   C1817262:DNA synthesis [Genetic Function]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0034678:RAS [Gene or Genome]
   753   C0205263:Induced [Functional Concept]
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]
   748 E C0598279:synthetic DNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "gene expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "oncogenic transformation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040682:Transformation [Cell Function]
   861   C1510411:Transformation [Pathologic Function]
   861   C1705163:Transformation [Research Activity]

Phrase: "(27,"

Phrase: "43,"

Phrase: "49,"

Phrase: "57,"

Phrase: "61"

Phrase: ")."
Processing 00000000.tx.401: Thus, evidence for an important role of RalGEFs and Ral in cellular signal transduction pathways has accumulated. 

Phrase: "Thus,"

Phrase: "evidence for an important role of RalGEFs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "and"

Phrase: "Ral in cellular signal transduction pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0812284:RAL [Gene or Genome]
   753   C1704992:RAL [Gene or Genome]

Phrase: "has"

Phrase: "accumulated."
Processing 00000000.tx.402: It will be important to examine the potential role of these proteins in Rit-mediated cellular transformation and the possibility that activated Rit will interact with, and signal through, additional RalGEF family proteins. 

Phrase: "It"

Phrase: "will"

Phrase: "be"

Phrase: "important to"

Phrase: "examine"

Phrase: "the potential role of these proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in Rit-mediated cellular transformation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1510411:Cellular Transformation [Pathologic Function]
           Transformation
   812   C0040682:Transformation [Cell Function]
   812   C1705163:Transformation [Research Activity]

Phrase: "and"

Phrase: "the possibility"

Phrase: "that activated Rit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0292818:RIT [Organic Chemical,Pharmacologic Substance]
   861   C1419390:RIT [Gene or Genome]

Phrase: "will"

Phrase: "interact with,"

Phrase: "and"

Phrase: "signal through,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1710082:Signal [Phenomenon or Process]

Phrase: "additional RalGEF family proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.403: RGL3 is the latest in a series of RalGEF family proteins that appear to serve as effectors of Ras, with at least RalGDS, RLF, and RGL3 all being ubiquitously expressed. 

Phrase: "RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "is"

Phrase: "the latest in a series of RalGEF family proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0205087:Late [Temporal Concept]

Phrase: "that"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "serve as effectors of Ras,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0034678:RAS [Gene or Genome]

Phrase: "with"

Phrase: "at least RalGDS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0378212:ral-GDS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1335588:RALGDS [Gene or Genome]

Phrase: "RLF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035344:RLF [Disease or Syndrome]
  1000   C1416453:RLF [Gene or Genome]
  1000   C1419392:RLF [Gene or Genome]

Phrase: "and"

Phrase: "RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "all"

Phrase: "being"

Phrase: "ubiquitously"

Phrase: "expressed."
Processing 00000000.tx.404: At present, it is not clear whether these RalGEFs are functionally redundant or if they have distinct physiological roles. 

Phrase: "At present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "whether"

Phrase: "these RalGEFs"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C0378212:ral Guanine Nucleotide Exchange Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C0120465:Guanine Nucleotide Exchange Factors [Amino Acid, Peptide, or Protein,Enzyme]
           exchange factor
   840   C0018328:guanine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0678640:exchange [Social Behavior]
   804   C0812284:RAL [Gene or Genome]
   804   C1704992:RAL [Gene or Genome]
   771   C1521761:Factor [Functional Concept]
   771   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "functionally redundant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0425087:Redundant [Finding]
   861   C1313915:Redundant [Functional Concept]

Phrase: "or"

Phrase: "if"

Phrase: "they"

Phrase: "have"

Phrase: "distinct physiological roles."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0035820:Roles [Social Behavior]
   793 E C1705810:Role [Conceptual Entity]
Processing 00000000.tx.405: Since RGL3 is only ~35% identical to other RalGEF family proteins at the amino acid level, it is likely that it and other members of this gene family contain distinct structural features. 

Phrase: "Since"

Phrase: "RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "is"

Phrase: "only ~35% identical to other RalGEF family proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205280:Identical [Qualitative Concept]

Phrase: "at the amino acid level,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "and"

Phrase: "other members of this gene family"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   783   C0086282:Family Members [Family Group]
   767 E C1611821:Family Member [Intellectual Product]
   753   C0680022:members [Population Group]
   719 E C2698041:Member [Professional or Occupational Group]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "distinct structural features."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1521970:Feature [Qualitative Concept]
   793   C1706388:Feature [Conceptual Entity]
   793   C2346469:Feature [Qualitative Concept]
   793   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.406: These sequence differences make it likely that RGL3 will play a unique role in mediating cellular signaling. 

Phrase: "These sequence differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "it likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "will"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a unique role in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "cellular signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]
Processing 00000000.tx.407: For example, each of the RalGEF proteins contain distinct proline-rich sequences that may serve as docking sites for distinct SH3 domain-containing proteins. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "each of the RalGEF proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0378212:RALGEF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1335588:RalGEF [Gene or Genome]
   760   C1457900:Each [Quantitative Concept]
   760   C1706345:RalGEF [Gene or Genome]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "distinct proline-rich sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0162326:Sequences [Nucleotide Sequence]
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]

Phrase: "that"

Phrase: "may"

Phrase: "serve as docking sites"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0205145:Sites [Spatial Concept]
   770   C0442632:docking [Manufactured Object]
   770   C1522290:Docking [Molecular Function]
   737 E C0330386:Dock [Plant]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "for distinct SH3 domain-containing proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.408: In addition, the RalGEFs may have different abilities to become activated by individual Ras family proteins. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the RalGEFs"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C0378212:ral Guanine Nucleotide Exchange Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C0120465:Guanine Nucleotide Exchange Factors [Amino Acid, Peptide, or Protein,Enzyme]
           exchange factor
   840   C0018328:guanine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0678640:exchange [Social Behavior]
   804   C0812284:RAL [Gene or Genome]
   804   C1704992:RAL [Gene or Genome]
   771   C1521761:Factor [Functional Concept]
   771   C2827422:Factor [Conceptual Entity]

Phrase: "may"

Phrase: "have"

Phrase: "different abilities to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085732:Abilities [Organism Attribute]
   743 E C1299581:Able [Finding]

Phrase: "become"

Phrase: "activated by individual Ras family proteins."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   783   C0242853:ras Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   767   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0015576:Family [Family Group]
   753   C0027361:Individual [Population Group]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0034678:RAS [Gene or Genome]
   753   C0237401:Individual [Human]
   753   C1704727:Family [Conceptual Entity]
   753   C1879547:Activated [Activity]
   719 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.409: In support of this notion, in vitro association studies have revealed large differences in the affinities between RalGEFs and Ras-like proteins (30, 35). 

Phrase: "In support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "of this notion,"

Phrase: "in vitro association studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   906   C0681828:in vitro study [Research Activity]
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "revealed large differences in the affinities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "between RalGEFs"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C0378212:ral Guanine Nucleotide Exchange Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C0120465:Guanine Nucleotide Exchange Factors [Amino Acid, Peptide, or Protein,Enzyme]
           exchange factor
   840   C0018328:guanine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0678640:exchange [Social Behavior]
   804   C0812284:RAL [Gene or Genome]
   804   C1704992:RAL [Gene or Genome]
   771   C1521761:Factor [Functional Concept]
   771   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "Ras-like proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C0812284:RAS-LIKE PROTEIN [Gene or Genome]
   858   C0242853:ras Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0034678:RAS [Gene or Genome]

Phrase: "(30,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.410: Through these interactions, distinct RalGEFs might be localized to distinct cellular membranes, serving to modulate their interactions with both Ral proteins and potentially additional factors. 

Phrase: "Through these interactions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "distinct RalGEFs"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   914   C0378212:ral Guanine Nucleotide Exchange Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0120465:Guanine Nucleotide Exchange Factors [Amino Acid, Peptide, or Protein,Enzyme]
           exchange factor
   827   C0018328:guanine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0678640:exchange [Social Behavior]
   799   C0812284:RAL [Gene or Genome]
   799   C1704992:RAL [Gene or Genome]
   766   C1521761:Factor [Functional Concept]
   766   C2827422:Factor [Conceptual Entity]

Phrase: "might"

Phrase: "be"

Phrase: "localized to distinct cellular membranes,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0007603:Cellular membrane [Cell Component]
   790   C3161472:Cellular Membrane [Cell Component]
   760   C0007634:Cellular [Cell]
   760   C0025255:Membranes [Tissue]
   760   C0178539:Cellular [Functional Concept]
   760   C0392752:Localized [Spatial Concept]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "serving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519269:Serving [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "their interactions with both Ral proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0872079:interactions protein [Molecular Function]
   719   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "potentially additional factors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.411: In this way, RalGEFs may mediate distinct signal transduction cascades from individual Ras-related proteins. 

Phrase: "In this way,"

Phrase: "RalGEFs"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C0378212:ral Guanine Nucleotide Exchange Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C0120465:Guanine Nucleotide Exchange Factors [Amino Acid, Peptide, or Protein,Enzyme]
           exchange factor
   840   C0018328:guanine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0678640:exchange [Social Behavior]
   804   C0812284:RAL [Gene or Genome]
   804   C1704992:RAL [Gene or Genome]
   771   C1521761:Factor [Functional Concept]
   771   C2827422:Factor [Conceptual Entity]

Phrase: "may"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "distinct signal transduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0037083:Signal Transduction [Cell Function]
   827   C1160185:transduction [Organism Function]
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "cascades from individual Ras-related proteins."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   822   C1335596:ras-related protein [Gene or Genome]
   822   C1335599:Ras-Related Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   822   C1704396:RAS-Related Protein [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0242853:ras Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0027361:Individual [Population Group]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0034678:RAS [Gene or Genome]
   753   C0237401:Individual [Human]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   753   C1707310:Cascade [Manufactured Object]
Processing 00000000.tx.412: Finally, although RalGDS, RLF, RGL, and RGL3 have all been shown to catalyze GDP/GTP exchange on Ral proteins, these studies do not exclude the possibility that other Ral-like proteins may be the authentic cellular targets of these GEFs or that additional cellular activities may be associated with these proteins. 

Phrase: "Finally,"

Phrase: "although"

Phrase: "RalGDS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0378212:ral-GDS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335588:RALGDS [Gene or Genome]

Phrase: "RLF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035344:RLF [Disease or Syndrome]
  1000   C1416453:RLF [Gene or Genome]
  1000   C1419392:RLF [Gene or Genome]

Phrase: "RGL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428954:RGL [Gene or Genome]

Phrase: "and"

Phrase: "RGL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428955:RGL3 [Gene or Genome]

Phrase: "have"

Phrase: "all"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "catalyze"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007382:catalyse [Natural Phenomenon or Process]

Phrase: "GDP/GTP exchange on Ral proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   855   C0120465:GDP-GTP Exchange Protein [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0678640:exchange [Social Behavior]

Phrase: "these studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility"

Phrase: "that"

Phrase: "other Ral-like proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0220304:ral Protein [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0812284:RAL [Gene or Genome]
   770   C1704992:RAL [Gene or Genome]

Phrase: "may"

Phrase: "be"

Phrase: "the authentic cellular targets of these GEFs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1521840:Target [Functional Concept]
   714   C2986546:TARGET [Diagnostic Procedure]

Phrase: "or"

Phrase: "that additional cellular activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "may"

Phrase: "be"

Phrase: "associated with these proteins."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.413: Therefore, the physiological function and cellular regulation of RGL3 remain topics for future investigation.  

Phrase: "Therefore,"

Phrase: "the physiological function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "cellular regulation of RGL3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0596286:Cellular Regulation [Cell Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "remain"

Phrase: "topics for future investigation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1522168:TOPIC [Functional Concept]
   737   C1555712:topic [Idea or Concept]
Processing 00000000.tx.414: ACKNOWLEDGEMENTS We thank Drs. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Drs."
Processing 00000000.tx.415: Lawrence Quilliam, Adrienne Cox, Channing Der, Jean de Gunzburg, and Gilbert White for reagents. 

Phrase: "Lawrence Quilliam,"

Phrase: "Adrienne Cox,"

Phrase: "Channing Der,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "Jean de Gunzburg,"

Phrase: "and"

Phrase: "Gilbert White for reagents."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007457:White [Population Group]
   770   C0043157:White [Population Group]
   770   C0220938:White [Qualitative Concept]
Processing 00000000.tx.416: Dr. 

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.417: Ginell Post, Dr. 

Phrase: "Ginell Post,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0687676:Post [Temporal Concept]
   861   C1704687:Post [Manufactured Object]
   789 E C1514253:Postal [Functional Concept]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.418: Brian Finlin, and members of the laboratory are acknowledged for comments on the manuscript.  

Phrase: "Brian Finlin,"

Phrase: "and"

Phrase: "members of the laboratory"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0680022:members [Population Group]
   737 E C2698041:Member [Professional or Occupational Group]

Phrase: "are"

Phrase: "acknowledged for comments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0282411:Comments [Intellectual Product]
   790   C0947611:comments [Intellectual Product]
   790   C1705247:Comments [Conceptual Entity]

Phrase: "on the manuscript."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]
Processing 00000000.tx.419: FOOTNOTES * This work was supported in part by National Institutes of Health Grant EY11231 and a grant from the Charlotte Geyer Foundation.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by National Institutes of Health Grant EY11231"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027468:National Institutes of Health [Health Care Related Organization]

Phrase: "and"

Phrase: "a grant from the Charlotte Geyer Foundation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0018173:Grant [Quantitative Concept]
   748   C1548284:Grant [Idea or Concept]
Processing 00000000.tx.420: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.421: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.422: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.423: The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF237669. 

Phrase: "The nucleotide sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0004793:Nucleotide Sequence [Nucleotide Sequence]
           Sequence
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "("

Phrase: "s)"

Phrase: "reported in this paper"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0030351:Paper [Manufactured Object]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1547566:Paper [Idea or Concept]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "submitted to the GenBankTM/EMBL Data Bank"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0242356:Data Bank [Intellectual Product]
   748   C0442598:Bank [Manufactured Object]
   748   C0872261:Bank [Manufactured Object]
   748   C1511726:Data [Idea or Concept]
   748   C1515023:Submitted [Functional Concept]
   748   C3245479:data [Medical Device]

Phrase: "with accession number"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1510755:Accession Number [Intellectual Product]
           Accession
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]
   861   C1706078:Accession [Activity]

Phrase: "("

Phrase: "s)"

Phrase: "AF237669."
Processing 00000000.tx.424: To whom correspondence should be addressed: Dept. of Biochemistry, College of Medicine, University of Kentucky, 800Rose St., Lexington, KY 40536-0084.Tel.: 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0557806:College [Manufactured Object]

Phrase: "University of Kentucky,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022557:Kentucky [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "800Rose St., Lexington,"

Phrase: "KY 40536-0084.Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0796520:TEL [Gene or Genome]
   812   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.425: 606-257-6775; 

Phrase: "606-257-6775"

Phrase: ";"
Processing 00000000.tx.426: Fax: 606-323-1037; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "606-323-1037"

Phrase: ";"
Processing 00000000.tx.427: E-mail: dandres@pop.uky.edu. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "dandres@pop.uky.edu."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.428: Published, JBC Papers in Press, June 26,2000,DOI 10.1074/jbc.M002241200 2 E. 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "June 26,"

Phrase: "2000,"

Phrase: "DOI 10.1074/jbc.M002241200 2 E."
Processing 00000000.tx.429: V.Rusyn, E.R.

Phrase: "V.Rusyn,"

Phrase: "E.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.430: Reynolds, H.Shao, T.M.Grana, T.O.Chan, D.A.Andres, A.D.Cox (2000) Oncogene in press.  

Phrase: "Reynolds,"

Phrase: "H.Shao,"

Phrase: "T.M.Grana,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205715:Grana [Cell Component]

Phrase: "T.O.Chan,"

Phrase: "D.A.Andres,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "A.D.Cox (2000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: ")"

Phrase: "Oncogene in press."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0029016:Oncogene [Gene or Genome]
Processing 00000000.tx.431: ABBREVIATIONS The abbreviations used are: GEF, guanine nucleotide exchange factor; 

Phrase: "ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "GEF,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120465:GEF [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1149049:GEF [Molecular Function]
  1000   C1423839:GEF [Gene or Genome]
  1000   C3539611:GEF [Gene or Genome]

Phrase: "guanine nucleotide exchange factor"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0120465:Guanine Nucleotide Exchange Factor [Amino Acid, Peptide, or Protein,Enzyme]
           exchange factor
   861   C0018328:guanine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0678640:exchange [Social Behavior]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.432: GST, glutathione S-transferase; 

Phrase: "GST,"

Phrase: "glutathione S-transferase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.433: GAP, GTPase-activating protein; 

Phrase: "GAP,"

Phrase: "GTPase-activating protein"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0061928:GTPase-Activating Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1419277:GTPase-ACTIVATING PROTEIN [Gene or Genome]
  1000   C2984553:GTPase-Activating Protein [Amino Acid, Peptide, or Protein]
   827   C0018296:GTPase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1879547:activating [Activity]
   793 E C1515877:Activate [Functional Concept]

Phrase: ";"
Processing 00000000.tx.434: GTPS, guanosine 5'-3-O-(thio)triphosphate; 

Phrase: "GTPS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "guanosine 5'-3-O-(thio"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1412102:THIO [Gene or Genome]

Phrase: ")"

Phrase: "triphosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0146894:triphosphate [Inorganic Chemical]

Phrase: ";"
Processing 00000000.tx.435: PAGE, polyacrylamide gel electrophoresis; 

Phrase: "PAGE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "polyacrylamide gel electrophoresis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   901   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   901   C0596607:Gel Electrophoresis [Laboratory Procedure]
   827   C0013855:Electrophoresis [Laboratory Procedure]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   827   C1382104:Gel [Substance]

Phrase: ";"
Processing 00000000.tx.436: PCR, polymerase chain reaction; 

Phrase: "PCR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "polymerase chain reaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.437: DTT, dithiothreitol; 

Phrase: "DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "dithiothreitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.438: HA, influenza hemagglutinin epitope; 

Phrase: "HA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018909:Haemagglutinin, NOS [Immunologic Factor]

Phrase: "influenza hemagglutinin epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003316:Epitope [Immunologic Factor]

Phrase: ";"
Processing 00000000.tx.439: PI-3K, phosphatidylinositol 3-kinase; 

Phrase: "PI-3K,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phosphatidylinositol 3-kinase"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.440: RACE, rapid amplification of cDNA ends; 

Phrase: "RACE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034510:Race [Population Group]
  1000   C1706779:RACE [Gene or Genome]

Phrase: "rapid amplification of cDNA ends"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1517480:Amplification [Molecular Biology Research Technique]
   760   C1521871:Amplification [Phenomenon or Process]
   760   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: ";"
Processing 00000000.tx.441: RBD, Rit binding domain; 

Phrase: "RBD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "Rit binding domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.442: BSA, bovine serum albumin; 

Phrase: "BSA,"

Phrase: "bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   901   C0728877:serum albumin [Laboratory or Test Result]
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007452:Bovine [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: ";"
Processing 00000000.tx.443: bp, base pair; 

Phrase: "bp,"

Phrase: "base pair"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0600436:Base Pair [Molecular Function]
   861   C0002055:base [Inorganic Chemical]
   861   C0178499:Base [Chemical Viewed Functionally]
   861   C1709450:Pair [Qualitative Concept]
   861   C1880279:Base [Biomedical or Dental Material]
   789 E C0205112:Basal [Spatial Concept]
   777 E C0016617:Foundation [Organization]
   777 E C1626935:Bases [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.444: Ni-NTA, nickel-nitrilotriacetic acid; 

Phrase: "Ni-NTA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0028132:NTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C2348274:Ni [Element, Ion, or Isotope]

Phrase: "nickel-nitrilotriacetic acid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0256984:nickel nitrilotriacetic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   901   C0028132:Nitrilotriacetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0028013:nickel [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0202406:Acid [Laboratory Procedure]
   827   C2348274:Nickel [Element, Ion, or Isotope]

Phrase: ";"
Processing 00000000.tx.445: PBS, phosphate-buffered saline.  

Phrase: "PBS,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "phosphate-buffered saline."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.446: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.447: Campbell, S. 

Phrase: "Campbell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331936:Campbell [Health Care Related Organization]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.448: L., Khosravi-Far, R., Rossman, K. 

Phrase: "L., Khosravi-Far,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205108:far [Spatial Concept]
   827   C0439394:l's [Quantitative Concept]
   827   C1706495:L- [Intellectual Product]
   827   C3642217:/L [Quantitative Concept]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rossman,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.449: L., Clark, G. 

Phrase: "L., Clark,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.450: J., and Der, C. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Der,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "C."
Processing 00000000.tx.451: J. 

Phrase: "J."
Processing 00000000.tx.452: (1998) Oncogene 17, 1395-1413[CrossRef][Medline] [OrderarticleviaInfotrieve] 2. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Oncogene 17,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "1395-1413"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.453: Macara, I. 

Phrase: "Macara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3428317:Macara [Eukaryote]

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.454: G., Lounsbury, K. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lounsbury,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.455: M., Richards, S. 

Phrase: "M."

Phrase: ","

Phrase: "Richards,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.456: A., McKiernan, C., and Bar-Sagi, D. 

Phrase: "A.,"

Phrase: "McKiernan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Bar-Sagi,"

Phrase: "D."
Processing 00000000.tx.457: (1996) FASEB J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "FASEB J."
Processing 00000000.tx.458: 10, 625-630[Abstract/Free FullText] 3. 

Phrase: "10,"

Phrase: "625-630"

Phrase: "[Abstract/Free FullText"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.459: Hall, A. 

Phrase: "Hall,"

Phrase: "A."
Processing 00000000.tx.460: (1998) Science 279, 509-514[Abstract/Free FullText] 4. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Science 279,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "509-514"

Phrase: "[Abstract/Free FullText"

Phrase: "] 4."
Processing 00000000.tx.461: Bourne, H. 

Phrase: "Bourne,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.462: R., Sanders, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Sanders,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1504648:Sander [Fish]

Phrase: "D."
Processing 00000000.tx.463: A., and McCormick, F. 

Phrase: "A.,"

Phrase: "and"

Phrase: "McCormick,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.464: (1991) Nature 349, 117-127[CrossRef][Medline] [OrderarticleviaInfotrieve] 5. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Nature 349,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "117-127"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.465: Quilliam, L. 

Phrase: "Quilliam,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.466: A., Khosravi-Far, R., Huff, S. 

Phrase: "A.,"

Phrase: "Khosravi-Far,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205108:far [Spatial Concept]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Huff,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0566520:huff [Finding]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.467: Y., and Der, C. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Der,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "C."
Processing 00000000.tx.468: J. 

Phrase: "J."
Processing 00000000.tx.469: (1995) BioEssays 17, 395-404[Medline] [OrderarticleviaInfotrieve] 6. 

Phrase: "(1995"

Phrase: ")"

Phrase: "BioEssays 17,"

Phrase: "395-404"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 6."
Processing 00000000.tx.470: Boguski, M. 

Phrase: "Boguski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.471: S., and McCormick, F. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "McCormick,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.472: (1993) Nature 366, 643-654[CrossRef][Medline] [OrderarticleviaInfotrieve] 7. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Nature 366,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "643-654"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 7."
Processing 00000000.tx.473: Malumbres, M., and Pellicer, A. 

Phrase: "Malumbres,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Pellicer,"

Phrase: "A."
Processing 00000000.tx.474: (1998) Front. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Front."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205094:front [Spatial Concept]
   928 E C0205123:Frontal [Spatial Concept]
   907 E C0016540:Forehead [Body Location or Region]
Processing 00000000.tx.475: Biosci. 

Phrase: "Biosci."
Processing 00000000.tx.476: 3, 887-912 8. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "887-912 8."
Processing 00000000.tx.477: Marshall, C. 

Phrase: "Marshall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551881:Marshall [Population Group]

Phrase: "C."
Processing 00000000.tx.478: J. 

Phrase: "J."
Processing 00000000.tx.479: (1996) Curr. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.480: Opin. 

Phrase: "Opin."
Processing 00000000.tx.481: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.482: 8, 197-204[CrossRef][Medline] [OrderarticleviaInfotrieve] 9. 

Phrase: "8,"

Phrase: "197-204"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 9."
Processing 00000000.tx.483: Robinson, M. 

Phrase: "Robinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443050:Robinson [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.484: J., and Cobb, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Cobb,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1149772:CobB [Molecular Function]
  1000   C2248714:CobB [Molecular Function]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.485: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.486: (1997) Curr. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.487: Opin. 

Phrase: "Opin."
Processing 00000000.tx.488: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.489: 9, 180-186[CrossRef][Medline] [OrderarticleviaInfotrieve] 10. 

Phrase: "9,"

Phrase: "180-186"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 10."
Processing 00000000.tx.490: Marshall, M. 

Phrase: "Marshall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551881:Marshall [Population Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.491: (1995) Mol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.492: Reprod. 

Phrase: "Reprod."
Processing 00000000.tx.493: Dev. 

Phrase: "Dev."
Processing 00000000.tx.494: 42, 493-499[Medline] [OrderarticleviaInfotrieve] 11. 

Phrase: "42,"

Phrase: "493-499"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 11."
Processing 00000000.tx.495: Treisman, R. 

Phrase: "Treisman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.496: (1994) Curr. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.497: Opin. 

Phrase: "Opin."
Processing 00000000.tx.498: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.499: &Dev. 

Phrase: "&Dev."
Processing 00000000.tx.500: 4, 96-101[Medline] [OrderarticleviaInfotrieve] 12. 

Phrase: "4,"

Phrase: "96-101"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 12."
Processing 00000000.tx.501: Treisman, R. 

Phrase: "Treisman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.502: (1996) Curr. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.503: Opin. 

Phrase: "Opin."
Processing 00000000.tx.504: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.505: 8, 205-215[CrossRef][Medline] [OrderarticleviaInfotrieve] 13. 

Phrase: "8,"

Phrase: "205-215"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 13."
Processing 00000000.tx.506: Bos, J. 

Phrase: "Bos,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265514:BOS [Disease or Syndrome]
  1000   C1265540:Bos [Mammal]

Phrase: "J."
Processing 00000000.tx.507: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.508: (1998) EMBO J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.509: 17, 6776-6782[Abstract/Free FullText] 14. 

Phrase: "17,"

Phrase: "6776-6782"

Phrase: "[Abstract/Free FullText"

Phrase: "] 14."
Processing 00000000.tx.510: Rodriguez-Viciana, P., Warne, P. 

Phrase: "Rodriguez-Viciana,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Warne,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.511: H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Dhand,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1415467:DHAND [Gene or Genome]
  1000   C3537326:dHAND [Amino Acid, Peptide, or Protein]
  1000   C3539567:DHAND [Gene or Genome]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Vanhaesebroeck,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gout,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018099:Gout [Disease or Syndrome]
   907 E C0003864:Arthritides [Disease or Syndrome]

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Fry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1825319:FRY [Gene or Genome]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.512: J., Waterfield, M. 

Phrase: "J.,"

Phrase: "Waterfield,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.513: D., and Downward, J. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Downward, J."
Processing 00000000.tx.514: (1994) Nature 370, 527-532[CrossRef][Medline] [OrderarticleviaInfotrieve] 15. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Nature 370,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "527-532"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 15."
Processing 00000000.tx.515: Franke, T. 

Phrase: "Franke,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.516: F., Yang, S. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.517: I., Chan, T. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Chan,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.518: O., Datta, K., Kazlauskas, A., Morrison, D. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Datta,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kazlauskas,"

Phrase: "A.,"

Phrase: "Morrison,"

Phrase: "D."
Processing 00000000.tx.519: K., Kaplan, D. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kaplan,"

Phrase: "D."
Processing 00000000.tx.520: R., and Tsichlis, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Tsichlis,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.521: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.522: (1995) Cell 81, 727-736[Medline] [OrderarticleviaInfotrieve] 16. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cell 81,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "727-736"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 16."
Processing 00000000.tx.523: Burgering, B. 

Phrase: "Burgering,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.524: M., and Coffer, P. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Coffer,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.525: J. 

Phrase: "J."
Processing 00000000.tx.526: (1995) Nature 376, 599-602[CrossRef][Medline] [OrderarticleviaInfotrieve] 17. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nature 376,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "599-602"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 17."
Processing 00000000.tx.527: Shao, H., Kadono-Okuda, K., Finlin, B. 

Phrase: "Shao,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kadono-Okuda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Finlin,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.528: S., and Andres, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Andres,"

Phrase: "D."
Processing 00000000.tx.529: A. 

Phrase: "A."
Processing 00000000.tx.530: (1999) Arch. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.531: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.532: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.533: 371, 207-219[CrossRef][Medline] [OrderarticleviaInfotrieve] 18. 

Phrase: "371,"

Phrase: "207-219"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 18."
Processing 00000000.tx.534: Vojtek, A. 

Phrase: "Vojtek,"

Phrase: "A."
Processing 00000000.tx.535: B., Hollenberg, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hollenberg,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.536: M., and Cooper, J. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.537: A. 

Phrase: "A."
Processing 00000000.tx.538: (1993) Cell 74, 205-214[Medline] [OrderarticleviaInfotrieve] 19. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Cell 74,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "205-214"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 19."
Processing 00000000.tx.539: James, P., Halladay, J., and Craig, E. 

Phrase: "James,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Halladay,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Craig,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551776:Craig [Population Group]

Phrase: "E."
Processing 00000000.tx.540: A. 

Phrase: "A."
Processing 00000000.tx.541: (1996) Genetics 144, 1425-1436[Abstract/Free FullText] 20. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Genetics 144,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]

Phrase: "1425-1436"

Phrase: "[Abstract/Free FullText"

Phrase: "] 20."
Processing 00000000.tx.542: Peterson, S. 

Phrase: "Peterson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.543: N., Trabalzini, L., Brtva, T. 

Phrase: "N., Trabalzini,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Brtva,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.544: R., Fischer, T., Altschuler, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Fischer,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Altschuler,"

Phrase: "D."
Processing 00000000.tx.545: L., Martelli, P., Lapetina, E. 

Phrase: "L., Martelli,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lapetina,"

Phrase: "E."
Processing 00000000.tx.546: G., Der, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Der,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "C."
Processing 00000000.tx.547: J., and White, G. 

Phrase: "J.,"

Phrase: "and"

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.548: C., II (1996) J. 

Phrase: "C., II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547547:C-II [Regulation or Law]

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.549: Biol. 

Phrase: "Biol."
Processing 00000000.tx.550: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.551: 271, 29903-29908[Abstract/Free FullText] 21. 

Phrase: "271,"

Phrase: "29903-29908"

Phrase: "[Abstract/Free FullText"

Phrase: "] 21."
Processing 00000000.tx.552: Finlin, B. 

Phrase: "Finlin,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.553: S., and Andres, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Andres,"

Phrase: "D."
Processing 00000000.tx.554: A. 

Phrase: "A."
Processing 00000000.tx.555: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.556: Biol. 

Phrase: "Biol."
Processing 00000000.tx.557: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.558: 272, 21982-21988[Abstract/Free FullText] 22. 

Phrase: "272,"

Phrase: "21982-21988"

Phrase: "[Abstract/Free FullText"

Phrase: "] 22."
Processing 00000000.tx.559: Mattingly, R. 

Phrase: "Mattingly,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.560: R., Sorisky, A., Brann, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Sorisky,"

Phrase: "A.,"

Phrase: "Brann,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.561: R., and Macara, I. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Macara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3428317:Macara [Eukaryote]

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.562: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.563: (1994) Mol. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.564: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.565: Biol. 

Phrase: "Biol."
Processing 00000000.tx.566: 14, 7943-7952[Abstract] 23. 

Phrase: "14,"

Phrase: "7943-7952"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.567: Andres, D. 

Phrase: "Andres,"

Phrase: "D."
Processing 00000000.tx.568: A., Shao, H., Crick, D. 

Phrase: "A.,"

Phrase: "Shao,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Crick,"

Phrase: "D."
Processing 00000000.tx.569: C., and Finlin, B. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Finlin,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.570: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.571: (1997) Arch. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.572: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.573: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.574: 346, 113-124[CrossRef][Medline] [OrderarticleviaInfotrieve] 24. 

Phrase: "346,"

Phrase: "113-124"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 24."
Processing 00000000.tx.575: Moolenaar, W. 

Phrase: "Moolenaar,"

Phrase: "W."
Processing 00000000.tx.576: H., Kranenburg, O., Postma, F. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kranenburg,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Postma,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.577: R., and Zondag, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Zondag,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.578: C. 

Phrase: "C."
Processing 00000000.tx.579: (1997) Curr. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.580: Opin. 

Phrase: "Opin."
Processing 00000000.tx.581: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.582: 9, 168-173[CrossRef][Medline] [OrderarticleviaInfotrieve] 25. 

Phrase: "9,"

Phrase: "168-173"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 25."
Processing 00000000.tx.583: de Rooij, J., and Bos, J. 

Phrase: "de Rooij,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Bos,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265514:BOS [Disease or Syndrome]
  1000   C1265540:Bos [Mammal]

Phrase: "J."
Processing 00000000.tx.584: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.585: (1997) Oncogene 14, 623-625[CrossRef][Medline] [OrderarticleviaInfotrieve] 26. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Oncogene 14,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "623-625"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 26."
Processing 00000000.tx.586: Taylor, S. 

Phrase: "Taylor,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.587: J., and Shalloway, D. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Shalloway,"

Phrase: "D."
Processing 00000000.tx.588: (1996) Curr. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.589: Biol. 

Phrase: "Biol."
Processing 00000000.tx.590: 6, 1621-1627[Medline] [OrderarticleviaInfotrieve] 27. 

Phrase: "6,"

Phrase: "1621-1627"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 27."
Processing 00000000.tx.591: Hofer, F., Berdeaux, R., and Martin, G. 

Phrase: "Hofer,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Berdeaux,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Martin,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.592: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.593: (1998) Curr. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.594: Biol. 

Phrase: "Biol."
Processing 00000000.tx.595: 8, 839-842[Medline] [OrderarticleviaInfotrieve] 28. 

Phrase: "8,"

Phrase: "839-842"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 28."
Processing 00000000.tx.596: Finlin, B. 

Phrase: "Finlin,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.597: S., and Andres, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Andres,"

Phrase: "D."
Processing 00000000.tx.598: A. 

Phrase: "A."
Processing 00000000.tx.599: (1999) Arch. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.600: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.601: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.602: 368, 401-412[CrossRef][Medline] [OrderarticleviaInfotrieve] 29. 

Phrase: "368,"

Phrase: "401-412"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 29."
Processing 00000000.tx.603: Albright, C. 

Phrase: "Albright,"

Phrase: "C."
Processing 00000000.tx.604: F., Giddings, B. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Giddings,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.605: W., Liu, J., Vito, M., and Weinberg, R. 

Phrase: "W., Liu,"

Phrase: "J.,"

Phrase: "Vito,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Weinberg,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.606: A. 

Phrase: "A."
Processing 00000000.tx.607: (1993) EMBO J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.608: 12, 339-347[Abstract] 30. 

Phrase: "12,"

Phrase: "339-347"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 30."
Processing 00000000.tx.609: Wolthuis, R. 

Phrase: "Wolthuis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.610: M., Bauer, B., van't Veer, L. 

Phrase: "M."

Phrase: ","

Phrase: "Bauer,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "van't"

Phrase: "Veer"

Phrase: ","

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.611: J., de Vries-Smits, A. 

Phrase: "J.,"

Phrase: "de Vries-Smits,"

Phrase: "A."
Processing 00000000.tx.612: M., Cool, R. 

Phrase: "M."

Phrase: ","

Phrase: "Cool,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548792:Cool [Qualitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.613: H., Spaargaren, M., Wittinghofer, A., Burgering, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Spaargaren,"

Phrase: "M."

Phrase: ","

Phrase: "Wittinghofer,"

Phrase: "A.,"

Phrase: "Burgering,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.614: M., and Bos, J. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Bos,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265514:BOS [Disease or Syndrome]
  1000   C1265540:Bos [Mammal]

Phrase: "J."
Processing 00000000.tx.615: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.616: (1996) Oncogene 13, 353-362[Medline] [OrderarticleviaInfotrieve] 31. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Oncogene 13,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "353-362"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.617: Kikuchi, A., Demo, S. 

Phrase: "Kikuchi,"

Phrase: "A.,"

Phrase: "Demo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.618: D., Ye, Z. 

Phrase: "D."

Phrase: ","

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "Z."
Processing 00000000.tx.619: H., Chen, Y. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "Y."
Processing 00000000.tx.620: W., and Williams, L. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Williams,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.621: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.622: (1994) Mol. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.623: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.624: Biol. 

Phrase: "Biol."
Processing 00000000.tx.625: 14, 7483-7491[Abstract] 32. 

Phrase: "14,"

Phrase: "7483-7491"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 32."
Processing 00000000.tx.626: Kozak, M. 

Phrase: "Kozak,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.627: (1984) Nucleic Acids Res. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.628: 12, 857-872[Abstract] 33. 

Phrase: "12,"

Phrase: "857-872"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 33."
Processing 00000000.tx.629: Spaargaren, M., and Bischoff, J. 

Phrase: "Spaargaren,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Bischoff,"

Phrase: "J."
Processing 00000000.tx.630: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.631: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.632: Natl. 

Phrase: "Natl."
Processing 00000000.tx.633: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.634: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.635: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.636: 91, 12609-12613[Abstract/Free FullText] 34. 

Phrase: "91,"

Phrase: "12609-12613"

Phrase: "[Abstract/Free FullText"

Phrase: "] 34."
Processing 00000000.tx.637: Hofer, F., Fields, S., Schneider, C., and Martin, G. 

Phrase: "Hofer,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Fields,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   966   C1521738:Field [Conceptual Entity]
   966   C2346620:Field [Conceptual Entity]
   966   C2349184:Field [Conceptual Entity]
   966   C3539073:FIELD [Spatial Concept]

Phrase: "S."

Phrase: ","

Phrase: "Schneider,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Martin,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.638: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.639: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.640: Natl. 

Phrase: "Natl."
Processing 00000000.tx.641: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.642: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.643: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.644: 91, 11089-11093[Abstract/Free FullText] 35. 

Phrase: "91,"

Phrase: "11089-11093"

Phrase: "[Abstract/Free FullText"

Phrase: "] 35."
Processing 00000000.tx.645: Herrmann, C., Horn, G., Spaargaren, M., and Wittinghofer, A. 

Phrase: "Herrmann,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Horn,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019939:Horn [Body Part, Organ, or Organ Component]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Spaargaren,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Wittinghofer,"

Phrase: "A."
Processing 00000000.tx.646: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.647: Biol. 

Phrase: "Biol."
Processing 00000000.tx.648: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.649: 271, 6794-6800[Abstract/Free FullText] 36. 

Phrase: "271,"

Phrase: "6794-6800"

Phrase: "[Abstract/Free FullText"

Phrase: "] 36."
Processing 00000000.tx.650: Yu, H., Chen, J. 

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "J."
Processing 00000000.tx.651: K., Feng, S., Dalgarno, D. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Feng,"

Phrase: "S."

Phrase: ","

Phrase: "Dalgarno,"

Phrase: "D."
Processing 00000000.tx.652: C., Brauer, A. 

Phrase: "C., Brauer,"

Phrase: "A."
Processing 00000000.tx.653: W., and Schreiber, S. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Schreiber,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.654: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.655: (1994) Cell 76, 933-945[Medline] [OrderarticleviaInfotrieve] 37. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Cell 76,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "933-945"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 37."
Processing 00000000.tx.656: Vojtek, A. 

Phrase: "Vojtek,"

Phrase: "A."
Processing 00000000.tx.657: B., and Hollenberg, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Hollenberg,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.658: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.659: (1995) Methods Enzymol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.660: 255, 331-342[Medline] [OrderarticleviaInfotrieve] 38. 

Phrase: "255,"

Phrase: "331-342"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 38."
Processing 00000000.tx.661: Rodriguez-Viciana, P., Warne, P. 

Phrase: "Rodriguez-Viciana,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Warne,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.662: H., Khwaja, A., Marte, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Khwaja,"

Phrase: "A.,"

Phrase: "Marte,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.663: M., Pappin, D., Das, P., Waterfield, M. 

Phrase: "M."

Phrase: ","

Phrase: "Pappin,"

Phrase: "D."

Phrase: ","

Phrase: "Das,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0051767:DAS [Organic Chemical,Pharmacologic Substance]
  1000   C0057671:DAS [Organic Chemical,Pharmacologic Substance]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Waterfield,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.664: D., Ridley, A., and Downward, J. 

Phrase: "D."

Phrase: ","

Phrase: "Ridley,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Downward, J."
Processing 00000000.tx.665: (1997) Cell 89, 457-467[Medline] [OrderarticleviaInfotrieve] 39. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Cell 89,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "457-467"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 39."
Processing 00000000.tx.666: Wolthuis, R. 

Phrase: "Wolthuis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.667: M., and Bos, J. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Bos,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265514:BOS [Disease or Syndrome]
  1000   C1265540:Bos [Mammal]

Phrase: "J."
Processing 00000000.tx.668: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.669: (1999) Curr. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.670: Opin. 

Phrase: "Opin."
Processing 00000000.tx.671: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.672: &Dev. 

Phrase: "&Dev."
Processing 00000000.tx.673: 9, 112-117[CrossRef][Medline] [OrderarticleviaInfotrieve] 40. 

Phrase: "9,"

Phrase: "112-117"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.674: Reuther, G. 

Phrase: "Reuther,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.675: W., and Der, C. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Der,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "C."
Processing 00000000.tx.676: J. 

Phrase: "J."
Processing 00000000.tx.677: (2000) Curr. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.678: Opin. 

Phrase: "Opin."
Processing 00000000.tx.679: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.680: 12, 157-165[CrossRef][Medline] [OrderarticleviaInfotrieve] 41. 

Phrase: "12,"

Phrase: "157-165"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 41."
Processing 00000000.tx.681: Lee, C. 

Phrase: "Lee,"

Phrase: "C."
Processing 00000000.tx.682: H.J., Della, N. 

Phrase: "H.J.,"

Phrase: "Della,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.683: G., Chew, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Chew,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024888:chew [Organ or Tissue Function]
  1000   C0699816:chew [Finding]
  1000   C1549534:Chew [Functional Concept]

Phrase: "C."
Processing 00000000.tx.684: E., and Zack, D. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Zack,"

Phrase: "D."
Processing 00000000.tx.685: J. 

Phrase: "J."
Processing 00000000.tx.686: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.687: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.688: 16, 6784-6794[Abstract/Free FullText] 42. 

Phrase: "16,"

Phrase: "6784-6794"

Phrase: "[Abstract/Free FullText"

Phrase: "] 42."
Processing 00000000.tx.689: Fam, N. 

Phrase: "Fam,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541878:FAM [Gene or Genome]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.690: P., Fan, W. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Fan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441039:Fan [Manufactured Object]
  1000   C1705854:Fan [Manufactured Object]
  1000   C3540815:FAN [Gene or Genome]

Phrase: "W."
Processing 00000000.tx.691: T., Wang, Z., Zhang, L. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Wang,"

Phrase: "Z.,"

Phrase: "Zhang,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.692: J., Chen, H., and Moran, M. 

Phrase: "J.,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Moran,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945650:moran [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.693: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.694: (1997) Mol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.695: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.696: Biol. 

Phrase: "Biol."
Processing 00000000.tx.697: 17, 1396-1406[Abstract] 43. 

Phrase: "17,"

Phrase: "1396-1406"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 43."
Processing 00000000.tx.698: Wolthuis, R. 

Phrase: "Wolthuis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.699: M., Franke, B., van Triest, M., Bauer, B., Cool, R. 

Phrase: "M."

Phrase: ","

Phrase: "Franke,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "van Triest,"

Phrase: "M."

Phrase: ","

Phrase: "Bauer,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Cool,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548792:Cool [Qualitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.700: H., Camonis, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Camonis,"

Phrase: "J."
Processing 00000000.tx.701: H., Akkerman, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Akkerman,"

Phrase: "J."
Processing 00000000.tx.702: W., and Bos, J. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Bos,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265514:BOS [Disease or Syndrome]
  1000   C1265540:Bos [Mammal]

Phrase: "J."
Processing 00000000.tx.703: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.704: (1998) Mol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.705: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.706: Biol. 

Phrase: "Biol."
Processing 00000000.tx.707: 18, 2486-2491[Abstract/Free FullText] 44. 

Phrase: "18,"

Phrase: "2486-2491"

Phrase: "[Abstract/Free FullText"

Phrase: "] 44."
Processing 00000000.tx.708: Park, S. 

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.709: H., and Weinberg, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Weinberg,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.710: A. 

Phrase: "A."
Processing 00000000.tx.711: (1995) Oncogene 11, 2349-2355[Medline] [OrderarticleviaInfotrieve] 45. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Oncogene 11,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "2349-2355"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 45."
Processing 00000000.tx.712: Jullien-Flores, V., Dorseuil, O., Romero, F., Letourneur, F., Saragosti, S., Berger, R., Tavitian, A., Gacon, G., and Camonis, J. 

Phrase: "Jullien-Flores,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454740:Flores [Geographic Area]

Phrase: "V.,"

Phrase: "Dorseuil,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Romero,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Letourneur,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Saragosti,"

Phrase: "S."

Phrase: ","

Phrase: "Berger,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tavitian,"

Phrase: "A.,"

Phrase: "Gacon,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Camonis,"

Phrase: "J."
Processing 00000000.tx.713: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.714: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.715: Biol. 

Phrase: "Biol."
Processing 00000000.tx.716: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.717: 270, 22473-22477[Abstract/Free FullText] 46. 

Phrase: "270,"

Phrase: "22473-22477"

Phrase: "[Abstract/Free FullText"

Phrase: "] 46."
Processing 00000000.tx.718: Cantor, S. 

Phrase: "Cantor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108263:Cantor [Organic Chemical,Pharmacologic Substance]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.719: B., Urano, T., and Feig, L. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Urano,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Feig,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.720: A. 

Phrase: "A."
Processing 00000000.tx.721: (1995) Mol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.722: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.723: Biol. 

Phrase: "Biol."
Processing 00000000.tx.724: 15, 4578-4584[Abstract] 47. 

Phrase: "15,"

Phrase: "4578-4584"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 47."
Processing 00000000.tx.725: Wolthuis, R. 

Phrase: "Wolthuis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.726: M., de Ruiter, N. 

Phrase: "M."

Phrase: ","

Phrase: "de Ruiter,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.727: D., Cool, R. 

Phrase: "D."

Phrase: ","

Phrase: "Cool,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548792:Cool [Qualitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.728: H., and Bos, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Bos,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265514:BOS [Disease or Syndrome]
  1000   C1265540:Bos [Mammal]

Phrase: "J."
Processing 00000000.tx.729: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.730: (1997) EMBO J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.731: 16, 6748-6761[Abstract/Free FullText] 48. 

Phrase: "16,"

Phrase: "6748-6761"

Phrase: "[Abstract/Free FullText"

Phrase: "] 48."
Processing 00000000.tx.732: Murai, H., Ikeda, M., Kishida, S., Ishida, O., Okazaki-Kishida, M., Matsuura, Y., and Kikuchi, A. 

Phrase: "Murai,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Kishida,"

Phrase: "S."

Phrase: ","

Phrase: "Ishida,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Okazaki-Kishida,"

Phrase: "M."

Phrase: ","

Phrase: "Matsuura,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Kikuchi,"

Phrase: "A."
Processing 00000000.tx.733: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.734: Biol. 

Phrase: "Biol."
Processing 00000000.tx.735: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.736: 272, 10483-10490[Abstract/Free FullText] 49. 

Phrase: "272,"

Phrase: "10483-10490"

Phrase: "[Abstract/Free FullText"

Phrase: "] 49."
Processing 00000000.tx.737: Urano, T., Emkey, R., and Feig, L. 

Phrase: "Urano,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Emkey,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Feig,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.738: A. 

Phrase: "A."
Processing 00000000.tx.739: (1996) EMBO J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.740: 15, 810-816[Abstract] 50. 

Phrase: "15,"

Phrase: "810-816"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 50."
Processing 00000000.tx.741: Orita, S., Kaibuchi, K., Kuroda, S., Shimizu, K., Nakanishi, H., and Takai, Y. 

Phrase: "Orita,"

Phrase: "S."

Phrase: ","

Phrase: "Kaibuchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kuroda,"

Phrase: "S."

Phrase: ","

Phrase: "Shimizu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nakanishi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Takai,"

Phrase: "Y."
Processing 00000000.tx.742: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.743: Biol. 

Phrase: "Biol."
Processing 00000000.tx.744: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.745: 268, 25542-25546[Abstract/Free FullText] 51. 

Phrase: "268,"

Phrase: "25542-25546"

Phrase: "[Abstract/Free FullText"

Phrase: "] 51."
Processing 00000000.tx.746: Porfiri, E., Evans, T., Chardin, P., and Hancock, J. 

Phrase: "Porfiri,"

Phrase: "E.,"

Phrase: "Evans,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Chardin,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Hancock,"

Phrase: "J."
Processing 00000000.tx.747: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.748: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.749: Biol. 

Phrase: "Biol."
Processing 00000000.tx.750: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.751: 269, 22672-22677[Abstract/Free FullText] 52. 

Phrase: "269,"

Phrase: "22672-22677"

Phrase: "[Abstract/Free FullText"

Phrase: "] 52."
Processing 00000000.tx.752: Takai, Y., Kaibuchi, K., Kikuchi, A., and Kawata, M. 

Phrase: "Takai,"

Phrase: "Y.,"

Phrase: "Kaibuchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kikuchi,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Kawata,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.753: (1992) Int. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.754: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.755: Cytol. 

Phrase: "Cytol."
Processing 00000000.tx.756: 133, 187-230[Medline] [OrderarticleviaInfotrieve] 53. 

Phrase: "133,"

Phrase: "187-230"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 53."
Processing 00000000.tx.757: Bielinski, D. 

Phrase: "Bielinski,"

Phrase: "D."
Processing 00000000.tx.758: F., Pyun, H. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Pyun,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.759: Y., Linko-Stentz, K., Macara, I. 

Phrase: "Y.,"

Phrase: "Linko-Stentz,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Macara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3428317:Macara [Eukaryote]

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.760: G., and Fine, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Fine, R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.761: E. 

Phrase: "E."
Processing 00000000.tx.762: (1993) Biochim. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.763: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.764: Acta 1151, 246-256[Medline] [OrderarticleviaInfotrieve] 54. 

Phrase: "Acta 1151,"

Phrase: "246-256"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 54."
Processing 00000000.tx.765: Hinoi, T., Kishida, S., Koyama, S., Ikeda, M., Matsuura, Y., and Kikuchi, A. 

Phrase: "Hinoi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kishida,"

Phrase: "S."

Phrase: ","

Phrase: "Koyama,"

Phrase: "S."

Phrase: ","

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Matsuura,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Kikuchi,"

Phrase: "A."
Processing 00000000.tx.766: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.767: Biol. 

Phrase: "Biol."
Processing 00000000.tx.768: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.769: 271, 19710-19716[Abstract/Free FullText] 55. 

Phrase: "271,"

Phrase: "19710-19716"

Phrase: "[Abstract/Free FullText"

Phrase: "] 55."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]
Processing 00000000.tx.770: Nancy, V., Wolthuis, R. 

Phrase: "Nancy,"

Phrase: "V.,"

Phrase: "Wolthuis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.771: M., de Tand, M. 

Phrase: "M."

Phrase: ","

Phrase: "de Tand,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.772: F., Janoueix-Lerosey, I., Bos, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Janoueix-Lerosey,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Bos,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265514:BOS [Disease or Syndrome]
  1000   C1265540:Bos [Mammal]

Phrase: "J."
Processing 00000000.tx.773: L., and de Gunzburg, J. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "de Gunzburg,"

Phrase: "J."
Processing 00000000.tx.774: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.775: Biol. 

Phrase: "Biol."
Processing 00000000.tx.776: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.777: 274, 8737-8745[Abstract/Free FullText] 56. 

Phrase: "274,"

Phrase: "8737-8745"

Phrase: "[Abstract/Free FullText"

Phrase: "] 56."
Processing 00000000.tx.778: Jiang, H., Luo, J. 

Phrase: "Jiang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "J."
Processing 00000000.tx.779: Q., Urano, T., Frankel, P., Lu, Z., Foster, D. 

Phrase: "Q., Urano,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Frankel,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "Z.,"

Phrase: "Foster,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242298:foster [Daily or Recreational Activity]
  1000   C0344349:foster [Family Group]

Phrase: "D."
Processing 00000000.tx.780: A., and Feig, L. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Feig,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.781: A. 

Phrase: "A."
Processing 00000000.tx.782: (1995) Nature 378, 409-412[CrossRef][Medline] [OrderarticleviaInfotrieve] 57. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nature 378,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "409-412"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 57."
Processing 00000000.tx.783: White, M. 

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.784: A., Vale, T., Camonis, J. 

Phrase: "A.,"

Phrase: "Vale,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Camonis,"

Phrase: "J."
Processing 00000000.tx.785: H., Schaefer, E., and Wigler, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Schaefer,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Wigler,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.786: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.787: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.788: Biol. 

Phrase: "Biol."
Processing 00000000.tx.789: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.790: 271, 16439-16442[Abstract/Free FullText] 58. 

Phrase: "271,"

Phrase: "16439-16442"

Phrase: "[Abstract/Free FullText"

Phrase: "] 58."
Processing 00000000.tx.791: Lee, T., Feig, L., and Montell, D. 

Phrase: "Lee,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Feig,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Montell,"

Phrase: "D."
Processing 00000000.tx.792: J. 

Phrase: "J."
Processing 00000000.tx.793: (1996) Development 122, 409-418[Abstract/Free FullText] 59. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Development 122,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "409-418"

Phrase: "[Abstract/Free FullText"

Phrase: "] 59."
Processing 00000000.tx.794: Sawamoto, K., Winge, P., Koyama, S., Hirota, Y., Yamada, C., Miyao, S., Yoshikawa, S., Jin, M. 

Phrase: "Sawamoto,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Winge,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Koyama,"

Phrase: "S."

Phrase: ","

Phrase: "Hirota,"

Phrase: "Y.,"

Phrase: "Yamada,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Miyao,"

Phrase: "S."

Phrase: ","

Phrase: "Yoshikawa,"

Phrase: "S."

Phrase: ","

Phrase: "Jin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.795: H., Kikuchi, A., and Okano, H. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kikuchi,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Okano,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.796: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.797: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.798: 146, 361-372[Abstract/Free FullText] 60. 

Phrase: "146,"

Phrase: "361-372"

Phrase: "[Abstract/Free FullText"

Phrase: "] 60."
Processing 00000000.tx.799: Okazaki, M., Kishida, S., Hinoi, T., Hasegawa, T., Tamada, M., Kataoka, T., and Kikuchi, A. 

Phrase: "Okazaki,"

Phrase: "M."

Phrase: ","

Phrase: "Kishida,"

Phrase: "S."

Phrase: ","

Phrase: "Hinoi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hasegawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tamada,"

Phrase: "M."

Phrase: ","

Phrase: "Kataoka,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Kikuchi,"

Phrase: "A."
Processing 00000000.tx.800: (1997) Oncogene 14, 515-521[CrossRef][Medline] [OrderarticleviaInfotrieve] 61. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Oncogene 14,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "515-521"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 61."
Processing 00000000.tx.801: Miller, M. 

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.802: J., Prigent, S., Kupperman, E., Rioux, L., Park, S. 

Phrase: "J.,"

Phrase: "Prigent,"

Phrase: "S."

Phrase: ","

Phrase: "Kupperman,"

Phrase: "E.,"

Phrase: "Rioux,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.803: H., Feramisco, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Feramisco,"

Phrase: "J."
Processing 00000000.tx.804: R., White, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.805: A., Rutkowski, J. 

Phrase: "A.,"

Phrase: "Rutkowski,"

Phrase: "J."
Processing 00000000.tx.806: L., and Meinkoth, J. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Meinkoth,"

Phrase: "J."
Processing 00000000.tx.807: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.808: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.809: Biol. 

Phrase: "Biol."
Processing 00000000.tx.810: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.811: 272, 5600-5605[Abstract/Free FullText] 62. 

Phrase: "272,"

Phrase: "5600-5605"

Phrase: "[Abstract/Free FullText"

Phrase: "] 62."
Processing 00000000.tx.812: Thompson, J. 

Phrase: "Thompson,"

Phrase: "J."
Processing 00000000.tx.813: D., Higgins, D. 

Phrase: "D."

Phrase: ","

Phrase: "Higgins,"

Phrase: "D."
Processing 00000000.tx.814: G., and Gibson, T. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Gibson,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.815: J. 

Phrase: "J."
Processing 00000000.tx.816: (1994) Nucleic Acids Res. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.817: 22, 4673-4680[Abstract] Copyright  2000 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "22,"

Phrase: "4673-4680"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Copyright  2000 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

